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Abstract: Während der Entwicklung von mehrzelligen Organismen reagieren Zellen auf Signale in ihrer
Umgebung, welche in das Innere der Zellen geleitet werden und in verschiedene biologische Antworten
übersetzt werden, wie zum Beispiel Zellproliferation und Differenzierung. Entwicklungsbiologische Prozesse
werden von konservierten, komplexen Signal-Netzwerken reguliert, welche in verschiedenen Modellorgan-
ismen studiert werden können. Die Entwicklung des Reproduktionsorganes von C. elegans Hermaphroditen
dient als ein etabliertes Modellsystem um diese komplexen Signalwege zu analysieren. Die Vulva der C.
elegans Hermaphroditen entsteht aus drei von sechs äquipotenten Vulvavorläuferzellen (P3.p-P8.p). Die
Ankerzelle in der Gonade produziert den epidermalen Wachstumsfaktor (EGF), welcher den konservierten
EGF-Rezeptor/RAS/MAPK Signalweg in P6.p aktiviert und somit das primäre Zellschicksal ausführt.
Um das Signal der Ankerzelle zu empfangen, muss der EGF-Rezeptor in P6.p auf der der Ankerzelle
zugewandten basolateralen Plasmamembran lokalisiert sein. Die basolaterale Lokalisierung des EGF-
Rezeptors ist essentiell für eine effiziente Aktivierung des Signalweges und somit für die Initiierung der
Vulvaentwicklung. Ein Proteinkomplex mit den PDZ (PSD-95/Dlg/ZO-1)- Proteinen LIN-7, LIN-2 und
LIN-10 wird für die basolaterale Lokalisierung des EGF- Rezeptors benötigt. Interessanterweise sind
PDZ-Proteine oft Adaptoren, welche die subzelluläre Lokalisierung und Aktivität von Plasmamembran-
proteinen regulieren. Proteine mit FERM (Band 4.1/Ezrin/Radixin/Moesin)-Domänen sind bekannt
dafür mit PDZ- Proteinen zu interagieren um gemeinsam die Lokalisierung und die Aktivität von Trans-
membranproteinen zu regulieren. Mutationen im EGF-Rezeptor, welche zu einer Überexpression, konsti-
tutiver Aktivität oder Misslokalisierung führen, können zum Beispiel zu Krebs führen. Während meiner
Doktorarbeit identifizierte und charakterisierte ich zuvor unbekannte Proteine, welche die Lokalisierung
des C. elegans EGF-Rezeptors regulieren. Somit war es mir möglich, den Zusammenhang zwischen
der Rezeptorlokalisierung und dem Zellschicksal zu erforschen. Ein im Voraus durchgeführter kandi-
datenbasierter Ansatz mit Hilfe von RNA Interferenz war die Basis für ein Projekt dieser Studie. RNA
Interferenz gegen die Gene frm-8 und tag-60 supprimierte den let-60 ras(gf) Multivulva Phänotyp und mis-
lokalisierte den EGF-Rezeptor zu den “Junctions” und intrazellulären Kompartimenten. In dieser Studie
wurden die Deletionsmutanten frm-8(zh67) und tag-60(zh93) generiert. Dabei zeigte tag-60(zh93) starke
und frm-8(zh67) schwache genetische Interaktionen mit dem EGF-Rezeptor Signalweg. Die Charakter-
isierung der tag-60(zh93) Mutante zeigte, dass TAG-60 ein neuer Regulator der Vulvaentwicklung sein
könnte, welcher im Prozess der EGF-Rezeptor Lokalisierung in den Vulvavorläuferzellen involviert sein
könnte. ERM-1 in C. elegans ist das einzige orthologe Protein von Ezrin, Radixin und Moesin in H.
sapiens. ERM-1 wurde untersucht, weil es ein potentieller Interaktionspartner von TAG-60 ist. In dieser
Studie zeigen wir, dass ERM-1 ein neuartiger Inhibitor der Vulvaentwicklung ist, der möglicherweise die
EGF-Rezeptor Lokalisierung an der basolateralen Plasmamembran der Vulvavorläuferzellen reguliert.
In einem zweiten Ansatz wurde ein klassischer genetischer Screen für Multivulva Tiere in einem gap-
1(ga133) Hintergrund durchgeführt, um entweder Mutanten mit apikal mislokalisiertem EGF-Rezeptor,
oder Mutanten von Inhibitoren des EGFR/RAS/MAPK Signalweges zu finden. In diesem Screen wur-
den zwei fertile Mutanten mit apikal mislokalisiertem EGF-Rezeptor gefunden, welche neue Allele von
lin-2 und lin-7 darstellen. Zusätzlich wurden zwei Allele von den zuvor charakterisierten Genen let-
19 und gap-3 isoliert. Die Kartierung der zwei verbleibenden Mutanten zh78 und zh95 ist noch nicht
abgeschlossen. Die Lokalisierung des EGF-Rezeptors in diesen Mutanten scheint normal zu sein, was da-
rauf hindeutet, dass die Mutationen negative Regulatoren des EGF-Rezeptor Signalweges beeinträchtigen.
Um die Kartierung der isolierten Mutanten vom klassischen genetischen Screen zu erleichtern, wurde ein
gross angelegter RNAi Screen von den Klonen der Chromosomen I, II und III in einem gap-1(lf) Hin-
tergrund durchgeführt. Sechsunddreissig Kandidatengene wurden gefunden, welche einen synthetischen
Multivulva Phänotyp in Kombination mit gap- 1(lf) zeigen. Dabei wurden zuvor charakterisierte negative
Regulatoren wie puf-8, fbf-1 und fbf-2, aber auch neue genetische Interaktoren von gap-1 identifiziert.
Diese Kandidaten müssen noch genauer analysiert werden und könnten sowohl Regulatoren der EGF-
Rezeptor Lokalisierung oder Inhibitoren der Vulvaentwicklung sein. Summary During the development
of multicellular organisms, cells respond to extracellular signals, which are transduced into the cells
and result in biological outcomes such as proliferation and differentiation. Developmental processes are
controlled by conserved complex signalling networks, which can be studied in model organisms. The
development of the egg-laying organ of the C. elegans hermaphrodite serves as a model system, in which
these complex signalling cascades can be analyzed. The C. elegans hermaphrodite vulva is formed from
the descendants of three out of six equipotent vulval precursor cells (VPCs, P3.p-P8.p). The gonadal
anchor cell (AC) produces the epidermal growth factor (EGF) that activates in P6.p the conserved EGF
receptor (EGFR)/RAS/MAPK pathway to specify the primary cell fate. In order to receive the AC
signal, the EGFR has to be kept on the basolateral surface of the VPCs facing the AC. The basolateral
localization of the EGFR is essential for the efficient activation of the RAS/MAPK signalling pathway
and consequently for correct vulval induction. A ternary complex formed by the PDZ domain proteins
LIN-7, LIN-2 and LIN-10 is required for EGFR localization to the basolateral compartment of the VPCs.
Interestingly, PDZ domains are often found in adaptor proteins that regulate the subcellular localization
and activity of plasma membrane proteins. Proteins with FERM (Band 4.1/Ezrin/Radixin/Moesin)-
domains are known to associate with PDZ-proteins and have been shown to regulate the localization and
activity of transmembrane receptors in other model organisms. In humans, mutations in the EGFR that
lead to overexpression, constitutive activity or missorting lead to malignancies such as cancer. During
my thesis, I identified and characterized novel factors involved in C. elegans EGFR localization and
explored the connection of receptor trafficking with cell fate specification. For this purpose, different
genetic approaches were used. A candidate-based approach involving RNAi had been used in a pre-
ceding screen. RNAi against frm-8 and tag-60 suppressed the let-60 ras(gf) Multivulva phenotype and
mislocalized EGFR to the junctional region and to intracellular punctae. In this study, the deletion
mutants frm-8(zh67) and tag-60(zh93) were generated, which showed that tag-60(zh93) had strong, and
frm-8(zh67) weak genetic interactions with the inductive EGFR signalling pathway. Characterization of
the tag-60(zh93) mutants indicated that TAG-60 is a novel regulator of vulval development, which might
be involved in EGFR localization in the VPCs. erm-1 is the only ortholog of Ezrin, Radixin and Moesin
in C. elegans. ERM-1 was studied because it is a putative binding partner of TAG-60. In this study,
we present evidence that ERM-1 is a novel attenuator of vulval development, possibly by regulating the
localization of EGFR at the basolateral plasma membrane of the VPCs. In a second approach, a forward
genetic screen for synthetic Multivulva animals in a gap-1(lf) background was performed to find mutants
that display mislocalized EGFR or mutants in inhibitors of the EGFR/RAS/MAPK pathway. In this
screen, we isolated two fertile mutants with apically mislocalized EGFR, which represent novel alleles
of lin-2 and lin-7. Additionally, we isolated two alleles of the previously characterized genes let-19 and
gap-3. The two remaining mutants zh78 and zh95 are still in the mapping process. EGFR localization
seems to be normal in these mutants, indicating that the mutations affect negative regulators of the
EGFR pathway. A preliminary genomewide RNAi screen of chromosomes I, II and III in a gap-1(lf)
background was performed in order to facilitate the mapping process of the mutants isolated in the for-
ward genetic screen. Thirty-six high confidence candidate genes were found, which showed a synthetic
Multivulva phenotype in combination with gap-1(lf). The candidates include not only formerly charac-
terized negative regulators such as puf-8, fbf-1 and fbf-2, but also many novel genetic interactors of gap-1.
These candidates have yet to be analyzed in more detail and could either encode regulators of EGFR
localization or attenuators of vulval development.
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Zusammenfassung 
 
Während der Entwicklung von mehrzelligen Organismen reagieren Zellen auf Signale in ihrer 
Umgebung, welche in das Innere der Zellen geleitet werden und in verschiedene biologische 
Antworten übersetzt werden, wie zum Beispiel Zellproliferation und Differenzierung. 
Entwicklungsbiologische Prozesse werden von konservierten, komplexen Signal-Netzwerken 
reguliert, welche in verschiedenen Modellorganismen studiert werden können. Die 
Entwicklung des Reproduktionsorganes von C. elegans Hermaphroditen dient als ein 
etabliertes Modellsystem um diese komplexen Signalwege zu analysieren. 
Die Vulva der C. elegans Hermaphroditen entsteht aus drei von sechs äquipotenten 
Vulvavorläuferzellen (P3.p-P8.p). Die Ankerzelle in der Gonade produziert den epidermalen 
Wachstumsfaktor (EGF), welcher den konservierten EGF-Rezeptor/RAS/MAPK Signalweg 
in P6.p aktiviert und somit das primäre Zellschicksal ausführt. Um das Signal der Ankerzelle 
zu empfangen, muss der EGF-Rezeptor in P6.p auf der der Ankerzelle zugewandten 
basolateralen Plasmamembran lokalisiert sein. Die basolaterale Lokalisierung des EGF-
Rezeptors ist essentiell für eine effiziente Aktivierung des Signalweges und somit für die 
Initiierung der Vulvaentwicklung. Ein Proteinkomplex mit den PDZ (PSD-95/Dlg/ZO-1)-
Proteinen LIN-7, LIN-2 und LIN-10 wird für die basolaterale Lokalisierung des EGF-
Rezeptors benötigt. Interessanterweise sind PDZ-Proteine oft Adaptoren, welche die 
subzelluläre Lokalisierung und Aktivität von Plasmamembranproteinen regulieren. Proteine 
mit FERM (Band 4.1/Ezrin/Radixin/Moesin)-Domänen sind bekannt dafür mit PDZ-
Proteinen zu interagieren um gemeinsam die Lokalisierung und die Aktivität von 
Transmembranproteinen zu regulieren. 
Mutationen im EGF-Rezeptor, welche zu einer Überexpression, konstitutiver Aktivität oder 
Misslokalisierung führen, können zum Beispiel zu Krebs führen. Während meiner 
Doktorarbeit identifizierte und charakterisierte ich zuvor unbekannte Proteine, welche die 
Lokalisierung des C. elegans EGF-Rezeptors regulieren. Somit war es mir möglich, den 
Zusammenhang zwischen der Rezeptorlokalisierung und dem Zellschicksal zu erforschen. 
Ein im Voraus durchgeführter kandidatenbasierter Ansatz mit Hilfe von RNA Interferenz war 
die Basis für ein Projekt dieser Studie. RNA Interferenz gegen die Gene frm-8 und tag-60 
supprimierte den let-60 ras(gf) Multivulva Phänotyp und mislokalisierte den EGF-Rezeptor 
zu den “Junctions” und intrazellulären Kompartimenten. In dieser Studie wurden die 
Deletionsmutanten frm-8(zh67) und tag-60(zh93) generiert. Dabei zeigte tag-60(zh93) starke 
und frm-8(zh67) schwache genetische Interaktionen mit dem EGF-Rezeptor Signalweg. Die 
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Charakterisierung der tag-60(zh93) Mutante zeigte, dass TAG-60 ein neuer Regulator der 
Vulvaentwicklung sein könnte, welcher im Prozess der EGF-Rezeptor Lokalisierung in den 
Vulvavorläuferzellen involviert sein könnte. 
ERM-1 in C. elegans ist das einzige orthologe Protein von Ezrin, Radixin und Moesin in H. 
sapiens. ERM-1 wurde untersucht, weil es ein potentieller Interaktionspartner von TAG-60 
ist. In dieser Studie zeigen wir, dass ERM-1 ein neuartiger Inhibitor der Vulvaentwicklung ist, 
der möglicherweise die EGF-Rezeptor Lokalisierung an der basolateralen Plasmamembran 
der Vulvavorläuferzellen reguliert. 
In einem zweiten Ansatz wurde ein klassischer genetischer Screen für Multivulva Tiere in 
einem gap-1(ga133) Hintergrund durchgeführt, um entweder Mutanten mit apikal 
mislokalisiertem EGF-Rezeptor, oder Mutanten von Inhibitoren des EGFR/RAS/MAPK 
Signalweges zu finden. In diesem Screen wurden zwei fertile Mutanten mit apikal 
mislokalisiertem EGF-Rezeptor gefunden, welche neue Allele von lin-2 und lin-7 darstellen. 
Zusätzlich wurden zwei Allele von den zuvor charakterisierten Genen let-19 und gap-3 
isoliert. Die Kartierung der zwei verbleibenden Mutanten zh78 und zh95 ist noch nicht 
abgeschlossen. Die Lokalisierung des EGF-Rezeptors in diesen Mutanten scheint normal zu 
sein, was darauf hindeutet, dass die Mutationen negative Regulatoren des EGF-Rezeptor 
Signalweges beeinträchtigen. 
Um die Kartierung der isolierten Mutanten vom klassischen genetischen Screen zu 
erleichtern, wurde ein gross angelegter RNAi Screen von den Klonen der Chromosomen I, II 
und III in einem gap-1(lf) Hintergrund durchgeführt. Sechsunddreissig Kandidatengene 
wurden gefunden, welche einen synthetischen Multivulva Phänotyp in Kombination mit gap-
1(lf) zeigen. Dabei wurden zuvor charakterisierte negative Regulatoren wie puf-8, fbf-1 und 
fbf-2, aber auch neue genetische Interaktoren von gap-1 identifiziert. Diese Kandidaten 
müssen noch genauer analysiert werden und könnten sowohl Regulatoren der EGF-Rezeptor 
Lokalisierung oder Inhibitoren der Vulvaentwicklung sein. 
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Summary 
 
During the development of multicellular organisms, cells respond to extracellular signals, 
which are transduced into the cells and result in biological outcomes such as proliferation and 
differentiation. Developmental processes are controlled by conserved complex signalling 
networks, which can be studied in model organisms. The development of the egg-laying 
organ of the C. elegans hermaphrodite serves as a model system, in which these complex 
signalling cascades can be analyzed. 
The C. elegans hermaphrodite vulva is formed from the descendants of three out of six 
equipotent vulval precursor cells (VPCs, P3.p-P8.p). The gonadal anchor cell (AC) produces 
the epidermal growth factor (EGF) that activates in P6.p the conserved EGF receptor 
(EGFR)/RAS/MAPK pathway to specify the primary cell fate. In order to receive the AC 
signal, the EGFR has to be kept on the basolateral surface of the VPCs facing the AC. The 
basolateral localization of the EGFR is essential for the efficient activation of the 
RAS/MAPK signalling pathway and consequently for correct vulval induction. A ternary 
complex formed by the PDZ domain proteins LIN-7, LIN-2 and LIN-10 is required for EGFR 
localization to the basolateral compartment of the VPCs. Interestingly, PDZ domains are often 
found in adaptor proteins that regulate the subcellular localization and activity of plasma 
membrane proteins. Proteins with FERM (Band 4.1/Ezrin/Radixin/Moesin)-domains are 
known to associate with PDZ-proteins and have been shown to regulate the localization and 
activity of transmembrane receptors in other model organisms. 
In humans, mutations in the EGFR that lead to overexpression, constitutive activity or 
missorting lead to malignancies such as cancer. During my thesis, I identified and 
characterized novel factors involved in C. elegans EGFR localization and explored the 
connection of receptor trafficking with cell fate specification. For this purpose, different 
genetic approaches were used. 
A candidate-based approach involving RNAi had been used in a preceding screen. RNAi 
against frm-8 and tag-60 suppressed the let-60 ras(gf) Multivulva phenotype and mislocalized 
EGFR to the junctional region and to intracellular punctae. In this study, the deletion mutants 
frm-8(zh67) and tag-60(zh93) were generated, which showed that tag-60(zh93) had strong, 
and frm-8(zh67) weak genetic interactions with the inductive EGFR signalling pathway. 
Characterization of the tag-60(zh93) mutants indicated that TAG-60 is a novel regulator of 
vulval development, which might be involved in EGFR localization in the VPCs.  
 10 
erm-1 is the only ortholog of Ezrin, Radixin and Moesin in C. elegans. ERM-1 was studied 
because it is a putative binding partner of TAG-60. In this study, we present evidence that 
ERM-1 is a novel attenuator of vulval development, possibly by regulating the localization of 
EGFR at the basolateral plasma membrane of the VPCs.  
In a second approach, a forward genetic screen for synthetic Multivulva animals in a gap-1(lf) 
background was performed to find mutants that display mislocalized EGFR or mutants in 
inhibitors of the EGFR/RAS/MAPK pathway. In this screen, we isolated two fertile mutants 
with apically mislocalized EGFR, which represent novel alleles of lin-2 and lin-7. 
Additionally, we isolated two alleles of the previously characterized genes let-19 and gap-3. 
The two remaining mutants zh78 and zh95 are still in the mapping process. EGFR localization 
seems to be normal in these mutants, indicating that the mutations affect negative regulators 
of the EGFR pathway. 
A preliminary genomewide RNAi screen of chromosomes I, II and III in a gap-1(lf) 
background was performed in order to facilitate the mapping process of the mutants isolated 
in the forward genetic screen. Thirty-six high confidence candidate genes were found, which 
showed a synthetic Multivulva phenotype in combination with gap-1(lf). The candidates 
include not only formerly characterized negative regulators such as puf-8, fbf-1 and fbf-2, but 
also many novel genetic interactors of gap-1. These candidates have yet to be analyzed in 
more detail and could either encode regulators of EGFR localization or attenuators of vulval 
development. 
 11 
Abbreviations 
 
1° primary 
2° secondary 
3° tertiary 
AC anchor cell 
CFP cyan fluorescent protein 
Chr. chromosome 
CSL CBF1/Su(H)/LAG-1 
DNA desoxyribonucleic acid 
Dpy dumpy: shortened body 
EBP-50 ERM binding phosphoprotein 50kDa 
EGF epidermal growth factor 
EGFR epidermal growth factor receptor 
EMS ethane methyl sulfonate 
ERM Ezrin / Radixin / Moesin 
EtOH ethanol 
F1 first filial generation 
F2 second filial generation 
FERM 4.1 protein / Ezrin / Radixin / Moesin 
FLP fragment length polymorphism 
GAP GTPase activating protein 
GEF guanine nucleotide exchange factor 
gf gain of function 
GFP green fluorescent protein 
GPCR G protein coupled receptor 
GTP guanosine -5’-triphosphate 
hyp hypodermis 
IPTG isopropyl -D-1-thiogalactopyranoside 
JA Julie Ahringer 
L1 – L4 larval stages 1 - 4 
LET lethal 
lf loss-of-function 
LG linkage group 
LIN lineage defective 
MAGUK membrane associated guanylate kinase 
MAPK mitogen activated protein kinase 
Muv multivulva 
N2 C. elegans wild-type strain 
Nf neurofibromatosis 
NGM nematode growth medium 
NHE-RF Sodium/Hydrogen exchanger regulatory factor 
P0 parental generation 
PCR polymerase chain reaction 
PDZ PSD-95 / Dlg / ZO-1 
PI3K phosphoinosite-3-kinase 
PLC phospho lipase C 
Pvl protruding vulva 
Q-H2O Mili-Q filtered water / sterile water 
RAS rat sarcoma 
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rf reduction-of-function 
RNA ribonucleic acid 
RNAi RNA interference 
RT room temperature 
RTK receptor tyrosine kinase 
SNP single nucleotide polymorphism 
SWL single worm lysate 
synMuv synthetic multivulva 
TAG temporary assigned gene name 
Unc uncoordinated 
VPC vulval precursor cells 
Vul Vulvaless 
WLB worm lysis buffer 
WT wild-type 
YFP yellow fluorescent protein 
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1. General introduction 
 
1.1 The ErbB signalling network 
Organs, which perform diverse highly specialised functions in the body of higher eukaryotes, 
are formed from many differently specified cells. Organogenesis during animal development 
is partly controlled by signals originating from the cellular environment surrounding the 
future organ. These intercellular signals are sensed by membrane localized receptors on the 
surface of the undifferentiated cells. The receptors transduce the signals into the cell and 
finally into the nucleus, where specific gene programs are activated to establish the 
corresponding cell fate. 
The ErbB family of receptor tyrosine kinases (RTK) consists of four members, namly EGFR 
(epidermal growth factor receptor)/ErbB1, ErbB2, ErbB3 and ErbB4 (Holbro and Hynes, 
2004). Each receptor type encodes an extracellular ligand binding domain, two cystein rich 
domains, a transmembrane domain, an intracellular tyrosine kinase domain and a carboxy-
terminus with several tyrosine residues, which serve as substrates for autophosphorylation 
events. These receptors have been implicated in various biological processes depending on 
the cellular context, including proliferation, differentiation, cell shape and contact 
establishment and motility. The ErbBs have been subject for extensive investigation for 
almost three decades, first of all because of their tumerogenic properties. It has been shown 
that in various types of cancer, ErbBs are overexpressed or harbour a mutation that renders 
them constitutively active (Yarden and Sliwkowski, 2001). 
In higher vertebrates, the ErbB signalling network is a sophisticated system composed of 
multiple levels that provide signal specificity and duration. First, different ligands harbouring 
EGF (epidermal growth factor)-like domains have various binding specificities towards the 
four ErbB receptors, meaning that the spacial and temporal control of ligand expression 
determines which receptor types are being activated (Riese and Stern, 1998). Second, the 
ErbBs have been shown to homo- or heterodimerize with each other upon ligand binding 
(Heldin 1995). 
Upon receptor activation, the intracellular kinase domain phosphorylates tyrosine residues on 
the C-terminus, which provides docking sites for a plethora of adaptor proteins or enzymes 
harbouring SH2 (Src-homology domain) or PTB (Phosphotyrosin binding)-domains (Sudol 
1998). The proto-oncogene Ras and the downstream MAPK (Mitogen activated protein 
kinase) cascade are almost invariant targets of all ErbB receptor combinations, but many other 
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signalling cascades have been associated with the ErbB network (Yarden and Sliwkowski, 
2001). 
 
1.2 Trafficking of ErbBs and its influence on signalling 
In addition to the signal specificity, the duration of the signalling event is an important 
determinant for the various biological outcomes. The major process for EGFR/ErbB1 
inactivation is initiated through receptor internalization via clathrin-coated vesicles (Hanover 
et al. 1984). Depending on the receptor-ligand combination (Muthuswamy et al. 1999), the 
pH of specialized endosomes results in dissociation of the ligand and subsequent recycling of 
the receptor to the cell surface (French et al. 1995). Persisting ligand-receptor complexes are 
thought to be ubiquitinated and targeted for lysosomal degradation in a Cbl (E3 ubiquitin 
ligase)-dependent manner (Levkowitz et al. 1998). ErbB2, ErbB3 and ErbB4 receptors were 
found to be endocytosis impaired and more often recycled back to the plasma membrane 
compared to EGFR/ErbB1 (Sorkin and Goh 2008). Trafficking of ErbB2-4 is much less 
understood but is believed to be based on clathrin-independent mechanisms (Baulida et al. 
1996). In general, the receptors undergo constant cycling between the cell surface and 
intracellular compartments. In the absence of the ligand, the EGFR is slowly internalized but 
quickly recycled back to the plasma membrane. In contrast, upon activation by EGF, the 
EGFR undergoes rapid internalization and is more frequently targeted to lysosomes for 
degradation (Wiley 2003). The dynamic distribution and the turn over of transmembrane 
proteins are in general dictated by specific trafficking motifs, which are typically found in the 
cytoplasmic domains (Mellman 1996). 
Importantly, receptor internalization is not a negative regulatory event per se. An interesting 
hypothesis emerged from different sources, which propose the existence of “signalling 
endosomes” (Sorkin and Von Zastrow, 2002). Experiments using conditional dynamin 
mutants with impaired receptor endocytosis showed that Ras can be activated from EGFR at 
the plasma membrane and endosomes, in contrast to PLC- (Phospholipase C ) and PI3K 
(Phosphatidylinsoitole-3 kinase), which are only activated by EGFR at the plasma membrane. 
Thus, the distribution of EGFR might modulate the specificity and duration of the signalling 
(Wiley 2003). 
In most human polarized epithelia cells, EGFR is predominantly displayed at the basolateral 
plasma membrane compartment, where it senses ligands originating from the underlying 
mesenchyme. However, mislocalization of the EGFR has direct consequences, as its ligands 
and substrates also show apical-basolateral polarity features. For example, the mislocalization 
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of EGFR to the apical membrane of renal tubular epithelial cells has been associated with 
autosomal dominant polycystic kidney disease (ADPKD or short PKD). The expansion of the 
renal tubules and the formation of multiple cysts is thought to be caused by overproliferation 
of the epithelia cells and by enhanced fluid secretion into the lumen. It was found that the cyst 
fluids possess high mitogenic potential towards renal epithelial cells (Du and Wilson 1995). 
The model suggests that these cells produce and secrete EGF into the lumen and that EGF is 
possibly necessary for epithelial repair and regeneration mechanisms (Du and Wilson 1995). 
Taken together, apically missorted EGFR is associated with ADPKD, where it is activated by 
autocrine EGF, leading to overproliferation of the epithelial cells (Du and Wilson 1995). 
 
1.3 PDZ-domains are interaction modules found in plasma membrane scaffold proteins 
Multiple PDZ (PSD-95/Dlg/ZO-1)-domain containing proteins function in the establishment 
and maintenance of epithelial apical-basolateral polarity (Fanning and Anderson, 1999). This 
polarity is maintained mainly by tight junctions, protein complex barriers that prevent passive 
translocation of transmembrane proteins and lipids from one plasma membrane compartment 
to the other (Tsukita et al. 2008). 
The polar distribution of transmembrane receptors or channels also require PDZ-scaffolds. 
This distribution is based on sorting mechanisms such as retention, recycling and targeting for 
lysosomal degradation mediated thorough PDZ proteins (Fanning and Anderson, 1999). In the 
case of ErbB2, it was shown that the PDZ protein ERBIN is a direct binding partner of the 
receptor in vitro and in vivo and is essential for basolateral restriction of the receptor in Caco-
2 (human colon carcinoma) and MDCK (Madin-Darby Canine Kidney) cells (Borg et al. 
2000). Interestingly, ErbB2 is the only member of the ErbB family that associates and 
depends on ERBIN (Borg et al. 2000). 
Another PDZ protein that has been shown to influence the localization of ErbB2 is called 
hLin-7/Veli. The N-terminal kinase interaction domain of hLin-7 directly binds to the kinase 
domain of ErbB2 and thereby promotes the basolateral targeting of the receptor (Shelly et al. 
2003). Moreover, the C-terminal PDZ domain of hLin-7 binds directly to the C-terminal tail 
(PDZ binding motif) of ErbB2, which stabilizes the receptor at the basolateral membrane, 
presumably by recruiting retention and/or recycling components (Shelly et al. 2003). 
The distribution of the transmembrane proteins has direct impact on their activity. 
Furthermore, PDZ domain proteins can also function as docking sites for receptor effectors or 
regulators (Brône and Eggermont 2005). 
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1.4 FERM-domain proteins: linkers between the membrane and the cytoskeleton 
The FERM (4.1 protein, Ezrin, Radixin, Moesin) family is essential for the attachment of 
transmembrane proteins or PDZ scaffolds at the cell periphery through its characteristic 
FERM domain (Bretscher et al. 2002). The subfamily of ERM-like proteins, which consist of 
Ezrin, Radixin and Moesin and the closely related tumor suppressor Nf2(Neurofibromastosis 
2)/Merlin, are believed to link plasma membrane proteins to the peripherical actin 
cytsokeleton and thus regulate the membrane distribution and activity of various receptors and 
channels (Chishti et al. 1998, Bretscher et al. 2002). Merlin was shown to be an important 
regulator of cellular proliferation in various model systems (Bretscher et al. 2002). However, 
the mechanism of its tumor suppressive function is not known in detail. Shaw et al. (2001) 
proposed that Merlin acts to negatively regulate Rac function, which was shown to have 
oncogenic properties. Curto et al. (2007) recently showed that Merlin functions in contact-
dependent inhibition of EGFR-signalling, which results in an attenuation of cell proliferation. 
 
1.5 The model organism Caenorhabditis elegans 
Evolutionarily distant organisms seem to share developmental mechanisms and underlying 
sigalling networks. This makes it possible to study developmental processes in lower 
organisms such as Caenorhabditis elegans. The Nobel Assembly awarded the Nobel prize in 
Physiology or Medicine for 2002 to Sydney Brenner, Robert Horvitz and John Sulston for 
their discoveries concerning genetic regulation of organ development and apoptosis in this 
nematode. 
C. elegans is a small nematode, measuring approximatively 1.5 mm in length and serves as a 
model organism to study animal development and behaviour (Brenner 1974). The wild-type 
strain (N2) was originally collected from a mushroom compost near Bristol, England 
(Brenner 1974). C. elegans is a predominantly hermaphroditic species and therefore, most 
populations in the wild consist of clones from one animal. The gender of C. elegans is defined 
by the ratio of autosomal to sex-chromosomes, hermaphrodites possess two X-chromosomes 
and males exhibit one (X0), which are generated by nondisjunction of the X-chromosome. 
The frequency of the appearance of males is about 0.1 %. 
There are many advantages in using C. elegans as an organism for genetic analysis. One 
hermaphrodite can give rise to 300 - 350 progeny and their life cycle is relatively rapid, taking 
only three days at 25°C. Before reaching the adult stage, the newly hatched C. elegans larvae 
undergo four larval stages (L1 to L4) that are separated by molting. The worms grow on agar 
plates and feed on genetically modified E. coli (OP-50). 
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The simplistic anatomy and the translucent nature of C. elegans make this nematode 
amenable to microscopical manipulations and analyses. Interestingly, there is very little 
variation in the cell lineage between wild-type individuals. Every division and migration of 
these invariant lineages is well known and described (Sulston and Horvitz, 1977). C. elegans 
can be stored long-term in liquid nitrogen or at –80°C. Therefore, it is possible to maintain a 
collection of genetically modified worms as stocks in a laboratory. 
Lastly, the complete sequencing of the C. elegans genome serves as an efficient tool for 
genetic analysis (The C. elegans Genome Sequencing Consortium, 1998). 
 
1.6 The EGFR system in C. elegans 
In contrast to four ErbB receptors in humans, C. elegans only encodes one EGFR like 
molecule called LET-23 (Aroian et al. 1991), which is essential for the development of many 
tissues and processes in C. elegans such as viability, vulval development, P12 fate 
determination, fertility and male spicule formation (Moghal and Sternberg, 2003). Many let-
23 alleles have reduced viability and have tissue-specific defects. For example, the allele sy1 
displays only vulval defects but does not affect the other tissues (Aroian et al. 1994). The sy1 
allele results in a C-terminal truncated form of LET-23, which disallows the interaction with 
the vulval specific component LIN-7 essential for vulval development (Kaech et al. 1998). 
The activation of LET-23 is thought to happen by the sole C. elegans epidermal growth factor 
(EGF) called LIN-3 (Moghal and Sternberg, 2003). However, the downstream signalling 
cascade is cell-context dependent. The small GTPase Ras for example acts downstream of 
LET-23 during the mechanisms involved in viability, vulval development, P12 fate 
determination and male spicule formation, but not during ovulation (Moghal and Sternberg, 
2003). 
Vulval development as a model system for LET-23 signalling has obvious advantages, as 
mutants of the LET-23 pathway have easily detectable phenotypes that are already observable 
under the dissecting microscope. Overactivation of the LET-23 pathway leads to ectopic 
induction of cells, normally determined to be fused with surrounding cells (Moghal and 
Sternberg, 2003). These ectopically induced cells lead to ventral protrusions called 
“pseudovulvae” and the phenotype referred to as “Multivulva” (Muv). In contrast, reduction 
of LET-23 signalling can lead to a partially or non-induced vulval tissue, resulting in a 
malformed or an absent vulva, which prevents the animal from laying the fertilized eggs 
(Moghal and Sternberg, 2003). Thus, underinduced animals exhibit the Vulvaless (Vul) 
General introduction 
 18 
 
phenotype. Some Vul mutant strains are viable, as the animals bloat with eggs, which hatch 
inside the mother animal (“bag of worms”). 
 
1.7 Vulval development 
The development of the C. elegans hermaphrodite vulva can be divided into three steps. First, 
the epithelial VPCs (Vulval Precursor Cells) are generated. Second, vulval patterning and 
development is triggered by a specialized gonadal cell called the Anchor Cell (AC). Third, the 
execution of the cell fates includes eversion after divisions along cell fate specific axis and 
morphogenesis forming the mature vulva (Sternberg 2005). 
 
1.7.1 Vulval induction and patterning 
Vulval cells are derived from the P cell lineage (Sulston and Horvitz, 1977). A total of 12 P 
cells migrate from the lateral sides of the worm to the ventral side during the L1 stage. 
Following cell migration, the P cells divide along the anterior-posterior axis. As a result, 12 
anterior P cells (Pn.a) divide and differentiate into neuronal cells, while 12 posterior P cells 
(Pn.p) form epidermal cells (Sulston and Horvitz, 1977). During the L2 stage, the 12 
epidermal Pn.p cells are aligned along the ventral midline. From these cells, P3.p to P8.p form 
equipotent Vulval precursor cells (VPCs) and the remaining cells, P1.p, P2.p and P9-12.p, 
fuse with the surrounding hypodermal syncitium hyp7. The six VPCs gain their potential to 
adopt a vulval fate by expressing the Hox factor LIN-39, which blocks their fusion to hyp7 
(Clark et al. 1993). Vulval development is triggered by a secreted signal originating from the 
somatic gonadal AC in the form of LIN-3 EGF (Hill and Sternberg 1992). 
 
1.7.2 The LET-23 EGFR pathway promotes the 1° vulval cell fate 
The AC is located dorsally of P6.p and produces the epidermal growth factor (EGF) 
orthologue LIN-3 (Hill and Sternberg 1992), which binds and activates the epidermal growth 
factor receptor (EGFR) orthologue LET-23 (Aroian et al. 1991). While LET-23 is expressed 
in all VPCs, P6.p (the VPC closest to the AC) receives the highest level of LIN-3 ligand 
(figure 1.1). LIN-3 is sequestered primarily by P6.p, but is also thought to be distributed 
gradually in the extracellular space, thus activating LET-23 in the remaining VPCs to a lesser 
extent (Sternberg and Horvitz, 1986; Katz et al. 1995). Binding of LIN-3 to LET-23 activates 
the evolutionary conserved Ras/MAPK pathway by similar mechanisms as found in 
mammalian systems (figure 1.1). Firstly, ligand binding leads to the dimerization and 
autophosphorylation of the receptor. This generates docking sites for the adaptor proteins like 
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SEM-5 Grb2 (Clark et al. 1992). Subsequent recruitment of SOS-1 (Chang et al. 2000), the 
RasGEF, leads to the activation of LET-60 RAS (Beitel et al. 1990) at peripherical 
membranes. As a result, the phosphorylation cascade of LIN-45/Raf (Han et al. 1993), MEK-
2/MEK (Wu et al. 1995, Kornfeld et al. 1995) and MPK-1/ERK (Lackner et al. 1994) is 
triggered. Activated MPK-1 translocates to the nucleus, where it phosphorylates different 
targets, including transcription factors, which control the expression of genes underlying the 
primary (1°) vulval fate (Sundaram, 2006). Two well characterized targets of MPK-1 are 
LIN-1, a transcription factor of the Ets family (Beitel et al. 1995) and LIN-31, a member of 
the forkhead family of transcription factors (Miller et al. 1993).  
Transcriptional targets of the LET-23 pathway include the gene egl-17, which encodes the C. 
elegans orthologue of the fibroblast growth factor FGF (Burdine et al. 1998) and lag-2, which 
represents a Delta-like Notch ligand (Chen and Greenwald 2004). 
 
1.7.3 The LIN-12 Notch pathway promotes the 2° vulval cell fate 
One of the downstream targets of LET-23 pathway is the gene lag-2 (Chen and Greenwald 
2004) that encodes a transmembrane ligand specific for LIN-12/Notch (figure 1.1 and 
Greenwald, 2005). Shortly after P6.p is induced, the LAG-2 ligand activates LIN-12 on the 
flanking VPCs P5.p and P7.p (Greenwald, 2005). Activated LIN-12 is proteolytically 
processed at the plasma membrane and the intracellular domain subsequently translocates into 
the nucleus.  In the nucleus it controls the expression of a variety of target genes together with 
the protein LAG-1 CSL (Greenwald, 2005). The LIN-12 target genes are believed to encode 
either factors responsible to adopt the secondary (2°) vulval fate or inhibitors of the LET-23 
pathway (figure 1.1 and Berset et al. 2001, Yoo et al. 2004). As mentioned above, the LET-23 
pathway is responsible for the establishment of the primary vulval fate. The LIN-12 pathway 
is also called the lateral inhibitory pathway, as it is crucial to inhibit the LET-23 pathway and 
therefore the primary vulval fate in P5.p and P7.p.  
 
1.7.4 GAP-1 is an inhibitor of LET-60 
The activity of the LET-23-pathway is tightly regulated, since aberrant signalling can lead to 
malformation of the vulval tissue and hence impairs the mating and egg-laying function of 
this organ. For example gap-1 encodes a RasGAP (GTPase activating protein), a negative 
regulator of LET-60 RAS (figure 1.1 and Hajnal et al. 1997). This small GTPase Ras switches 
from the active GTP-bound state to the incactive GDP-bound state (and vice versa). The 
hydrolysis of this step is performed by Ras itself, but is greatly enhanced by the GAP proteins 
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(Bollag and McCormick 1991, Boguski and McCormick 1993). gap-1 loss-of-function 
animals exhibit a wild-type phenotype but are thought to have elevated LET-60 signalling 
(Hajnal et al. 1997, Yoo et al. 2004). Interestingly, some combinations of loss-of-function 
alleles of gap-1 and other negative regulators (from which both are superficially wild-type) 
show a synthetic Muv phenotype (Gupta et al. 2006, Walser et al. 2006, Stetak et al. 2008). It 
is believed that by additionally removing the activity of another negative regulator, the 
signalling level overcomes a threshold, which leads to ectopic inductions. 
So far, three different RasGAPs with different tissue specificity have been identified: gap-1, 
gap-2 and gap-3 (Stetak et al. 2008). However, genetic analysis shows that only gap-1 and 
gap-3 act as negative regulators of vulval development. Consistently, double mutants of gap-
1(lf) with gap-3(lf) result in a Multivulva phenotype (Stetak et al. 2008, this study). 
 
1.7.5 LIP-1 is a negative regulator of MPK-1 
As mentioned above, the LIN-12 pathway is activated in P5.p and P7.p to inhibit the primary 
vulval fate in these cells. One of the key players in this lateral inhibition is LIP-1 (Lateral 
induced phosphatase) (Berset et al. 2001). Transcription of lip-1 is regulated by the LIN-12 
pathway (figure 1.1; Berset et al. 2001). It has been shown that LIP-1 interacts directly with 
and dephosphorylates MPK-1, which renders it inactive (Berset et al. 2001). The main focus 
of LIP-1 are the secondary VPCs, where it inhibits the LET-23 pathway at the level of MPK-1 
and consequently the 1° vulval fate (Berset et al. 2001). Transcription of other negative 
regulators of the LET-23 pathway have been found to be regulated by LIN-12, such as ark-1, 
dpy-23, lst-1, lst-2, lst-3 and lst-4 (Yoo et al. 2004). These studies show that a sophisticated 
crosstalk between the LET-23 and the LIN-12 pathway controls the patterning of the vulval 
cells. 
 
1.7.6 DEP-1 is a negative regulator of LET-23 
The existence of negative regulators of the inductive pathway within the 2° VPCs, whose 
transcription is independent from the LIN-12 pathway, was shown through the identification 
of dep-1 (figure 1.1; Berset et al. 2005). DEP-1 (Density enhanced phosphatase) is a receptor 
tyrosine phosphatase, which is thought to dephosphorylate activated LET-23. Interestingly, 
the subcellular localization of a DEP-1::GFP reporter is in peripherical intracellular punctae 
(Berset et al. 2005), suggesting internalized LET-23 is dephosphorylated by DEP-1. 
Presently, it is unknown which signals are responsible to transcribe and regulate the dep-1 
gene product. However, it was shown that DEP-1 expression is negatively regulated by SUR-
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2 in the 1° cells. SUR-2 is a component of the mediator complex that acts downstream of the 
EGFR/RAS/MAPK pathway to induce LIN-12 down-regulation (Berset et al. 2005).  
 
1.7.7 The synMuv genes negatively regulate vulval development 
The synMuv (synthetic Multivulva) genes ensure that the distal VPCs P3.p, P4.p and P8.p 
adopt the tertiary (3°) nonvulval fate (Fay and Yochem, 2007). The synMuv genes are 
grouped into three classes: A, B and C. Most of single mutants of the synMuv genes do not 
exhibit defects in vulval development. But a loss-of-function combination of a synMuv class 
A with a synMuv class B leads to a highly penetrant synthetic Muv phenotype (Fay and 
Yochem, 2007). Combining either two mutants of class A or class B does not have any impact 
on vulval development. The class C synMuvs elicit a Muv phenotype only in combination 
with mutants of either class A or class B (Fay and Yochem, 2007). Two kinds of mechanisms 
are proposed to fulfil the inhibitory function of the synMuv genes. Firstly, the repression of 
lin-3 transcription in hyp7 (Cui et al. 2006) and secondly, the repression of lin-39 in the distal 
VPCs, which promotes their fusion to hyp7 (Chen and Han 2001a).  
 
1.7.8 The small GTPase RHO-1 is a positive regulator of 1° cell fate specification 
Canevascini et al. (2005) demonstrated that Rho signalling positively regulates vulval 
development. Gain-of-function of ect-2, a gene encoding a RhoGEF (Guanine nucleotide 
exchange factor), exhibits a Multivulva phenotype in combination with a loss-of-function 
allele of gap-1. The ubiquitous expression of a dominant negative form of RHO-1 was 
sufficient to neutralize the effects provoked by the ect-2(gf) allele. Furthermore, it was found 
that ECT-2 most likely represents the GEF for RHO-1 and that this pathway feeds either 
upstream or at the level of the RasGEF SOS-1 (Canevascini et al. 2005). 
 
1.7.9 Execution of the vulval cell fates 
Both primary and secondary vulval lineages undergo three rounds of cell divisions 
(henceforth called 1-, 2-, 4- and 8-cell stage) (figure 1.2). P6.p gives rise to 8 descendants and 
P5.p and P7.p each give rise to 7 descendants. In the early L4 stage, the primary vulval cells 
detach from the cuticule and migrate dorsally, which induces the invagination of the vulval 
tissue. The secondary vulval cells facing the primary cells follow their neighbouring primary 
cells, resulting in the mid L4 stage structure called the “Christmas Tree” (figure 1.2 F). It is a 
symmetrical structure, where the primary cells constitute the upper building block of the 
“tree” and the secondary cells form the lateral branches of the “tree”.  Subsequent homotypic 
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fusion of the vulval cells lead to a stack of vulval rings (toroids) that form a tubular structure 
connecting the uterine tissue with the outside space (Sharma-Kishore et al. 1999). 
Vulval development is very sensitive to changes in gene function and these aberrations can be 
quantified by scoring the vulval induction index at the L4 stage, which ranges from 0 to 6. 
Additionally, hybrid inductions can occur when a VPC divides once and one daughter cell 
continues proliferating, while the other daughter cell arrests. This event is scored as an 
induction of 0.5.  
 
1.7.10 LET-23 expression and localization during vulval development 
As mentioned above, LET-23 is expressed in all VPCs at the time of induction and later on 
upregulated in P6.p and descendants, but downregulated in all remaining VPCs (Kaech et al. 
1998). The VPCs are polarized, much like all epithelial cells, with their plasma membrane 
divided into an apical and basolateral compartment by a large protein complex structure 
called apical junctions (Cox and Hardin, 2004). The C. elegans apical junctions represent one 
electrodense structure, which can be divided into 2 subcomplexes; First the HMR-1A 
(Cadherin)/HMP-1 (-Catenin)/HMP-2 (-catenin) complex and second the more basal DLG-
1 (Disks large) - AJM-1 (novel coiled-coil protein) complex (Cox and Hardin 2004). One of 
their function is to hinder membrane components from diffusing between different 
compartments. Since the AC faces the basolateral membrane of P6.p, LET-23 must be 
expressed on this side in order to process the inductive signal (Kaech et al. 1998). 
Immunostaining experiments show a predominant basolateral localization of LET-23 at the 
time of induction (figure 1.3 A, B), which is enhanced during vulval development (Kaech et 
al. 1998). Minor localization is found in intracellular punctae and in a sub apical compartment 
(Whitfield et al. 1999). Furthermore, correct basolateral targeting of LET-23 is crucial for 
proper vulval induction by the AC (Kaech et al. 1998, Whitfield et al. 1999). 
 
1.7.11 The ternary complex LIN-7/LIN-2/LIN-10 
Some of the first mutants with vulval phenotypes were isolated and published by Horvitz and 
Sulston in 1980. The mutants of the genes lin-2, lin-7 and lin-10, exhibit aberrant vulval 
lineages and were positionally mapped and characterized (Hoskins et al. 1996, Simske et al. 
1996). They have been shown to act as positive regulators of the LET-23 pathway as loss-of-
function mutants of these genes show a highly penetrant Vulvaless phenotype (Hoskins et al. 
1996, Simske et al. 1996). Visualization of LET-23 in these mutants revealed that the receptor 
was fully mislocalized to the apical compartment of the VPCs (figure 1.3 C, D) (Kaech et al. 
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1998, Whitfield et al. 1999). Similar localization of LET-23 was found in the let-23(sy1) 
hypomorphic allele (Kaech et al. 1998), encoding a LET-23 variant which lacks the five distal 
C-terminal amino acids (Aroian et al. 1994). The distal 3 amino acids represent the PDZ-
binding motif TCL, which constitutes a binding interface for the PDZ domain of LIN-7 
(Kaech et al. 1998).  
Sequence analysis of LIN-2, LIN-7 and LIN-10 showed that all three proteins harbour PDZ 
(PSD-95/Dlg/ZO-1) domains, known protein interaction modules (Kaech et al. 1998). Kaech 
et al. (1998) furthermore showed that LIN-2 directly binds both LIN-7 and LIN-10 
simultaneously in vitro. Altogether these results lead to the model in which the ternary 
complex, consisting of LIN-7, LIN-2 and LIN-10, binds to the C-terminus of LET-23 via 
LIN-7, thus targetting the receptor to the basolateral membrane of the VPCs (figure 1.3 E) 
(Kaech et al. 1998, Whitfield et al. 1999). 
Another positive regulator of LET-23 is EPS-8, a protein that is required for proper retention 
of LET-23 at the basolateral membrane (Stetak et al. 2006). Consequently, removal of EPS-8 
results in mislocalization of LET-23 to intracellular punctae (Stetak et al. 2006). Additionally, 
Stetak et al. (2006) showed that overexpression of EPS-8 in all six VPCs resulted in persisting 
LET-23 expression in these cells, indicating that EPS-8 functions to block degradation of the 
receptor. Lastly, it was found that EPS-8 function is dependent on LIN-2 but not on LIN-7 
(Stetak et al. 2006). 
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2. Objectives of this study 
 
The aim of my thesis was to identify and characterize novel proteins involved in the 
trafficking of the C. elegans EGF-receptor LET-23. It is the general belief that the localization 
of a receptor tyrosin kinase is directly coupled to the duration and specificity of the signalling. 
Therefore the targeting of EGFR LET-23 to specific membrane compartments has 
consequences in cell fate determination. In this study, C. elegans vulval development was 
used as a system to identify regulators of LET-23 localization by different genetic approaches. 
 
Our lab is especially interested in genes encoding PDZ-domains and FERM-domains. In a 
preceding candidate-based RNAi screen, genes encoding PDZ or FERM-domains were 
downregulated in let-60(gf) Multivulva animals to find genetic interactors of the LET-23 
pathway. RNAi experiments, which modulated the Muv phenotype, were repeated in wild-
type animals and LET-23 localization was assessed using immunostaining. The genes frm-8 
and tag-60 were found as candidate regulators of LET-23 localization (A. Stetak, unpublished 
results). The main project of my thesis was to generate deletion mutants of frm-8 and tag-60 
and to characterize their role in LET-23 localization and vulval development. ERM-1 was 
found to be a putative binding partner of TAG-60 and was as well part of the investigations 
presented in this study. 
 
In a second approach I performed a forward genetic screen for animals exhibiting a Muv 
phenotype in a gap-1(lf) sensitized background. In this screen I was hoping to find not only 
other negative regulators of the EGFR/Ras/MAPK pathway, but also proteins that are 
involved in the targeting of LET-23 to the basolateral membrane. Six mutants strains were 
isolated and the goal of this side project was to positionally map the mutations and to 
characterize one interesting candidate. 
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3. Part I: A reverse genetics approach to identify regulators of 
LET-23 localization 
 
3.1 Characterization of frm-8 
 
3.1.1 Preliminary data 
frm-8 is located on chromosome III and encodes a protein with one PDZ, one WW and one 
FERM-domain (Figure 3.1). A genetic interaction was previously found between frm-8 and 
let-60 Ras (A. Stetak, personal communication).  RNAi against frm-8 was found to suppress 
the Muv phenotype of the let-60(n1046gf) mutant in a candidate based RNAi screen (A. 
Stetak, personal communication). frm-8 RNAi suppressed the Muv phenotype of let-
60(n1046gf) from 5.4 to an average of 4.9 induced VPCs. In a subsequent experiment, 
downregulation of frm-8 by RNAi in the rrf-3(pk1426) RNAi hypersensitive background 
(Simmer et al. 2003) seemed to mislocalize LET-23 in the primary VPCs to the apical 
junctions and intracellular punctae (A. Stetak, personal communication). 
 
3.1.2 Isolation of the frm-8(zh67) allele 
In order to examine the function of frm-8, it was indispensable to generate a deletion mutant. 
Deletion libraries were screened as described in the Methods section, which led to the 
isolation of the frm-8(zh67) deletion allele that was subsequently backcrossed 8 times with 
wild-type. As shown in figure 3.1, the zh67 deletion removes 1’677bp, which contains exons 
4, 5 and parts of 6th exon of the a-isoform. The deleted sequence encodes parts of the 
predicted PDZ and FERM domains. Therefore, the zh67 allele is likely to encode a 
hypothetical protein with reduced or impaired function with respect to the PDZ and/or the 
FERM domains. Assuming that exon 3 would be spliced with exon 7, this would lead to a 
frameshift and hence zh67 is predicted to introduce a premature STOP codon. Nevertheless, 
frm-8(zh67) was found to be superficially wild-type. A closer look into vulval development 
confirmed that the vulva was formed as in wild-type animals. 
 
3.1.3 frm-8(zh67) appears to mislocalize LET-23 in the VPCs 
As previously discussed, LET-23 is predominantly localized on the basolateral plasma 
membrane of primary VPCs (Figure 3.2 A), whereas frm-8(zh67) mutants seemed to show 
intracellular accumulation of LET-23 (Figure 3.2 B). At the 2- and 4-cell stage in frm-8(zh67) 
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animals, LET-23 seemed to be enriched predominantly on the basolateral membrane, which is 
facing the respective sister cell and in intracellular punctae (30-40% of the cases, n=18, figure 
3.2 D arrow compared to the arrowheads), whereas in the control animals the distribution of 
LET-23 appeared more uniformly on the basolateral membrane (figure 3.2 C). At the 4-cell 
stage, 50% (n=20) of the analyzed frm-8(zh67) animals had a higher expression level of LET-
23 in the 2 inner VPCs (Figure 3.2 F, P6.pap and P6.ppa, arrows) than the two outer VPCs 
(Figure 3.2 F, P6.paa and P6.ppp, arrowheads), whereas most wild-type animals showed equal 
expression levels in all 4 primary VPCs (Figure 3.2 E, G). In 5% (n=20) of the analyzed 
animals, LET-23 was expressed in 3 cells (instead of 4), which could represent VPCs with 
slightly aberrant timing of cell-division, where one P6.px cell already finished division and 
the sister cell did not complete the cell cycle yet (Figure 3.2 H). Altogether, the general 
feature of frm-8(zh67) animals seemed to be the intracellular accumulation of LET-23 in the 
VPCs. These results were consistent with what was observed in the candidate based RNAi 
screen and supported the assumption that frm-8 might be involved in the regulation of LET-23 
localization. 
 
3.1.4 frm-8(zh67) shows a weak genetic interaction with the LET-23 pathway 
Since RNAi of frm-8 suppressed the Muv phenotype of let-60(n1046gf) in the RNAi screen, 
the genetic interaction between frm-8(zh67) and mutants of the EGFR/Ras/MAPK pathway 
was tested. frm-8(zh67) was combined with either let-60(n1046gf) or lin-2(n105rf). The 
average induced VPCs of frm-8(zh67); let-60(n1046gf) was 3.4 (n=41) and therefore not 
significantly different from the induction of let-60(n1046gf), which was 3.5 (n=46) (Table 
3.1, rows 3, 4). Additionally, frm-8(zh67); lin-2(n105) animals showed an induction index of 
1.1 (n=27) compared to lin-2(n105) single mutants which had 0.9 (n=25) induced VPCs in 
average. Although weak, the suppression of the lin-2(n105) was significant (P<0.05) (Table 
3.1, rows 5, 6). 
GFP-reporter expression analysis was next used to assay the activity of the LET-60 RAS 
pathway, using a previously established downstream target of the LET-23 cascade. EGL-17 is 
the orthologue of the human fibroblast growth factor and is transcriptionally regulated by the 
LET-23 pathway in the primary VPCs during the early steps of vulval development (Burdine 
et al. 1998, Yoo et al. 2004, Stetak et al. 2006). The expression of a transcriptional CFP 
reporter for egl-17 (integrated transgene arIs92, Yoo et al. 2004) was quantified at the 1-cell 
stage of either wild-type or frm-8(zh67) animals (Figure 3.3 A, B). However, the mean 
intensity CFP signal of the analyzed frm-8(zh67) animals was not significantly different from 
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the wild-type samples (Figure 3.3 C). These epistasis results obtained with the zh67 allele are 
inconsistent with the data from the RNAi screen where frm-8 RNAi clearly suppressed the 
let-60(gf) phenotype. A possible explanation for these conflicting results is that the zh67 allele 
represents a weak reduction-of-function mutation, which would give a weaker effect 
compared to frm-8 RNAi. Another possibility is that frm-8 RNAi in the screen was not 
specific for frm-8 alone, resulting in a simultaneous downregulation of a gene of similar 
sequence. 
 
3.1.5 Downregulation of FERM genes in frm-8(zh67) does not result in a synthetic vulval 
phenotype, nor in enhanced mislocalization of LET-23. 
In order to test the possibility of functional redundancy with other FERM encoding genes 
similar to frm-8, all FERM-domain encoding genes (including frm-8 itself) were 
downregulated by RNAi in a frm-8(zh67) background. None of the tested RNAi clones 
resulted in a synthetic phenotype (data not shown). Additionally, the same set of RNAi 
experiments was subjected to immunostaining of LET-23 and its localization was assessed. 
No obvious change in LET-23 localization was observed following RNAi in the frm-8(zh67) 
background (data not shown). 
 
3.1.6 Expression pattern of frm-8 
To assess the expression pattern of frm-8, two transcriptional GFP reporters were constructed. 
Approximatively 9kb of the upstream sequence from the second exon of the frm-8a isoform 
and 6kb of the upstream sequence from the ATG of the frm-8b isoform were used as putative 
promoters, respectively. Reporters showed expression in the nervous system (head region and 
ventral nerve cord), the excretory cell and some unidentified cells in the tail region. The only 
difference between the expression pattern of the two constructs was for the frm-8b isoform 
reporter, which showed additional expression in the intestinal cells and some unidentified 
cells surrounding the pharynx (data not shown). In all analyzed animals, no expression was 
detected in the vulval cells.  
The results presented in this section led to the conclusion that frm-8 effects were generally 
weak and therefore the project was not continued. Instead I concentrated on the 
characterization of other candidate regulators of LET-23 localization. 
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3.2 Characterization of tag-60 
 
3.2.1 General gene information and alleles 
A genetic interaction between tag-60 and let-60 Ras was previously found in a candidate-
based RNAi screen (A. Stetak, personal communication).  RNAi against tag-60 was found to 
suppress the Muv phenotype of the let-60(n1046gf) mutant (A. Stetak, personal 
communication). In a subsequent experiment, downregulation of tag-60 by RNAi in the rrf-
3(pk1426) RNAi hypersensitive background (Simmer et al. 2003) seemed to mislocalize LET-
23 in the primary VPCs to the apical junctions and intracellular punctae (A. Stetak, personal 
communication). 
tag-60 is a gene encoded on chromosome IV at the genetic position of 4.05cM. There are 
presently 5 different isoforms confirmed by cDNA(s). Isoform a, c and d encode proteins with 
two PDZ domains and isoforms b and e with one PDZ domain (figure 3.5 B). All isoforms 
encode a putative ERM binding domain (EBD) at the C-terminus. tag-60 does not have any 
paralogues in the C. elegans genome. 
At the beginning of this study, only the tag-60 allele ok297 was available. ok297 is a 724bp 
deletion which is located approximatively 500bp upstream of the ATG of the e isoform 
(figure 3.5 A). ok297 does not remove any predicted regulatory or coding sequences. The 
ok297 animals were received from the C. elegans knockout consortium but were not 
backcrossed. Interestingly they show a Pvl (Protruding vulva) phenotype, but no defects 
regarding vulval induction nor LET-23 localization were found (data not shown). Therefore, 
the first step of this project was to generate another deletion mutant of tag-60. The zh93 allele 
was isolated following screening of six deletion libraries. This allele produces an in-frame 
deletion of 1’565bp that has its left breakpoint in exon 5a and its right breakpoint in exon 8a. 
zh93 does not remove any predicted protein domains and it is the main allele used in this 
study (figure 3.5 A). tag-60(zh93) animals are superficially indistinguishable from wild-type 
worms. 
The tag-60(tm3501) deletion was just recently generated by the Japan National Bioresource 
Project. tag-60(tm3501) animals harbour a 953bp deletion which begins in the exon 8a and 
ends within the predicted 3’UTR (figure 3.5 A). Therefore, the tm3501 allele is likely a strong 
reduction-of-function allele. Further genetical experiments have to be done in the future to 
support this notion. However, also tag-60(tm3501) animals look superficially wild-type. 
The tag-60(ok2292) deletion was recently generated by the C. elegans knockout consortium. 
The ok2292 deletion has a size of 1’117bp and covers the ATG plus the exons 1, 2 and 3 of 
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the tag-60e isoform (figure 3.5 A), that encodes the PDZ 2 domain. Therefore, it is likely that 
ok2292 represents a “null” allele of the tag-60e isoform. Regarding the other tag-60 isoforms, 
the ok2292 allele represents an “in-frame” deletion that removes the whole second PDZ 
domain. The phenotype of tag-60(ok2292) has not been investigated yet, although it is already 
known that they are viable and fertile. 
 
3.2.2 TAG-60 is the putative C. elegans orthologue of EBP-50/NHE-RF1 
There are 2 different human genes that encode a protein with the same domain architecture as 
TAG-60: EBP-50/NHE-RF1 (ERM binding phosphoprotein 50 / Sodium/Hydrogen exchanger 
regulatory factor 1) and NHE-RF2/E3KARP (Sodium/Hydrogen exchanger regulatory factor 
2 / Exchanger isoform 3 protein kinase A regulatory protein). Both genes encode scaffolding 
proteins with a tandem PDZ domain and a large C-terminus, which does not harbour any 
predicted domains. As shown in figure 3.4, the alignment of the TAG-60a protein with EBP-
50 and NHE-RF2 shows high degrees of similarity in the predicted PDZ domains and the C-
terminus. Interstingly, the 30 distal amino acids of the EBP-50 C-terminus have been reported 
to bind ERM proteins in crystal structure analysis (Finnerty et al. 2004). The conserved 
domain architecture with 2 PDZ proteins and the similar C-terminus indicates that TAG-60 is 
the putative orthologue of EBP-50/NHE-RF1 and NHE-RF2/E3KARP. Since there are no 
other predicted genes that encode similar proteins in C. elegans, tag-60 may be the sole gene 
encoding a EBP-50/NHE-RF1 or NHE-RF2/E3KARP homologue. 
The N-terminal PDZ domain of EBP-50 has been shown to bind a plethora of different 
transmembrane proteins such as NHE-3 (Sodium/Hydrogen exchanger isoform 3), CFTR 
(Cystic fibrisis conductance transmembrane receptor), 2-adrenergic receptor, PDGF-R 
(Platelet derived growth factor receptor) and EGFR and regulate their localization and 
activation (Bretscher et al. 2000 and Weinman et al. 2006). Furthermore, the C-terminus of 
EBP-50 can bind the FERM-domains of Ezrin and Merlin, two related proteins of the FERM 
superfamily (Bretscher et al. 2002). EBP-50 has been suggested as a candidate tumor 
suppressor gene in human breast cancer, as it was found to be associated with the two tumor 
suppressors Merlin/Nf2 and SYK (spleen tyrosin kinase). Loss of heterozygosity (LOH) at the 
EBP-50 locus was associated with breast cancer initiation and/or progression and the 
mutations affected the SYK and Merlin/Nf2 binding sites within EBP-50 (Le Dai, 2004). 
EBP-50 is proposed to act as a scaffold protein that organizes signal transduction complexes 
at the plasma membrane. Lazar et al. (2004) showed that EBP-50 inhibits ligand induced 
internalization of EGFR. Curto et al. (2007) and Cole et al. (2008) demonstrate that Merlin 
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and EBP-50 mediate contact-dependent EGFR inhibition. In contrast to these retention 
functions, EBP-50 was found to be a necessary component of the endocytic recycling of the 
2-adrenergic receptor (Cao et al. 1999). 
 
3.2.3 TAG-60 is a putative regulator of LET-23 localization 
The tag-60(zh93) mutant was used to confirm the genetic interaction observed in the initial 
RNAi screen of A. Stetak. Monitoring the localization of LET-23 in the primary VPCs was 
performed by immunostaining and subsequent epifluorescence or confocal laser scanning 
microscopy. In wild-type worms, LET-23 was expressed at the time of induction in all 6 
VPCs (data not shown). Upon induction by the LIN-3 ligand, the receptor was upregulated in 
P6.p and degraded in all the other VPCs. As development proceeds, the expression levels of 
LET-23 were increased in the primary vulval lineage. In P6.p, LET-23 was predominantly 
localized at the basolateral membrane (figure 3.6 A). Additionally, LET-23 was localized to a 
lesser amount in the intracellular space and in an unidentified compartment facing the apical 
side of the cell (figure 3.6 A). In tag-60(zh93) animals, there seemed to be similar amounts of 
receptor in the VPCs, but the localization of LET-23 was slightly aberrant, as the basolateral 
localization was reduced and the accumulation of LET-23 in intracellular punctae enhanced 
(figure 3.6 B). This effect seemed to persist in the 2-cell stage (figures 3.6 D, F compared to 
3.6 C, E). Immunostaining of LET-23 is variable, in which high levels of LET-23 intracellular 
signal compared to predominantly basolateral localization occurred with a penetrance of 10% 
and 90% (n=many) in wild-type, respectively (figure 3.6 C, E). The fraction of animals 
having intracellular accumulation of LET-23 was increased to approximatively 40% (n= 31) 
in tag-60(zh93) animals (figure 3.6 D). In the remaining 60% of cases, LET-23 seemed to 
have predominant basolateral localization similar to wild-type worms (figure 3.6 C). In 
conclusion, a significant fraction of the tag-60(zh93) worms appeared to have mislocalized 
LET-23 to unidentified intracellular compartments, relative to wild-type worms. Since VPC 
induction is unaffected in tag-60(zh93) animals, it is likely that LET-23 is delivered correctly 
to the basolateral membrane. Thus, TAG-60 rather plays a role in the retention of LET-23 at 
the plasma membrane or during post-endocytic LET-23 recycling. 
 
3.2.4 tag-60(zh93) genetically interacts with mutants of the LET-23 pathway 
The first criteria of the initial RNAi screen was the genetic interaction with let-60(n1046gf). 
tag-60 RNAi significantly suppressed the let-60(gf) Muv phenotype, which indicated that tag-
60 encodes a positive regulator of the inductive pathway (A. Stetak, personal 
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communication). Since the two genes let-60 ras and tag-60 are both located on chromosome 
IV and less than 1cM apart, the construction of the double mutant tag-60(zh93); let-
60(n1046gf) was not attempted. Instead, a heat-shock inducible transgene combination of 
MPK-1 and MEK-2 (gaIs36, Lackner et al. 1994) was used to induce a Muv phenotype in a 
tag-60(zh93) background. However, tag-60(zh93) did not significantly alter the average 
number of induced VPCs of gaIs36 animals after heat-shock treatment (figure 3.7). 
Reduction-of-function alleles of positive regulators of the LET-23 pathway were also used to 
quantify the effects of tag-60(zh93) on vulval induction. The lin-2(n105rf) weak Vul mutant 
was used to test whether this phenotype was enhanced in combination with tag-60(zh93). 
Surprisingly, tag-60(zh93) suppressed the lin-2(n105) Vulvaless phenotype (I=2.2) to wild 
type levels (I=3; figure 3.7). This result was reproduced with the stronger lin-2(n397) allele, 
where the average induction index was supressed from 0.2 to 1.8 in a tag-60(zh93); lin-
2(n397) double mutant. In contrast, tag-60(zh93) was not able to significantly suppress the 
vulvaless phenotypes of lin-7(e1413). In the double mutant with lin-10(e1439), a certain 
degree of suppression was observed, which was not statistically significant (figure 3.7). Since 
lin-2(n397) is supposed to be a null allele (Hoskins et al. 1996), the genetic interaction with 
tag-60(zh93) indicates that it acts in parallel to or downstream of lin-2. On the other hand the 
strong loss-of-function alleles of lin-7 and lin-10, did not show any statistically significant 
alteration of the induction index, indicating that either tag-60 acts genetically upstream of lin-
7 and lin-10, or that the regulation mechanism of vulval development by TAG-60 is 
dependent on LIN-7 and LIN-10. 
The combination of tag-60(zh93) with different reduction-of-function alleles of let-23 
uncovered interesting genetic interactions. The double mutant with let-23(sy10), which 
encodes a receptor with a missense mutation in the first cystein-rich region of the extracellular 
domain (Aroian et al. 1994), showed a suppression of the Vulvaless phenotype (I=1.7) in 
comparison to the single mutant (I=0.5). In contrast, let-23(sy1); tag-60(zh93) did not show 
any suppression compared to the let-23(sy1) single mutant (figure 3.7). The sy1 allele is a 
LET-23 variant, which lacks the last 6 amino acids and thereby fails to interact physically 
with LIN-7 and so it is mainly localized at the apical compartment of the VPCs (Aroian et al. 
1994, Simske et al. 1996, Kaech et al. 1998). Thus, the C-terminus of LET-23 is probably 
involved in the regulation of vulval development by TAG-60. 
Additionally, the Vulvaless reduction-of-function allele sem-5(n2019) (Clark et al. 1992) was 
suppressed by tag-60(zh93). However, it is not clear if tag-60 acts up- or downstream of sem-
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5, since the sem-5(n2019) allele does not represent a null allele and null alleles of sem-5 are 
lethal (figure 3.7). 
Collectively, these results indicate that tag-60(zh93) mutants have augmented activity of the 
inductive and/or lateral signalling pathway, which is able to suppress the Vul phenotypes of 
lin-2(lf), let-23(sy10) and sem-5(n2019), but not of  lin-7(e1413), lin-10(e1439) and let-
23(sy1). However, the combination of tag-60(zh93) with mutants of previously characterized 
negative regulators of the inductive pathway, gap-1(ga133) (Hajnal et al. 1997), sli-1(sy143) 
(Jongeward et al. 1995), unc-101(sy108) (Lee et al. 1994), dpy-23(e840) (Pan et al. 2008) and 
dep-1(zh34) (Berset et al. 2005) did not result in a synthetic phenotype (figure 3.7). 
 
3.2.5 egl-17::cfp expression is reduced in the 1° cells of tag-60(zh93) 
To test whether tag-60(zh93) influences the inductive pathway, a transcriptional reporter for 
egl-17 was used as a read-out. egl-17 encodes the C. elegans fibroblast growth factor (FGF) 
homologue which is the attracting cue for the sex myoblasts, which later form the muscles for 
the whole egg-laying system (Burdine et al. 1998). egl-17 has been shown to be 
transcriptionally regulated by the inductive pathway and is expressed in the 1° lineage of the 
vulva from the 1-cell stage to the 4-cell stage. The arIs92[egl-17::cfp] transcriptional reporter 
has repeatedly been used as a marker for the 1° VPCs and hence as an indicator for the 
activity of the inductive pathway (Yoo et al. 2004, Stetak et al. 2006). Worms harbouring the 
transgene arIs92 in a wild-type or tag-60(zh93) background were synchronized and L1 larvae 
grown at 20°C for 28h, 32h and 36h. The timepoints represent 1-cell, 2-cell and 4-cell stage 
of vulval development. For each timepoint the worms were mounted on a microscope and the 
focal plane set to the approximate midplane of the nuclei of the VPCs. Pictures were taken in 
the DIC and the CFP filter and the average egl-17::cfp intensity was measured. Interestingly, 
the tag-60(zh93) mutant showed in average a significant reduction of 20-30% in egl-17::cfp 
expression in the 1° cells at the 2- and 4 cell stage (figure 3.8, P6.px and P6pxx respectively). 
This result suggests, that the LET-23 pathway activity is reduced in the primary vulval cells 
of tag-60(zh93) animals. 
Previously characterized mutants of negative regulators of the inductive pathway, as for 
expample puf-8, showed as well a reduction of egl-17::cfp in the 1° lineage, but additionally 
display ectopic expression in the 2° lineage (Walser et al. 2006), which is not the case in wild-
type nor in the tag-60(zh93) mutant backgrounds. In addition, reduction-of-function alleles of 
negative regulators like puf-8, show a synthetic Multivulva phenotype in combination with 
other mutants of negative regulators of the inductive pathway such as gap-1 (Walser et al. 
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2006). The fact that tag-60(zh93); gap-1(ga133) showed wild-type vulval development 
(figure 3.7), can be interpreted in several ways. tag-60 might encode a negative regulator of 
the inductive pathway (assuming that zh93 is a reduction-of-function allele), which acts 
genetically upstream of gap-1. On the other hand, assuming that tag-60 and gap-1 act in 
parallel pathways, it is possible that in the double mutant LET-23 signalling is not sufficiently 
increased to bypass the threshold to produce ectopic inductions. Alternatively, that tag-60 
might not only regulate the inductive pathway but other signalling pathways involved in 
vulval development. Further genetic data is required to dissect the different functions of tag-
60 during vulval development. 
 
3.2.6 zh93 is a dominant allele of tag-60 
As described before, the zh93 allele is an in-frame deletion, which does not affect any 
predicted domains of TAG-60. In order to assess the nature of the zh93 allele, different kinds 
of experiments were performed. For example, if a mutant phenocopies the effects observed in 
the corresponding RNAi experiment leads to the conclusion that the mutant allele represents a 
reduction-of-function allele. Following this idea, the defects associated with the tag-60(zh93) 
allele were compared to tag-60 RNAi experiments. 
Hamilton et al. (2005) found tag-60 to increase the average lifespan of C. elegans when 
downregulated by RNAi. tag-60(zh93) was therefore tested for its effect on lifespan. The idea 
behind this experiment was to test if tag-60(zh93) mimicks the “reduction-of-function” effect 
of the RNAi observed in the longevity screen. 100 L4 wild-type and tag-60(zh93) worms 
were observed and their lifespan scored. In my experiments, the tag-60(zh93) allele did not 
have a significant effect on the lifespan compared to the wild-type control (data not shown). 
Alternatively, RNAi experiments were performed to examine whether tag-60 RNAi 
phenocopies the suppressive effect of tag-60(zh93) with the lin-2(n397) Vulvaless phenotype. 
If tag-60(zh93) represented a gain-of-function allele, the tag-60(zh93); lin-2(n397) induction 
would be reduced by tag-60 RNAi. Therefore, either lin-2(n397) or tag-60(zh93); lin-2(n397) 
worms were subjected to tag-60 RNAi by feeding. The tag-60 RNAi clone from the Vidal 
feeding library was used (Rual et al. 2004), which consists of the tag-60a cDNA flanked by 
T7 promoters. As shown in Table 3.2, both experiments resulted in no significant change in 
the VPC induction index. Nevertheless, the average induction of tag-60(zh93); lin-2(n397) 
was slightly reduced from 1.6 (RNAi vector control) to 1.2 or 1.1 respectively. It is notable 
that the P-Value for one of these comparisons was 0.057 (Table 3.2, row 6). Given the 
possibility that the RNAi of tag-60 is not very efficient, maybe scoring a larger population of 
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worms would result in a significant change. If that were to be true, zh93 would represent a 
gain-of-function mutation. 
To further examine the nature of the tag-60(zh93) allele, the tag-60(zh93) mutation was 
placed in trans to the balancer nT1 in a lin-2(n397) background. Heterozygous tag-60(zh93) 
also suppressed the Vul phenotype of lin-2(n397) to the same extent as homozygous tag-
60(zh93) (data not shown), strongly suggesting that zh93 is a dominant mutation. This is 
consistent with the hypothesis posted after the RNAi results. Thus, zh93 represents a 
dominant allele of tag-60, which might be a gain-of-function variant. Experiments using other 
tag-60 alleles (tm3501 and ok2292) are currently being performed to clarify this issue. 
 
3.2.7 Expression analysis of tag-60 
Given the complexity of the tag-60 locus (figure 3.5), 3 different transcriptional GFP 
reporters were generated. The different putative promoters were fused with the coding 
sequence of NLS::GFP::LacZ by PCR fusion. 
The first reporter harboured 2kb upstream sequence of the ATG of the tag-60a isoform and 
showed GFP expression in the pharynx, the intestine, one unidentified cell in the head region 
that could potentially be part of the excretory system and some unidentified cells in the tail 
(data not shown). The second reporter contains 2kb of upstream region of the b isoform ATG 
until the first cluster of exons of the a isoform. Three independent transgenic lines were 
analyzed, but no GFP expression was observed at all (data not shown). This can be interpreted 
as a non-functional reporter lacking important regulatory elements for expression. The third 
reporter consisted of the putative promoter of the tag-60e isoform, which contains 6kb from 
the ATG until the first exon of the tag-60b isoform. This reporter showed a very similar 
expression pattern as the reporter for the tag-60a isoform in three independent transgenic 
lines (data not shown). 
Taken together, these results indicate that tag-60 messages of the a, c, d and e isoforms might 
be generated in the pharynx, the intestine and some unidentified cells, but not in the 
developing vulva. Therefore, tag-60 might acts cell-nonautonomously during vulval 
development, or the GFP reporters used did not contain all regulatory sequences for complete 
expression (including putative expression in the VPCs). 
To further examine the expression of TAG-60 and to analyze its subcellular localization, two 
different polyclonal rabbit antisera were raised. Two peptides were used as epitopes for the 
generation of TAG-60 antibodies. The first peptide (TAG-60e amino acids 28-41 / 
NSAYQYKESSTAYD; referred to as “peptide 1”), is present in TAG-60a, b and e isoforms 
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only and is located within the zh93 deletion (figure 3.9 A) The second peptide is located in the 
N-terminus of the TAG-60e isoform (TAG-60e amino acids 4-16 / LPRLAELNKGTPD; 
referred to as “peptide 2”) and is present in all predicted TAG-60 isoforms (figure 3.9 B). 
Antibodies generated against peptide 1 and peptide 2 are referred to as TAG-60-1 and 
TAG-60-2, respectively. 
Immunostaining of worms with TAG-60-1 showed a similar expression pattern as observed 
with the transcriptional GFP reporters, with staining in the intestine, the pharynx and 
unidentified cells in the head and tail regions (figure 3.9 C). Additionally, signals were 
detected in the developing uterus and vulva originating from intracellular compartments at the 
early L4 stage (invagination of vulval tissue, figure 3.9 E, E’), which fades during the L4 
stage (figure 3.9 F, F’). The function of TAG-60 in late vulval and early uterine development 
is not known to date. Curiously, TAG-60 expression was absent throughout the early 
inductive stages of vulval development. Interestingly, the intestinal cells show exclusive 
apical localization of TAG-60, as reported for its orthologue EBP-50 in mammals, where it 
forms a functional unit with Ezrin to link transmembrane proteins to the peripherical actin 
cytoskeleton (Bretscher et al. 2002). 
Except for the pharynx, all signals observed following immunostainings with TAG-60-1 
were absent in tag-60(zh93) animals and hence, specific for TAG-60 (data not shown). 
Henceforth, the antibody TAG-60-1 was used in other experiments of this study. 
The immunostaining showed expression of TAG-60 during late vulval development much 
later than the vulva induction and patterning events. It is possible that TAG-60 is expressed at 
low levels during the time of induction, but not detectable by TAG-60-1. Alternatively, it is 
known that adjacent tissues such as the hypodermis (Cui et al. 2006) and the nervous system 
(Battu et al. 2003) can influence vulval induction. No gene has yet been reported to influence 
VPC induction from the intestine or uterus. 
Immunostaining with TAG-60-2 showed expression in structures resembling the nerve ring 
(figure 3.9 D) and the ventral nerve cord (data not shown). The signal from the TAG-60-2 
was insensitive to the zh93 deletion, as mixed stage tag-60(zh93) animals showed the same 
expression pattern as wild-type animals (data not shown). 
 
3.2.8 Investigation of the cellular focus of tag-60 
Tissue-specific rescue experiments were conducted to investigate the cell autonomy of TAG-
60 during vulval development, owing to lack of expression of TAG-60 in the VPCs during 
induction (N.B. these experiments were performed prior to determining the dominant nature 
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of the zh93 allele). Tissue specific promoters were used to construct translational YFP fusion 
proteins of the TAG-60a isoform. The TAG-60a isoform was chosen because it represented 
the predominant transcript, when analyzing the cDNAs originating from the tag-60 locus 
(data not shown). The opt-2 promoter was used for specific expression in the intestine 
(Nehrke 2003), the vab-9 promoter for all epithelial cells (Simske et al. 2003) and the vulva 
specific element of the lin-31 gene for exclusive VPC expression (Tan et al. 1998, A.Stetak, 
personal communication). These constructs were injected into tag-60(zh93); lin-2(n397) 
animals, analyzed for proper expression and the vulval induction index was scored. If zh93 
was a reduction-of-function allele, the average induction index would be expected to reduce 
to levels similar to lin-2(n397), as the transgene would rescue the effects of the zh93 allele. 
Alternatively, if zh93 represented a gain-of-function allele, the average induction index would 
be expected to increase, since the additional gene dosage would likely enhance the effect of 
zh93. 
As shown in figure 3.10, all established transgenic lines did express the TAG-60a::YFP 
fusion protein in the expected tissues. Notably, the YFP signal from the construct with the 
opt-2 promoter mimicked the apical localization of TAG-60 in the intestinal cells (figure 3.10 
A, A’), observed in the immunostaining experiments (figure 3.9 C), indicating that the YFP 
did not interfere with the localization, and potentially the function, of the fusion protein.  
In the construct with the vab-9 promoter, no clear expression was observed in the VPCs, 
although a bias towards the apical compartment of the late vulval cells was observed (figure 
3.10 B, B’, arrowheads). In a few animals also basolateral (figure 3.10 B, B’, arrow) 
localization was observed. The vab-9 promoter is highly expressed in the developing uterus 
and hence masks the signal in the early VPCs. Therefore, the localization of the fusion protein 
driven by the vab-9 promoter was not determinable at the time of induction. 
The reporter with the lin-31 promoter element showed very weak activity. By pushing the 
sensitivity of the camera, expression in the VPCs was seen and the fusion protein localized 
generally to the entire plasma membrane (figure 3.10 C, C’, arrowheads) and to the junctions 
(figure 3.10 C, C’ arrows) at the time of induction. Taken together, the TAG-60a::YFP fusion 
protein can localize to plasma membrane compartments and the junctions depending on the 
cellular context. 
As shown in table 3.3, none of the established transgenic lines could suppress or enhance the 
induction index of the tag-60(zh93); lin-2(n397) animals (rows 2-9 compared with row 1). 
Different explanations could account for this finding: first, the YFP tag might not interfere 
with the localization but diminish the activity of the fusion protein. Second, the transgenes are 
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encoded on extrachromosmal arrays, which are transmitted randomly in the cell-lineages and 
therefore the established lines could represent mosaic animals. Therefore, it is possible that 
not all cells, which require TAG-60 function possess the transgene. Third, the cDNA of the 
tag-60a isoform was used to construct the fusion proteins because it seems to be the most 
abundant of all tag-60 isoforms. It is possible that the wrong isoform was used for this 
experiment, or that different isoforms act in a cooperative manner and are thus all necessary 
for proper TAG-60 function. Lastly, the described suppression of the lin-2(n397) Vulvaless 
phenotype might be due to another mutation in the background of the tag-60(zh93) mutant 
strain. 
In order to address these possibilities, a similar approach was used, where a 17kb genomic 
piece of the tag-60 locus was amplified by PCR. Three different PCR products covering 5.8kb 
upstream of the ATG of the a isoform until 1kb downstream the STOP of all tag-60 isoforms 
were fused together and injected into tag-60(zh93); lin-2(n397) animals. It was rationalized 
that the resulting extrachromosomal arrays would represent overexpressions of all 
endogenous tag-60 isoforms. One out of five established lines enhanced the suppression of 
tag-60(zh93) towards lin-2(n397) from 1.77 to 2.60 average induced VPCs (table 3.3, rows 1, 
10). The remaining four lines showed no significant change in the average number of induced 
VPCs (table 3.3, rows 1, 11-14). These results may indicate that the zh93 mutation is a gain-
of-function allele of tag-60, whose effect on the lin-2(n397) Vul phenotype was enhanced by 
providing additional tag-60 gene copies on the extrachromosomal array. 
 
3.2.9 TAG-60-1 recognizes a putative novel TAG-60 isoform of  ~80kDa 
The purified TAG-60 antibodies described above were tested in Western Blot experiments. 
Mixed-staged wild-type or tag-60(zh93) animals were lysed in 2xSDS loading buffer and 
separated on a SDS-PAGE gel. In the case of TAG-60-1, a band of the approximative size 
of 80kDa was present in the wild-type lysate (figure 3.11, red star), but was absent in the tag-
60(zh93) sample. Since TAG-60-1 recognizes an epitope within the zh93 deletion, this 
80kDa band is very likely to represent a TAG-60 isoform. Since TAG-60b is the isoform with 
the highest predicted molecular weight (68.2kDa), the higher band found in this experiment 
indicates that either TAG-60 proteins are being posttranslational modified or that larger TAG-
60 isoforms are existing. It is unclear why no other bands sensitive to the zh93 deletion were 
detected, as the confirmed cDNAs predict proteins of different molecular weights: 52kDa (a 
isoform), 68.2kDa (b isoform) and 37.1kDa (e isoform). More detailed analysis of different 
stages throughout development might uncover stage-specific expression of the TAG-60 
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isoforms. As already mentioned above, TAG-60-1 might not recognize the isoforms c 
(47.5kDa) and d (50.1kDa). 
To assess the possibility of the existance of a larger TAG-60 isoform, we hypothesized that an 
alternative a isoform, spliced with the first exon of the b isoform might be formed. This new 
isoform, “tag-60a+b”, would account for the approximate 80kDa seen on the Western Blot. 
cDNA samples of whole wild-type RNA were generated and analyzed by PCR using one 
forward primer within the first exon of tag-60a and one reverse primer within the first exon of 
tag-60b. Indeed, the two primers could amplify a sequence harbouring the first 3 exons of 
tag-60a and the first exon of tag-60b (data not shown). This experiment indicated that the 
putative isoform “tag-60a+b” exists, although cloning of the whole cDNA still has to be 
performed. 
The TAG-60-2 antibody, which presumably recognized head neurons in immunostaining 
experiments (figure 3.9 D), produced multiple bands in wild-type lysates which were also 
present in the tag-60(zh93) lysates (data not shown). Truncated TAG-60 proteins were 
expected, assuming that the tag-60(zh93) deletion produces proteins of smaller molecular 
weight, which was not the case. Therefore, TAG-60-2 might not be suitable for Western 
Blot analysis. 
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3.3 Characterization of erm-1 
 
3.3.1 ERM-1 is the orthologue of Ezrin, Radixin and Moesin 
C. elegans ERM-1 was investigated during this study, since it is a putative physical interactor 
of TAG-60 (see chapter 3.3.3). Ezrin, Radixin and Moesin are members of the FERM 
(4.1/Ezrin/Radixin/Moesin) superfamily. These family members share a FERM domain, 
which is a protein interaction module (Chishti et al. 1998, Bretscher et al. 2002). A subfamily 
is the ERM-like proteins, which consists of Ezrin, Radixin, Moesin and Merlin (Bretscher et 
al. 2002). These proteins have been shown to self-associate through intramolecular 
association of the distal termini (Pearson et al. 2000). One of the main differences between 
these proteins is that Ezrin, Radixin and Moesin contain an F-actin binding interface at the C-
terminus, which is not present in Merlin. ERM proteins are known to be organizers at the 
plasma membrane, by linking the peripherical actin cytoskeletion with transmembrane 
proteins (Bretscher et al. 2002). It is thought that in this way, functionally distinct 
microdomains are formed at the plasma membrane. As shown in figure 3.12, the sole C. 
elegans orthologue of Ezrin, Radixin and Moesin is called ERM-1 (Göbel et al. 2004). The N-
terminal FERM-domain is very well conserved (figure 3.12, red line), whereas the C-terminus 
displays lower levels of sequence conservation. C. elegans ERM-1 was investigated in this 
study, as it is a putative physical interactor of TAG-60 (see chapter 3.3.3). 
Biochemical and structural analysis of proteins of the ERM family have revealed that they 
exist in two different states: a folded, globular (inactive) and an extended (active) state. 
Transition between these two states is thought to be regulated by the phosphorylation status of 
a C-terminal threonine (figure 3.12, red dot, Bretscher et al. 2002) and by binding of 
phospholipids to the FERM-domain (figure 3.13). It has been proposed that ERMs can homo-
and heterodimerize, but also form oligomers in their active state (Berryman et al. 1995, 
Gautreau et al. 2000). The subcellular localization of ERMs is tissue-specific, but the 
generally localize to the periphery of most cells. 
The FERM domain has been shown to bind transmembrane proteins directly, or indirectly via 
the scaffolding PDZ-domain proteins EBP-50/NHERF1 or E3KARP/NHERF2 (Bretscher et 
al. 2002, figure 3.13). This set up has been proposed to form functionally distinctive 
microdomains at the plasma membrane. However, the biological outcome of this interaction 
seems to be dependent on the cellular context, and also on its interacting transmembrane 
proteins and its associated factors. It has also been proposed that the linkage between the actin 
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cytoskeleton and the plasma membrane can influence the activity and the trafficking of 
certain transmembrane receptors (Bretscher et al. 2000, Bretscher et al. 2002). 
ERM-like proteins have been demonstrated to influence EGFR activity in human tissue 
culture cells, as Merlin together with EBP-50, control the contact dependent inhibition of 
EGFR. The model is that association of EGFR with EBP-50 and Merlin renders the receptor 
to an inactive state, and shifts it to a microdomain, where its endocytosis is blocked (Curto et 
al. 2007, Cole et al. 2008). 
Ezrin is a putative target of EGFR in human epidermoid carcinoma A431 cells (Krieg and 
Hunter 1992). After stimulation of A431 cells with EGF, Tyr145 and Tyr353 of Ezrin are 
phosphorylated. Subsequent in vitro expriments showed that EGFR directly phosphorylates 
Ezrin at the proposed tyrosine residues (Krieg and Hunter 1992). However, Ezrin Tyr145 and 
Tyr353 are not conserved with C. elegans ERM-1 (figure 3.12, blue dots). 
 
3.3.2 erm-1 is an essential gene involved in tubular morphogenesis 
The C. elegans erm-1 gene encodes the sole orthologue of the human proteins Ezrin, Radixin 
and Moesin. It is located in the middle of chromosome I (-0.18cM / 5291608bp) and encodes 
a protein of 563 amino acids. Göbel et al. (2004) showed that erm-1 is an essential gene, as 
animals homozygous for the loss-of-function allele erm-1(tm677) are maternally rescued for 
the lethality but some animals show an enlarged intestinal lumen and a Pvl (protruding vulva) 
phenotype. These animals have reduced fertility, but most of the F2 progeny dies as early 
larvae. The tm677 allele represents a 972bp deletion spanning from the 6th to the 7th exon of 
the a isoform (figure 3.15). tm677 furthermore seemed to represent a “null” allele, as trans-
heterozygotes with a deficiency did not result in enhanced defects. However, erm-1(tm677) 
animals undergo wild-type induction of the VPCs and only develop morphological defects at 
the stage where the vulva tissue starts to invaginate (migration and elongation of vulval cells). 
Göbel et al. (2004) showed that erm-1 is expressed in all tubular epithelia as the pharynx, 
intestine, excretory system, the uterus and the vulva. Since the erm-1(tm677) animals show 
severe morphological defects in these tissues, they proposed a cell-autonomous role of erm-1 
in lumen morphogenesis. Consistent with these results, they showed that a translational GFP 
reporter of erm-1 was localized exclusively on the apical compartment (facing the lumen) of 
these polarized cells. These results suggested that ERM-1 is a valid orthologue of Ezrin, since 
this protein has been found to be expressed at the apical side of intestinal cells, where it is 
necessary for microvilli architecture by linking the cortical cytoskeleton to the plasma 
membrane. Importantly it was also shown that the erm-1 mutation does not disturb the apico-
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basolateral polarity per se, but affects the remodelling of the apical surface of intestinal cells 
(Göbel et al. 2004). 
 
3.3.3 ERM-1 is necessary for TAG-60 localization in C. elegans 
Some observations lead to the intriguing hypothesis that ERM-1 and TAG-60 form a complex 
in C. elegans. First, it has been shown that human EBP-50 binds to the FERM-domain of 
Ezrin via its 30 distal carboxy-terminal amino acids (Finnerty et al. 2004). As shown in figure 
3.14 A, the alignment of the C-termini of TAG-60a, EBP-50 and NHERF2 shows low level of 
similarity and hence no good conclusion can be drawn from the sequence analysis. If C. 
elegans TAG-60 and ERM-1 physically associate, removal of one component may influence 
the localization of its respective partner. To examine this possibility, control and erm-1 RNAi 
(Vidal RNAi clone, Rual et al. 2004) worms were immunostained with TAG-60-1 to 
visualize TAG-60 localization. Control RNAi experiments showed the previously 
characterized apical localization of TAG-60 in the intestine (figures 3.9 C and 3.14 B, 
arrowheads). In contrast, the erm-1 RNAi animals mislocalized TAG-60, with enrichment in 
subapical intracellular compartments (figure 3.14 C, arrows). Therefore, the proper 
localization of TAG-60 is dependent on the presence of ERM-1. Moreover, D. Kradolfer and 
E. Fröhli showed that the ERM-1::CFP fusion protein is coimmunoprecipitated with TAG-60 
(unpublished results). Additionally, ERM-1 has been found to physically interact with TAG-
60 in Yeast-2-Hybrid experiments (Li et al. 2004). Altogether, these results indicate that 
ERM-1 and TAG-60 might form a functional unit in C. elegans as demonstrated in other 
systems (Bretscher et al. 2002). 
 
3.3.4 LET-23 appears to be mislocalized in erm-1(tm677) animals 
While erm-1(tm677) animals display obvious defects in vulval morphogenesis, they exhibit 
wild-type induction of the VPCs. erm-1 was a candidate in the initial RNAi screen of A. 
Stetak. The RNAi experiment (Ahringer clone, Kamath et al. 2003) did not cause any effects 
reminiscent to the phenotype of the allele tm677. Therefore, this particular mutant was 
analyzed in respect to vulval development and LET-23 localization. At this timepoint we 
obtained the strain VJ311 with the genotype erm-1(tm677) / unc-63(x18) dpy-5(e61). The 
erm-1(tm677) was balanced over two markers visible under the dissecting microscope. This 
strain was subjected to immunostaining to visualize LET-23 and the apical junctions and 
optical sections were recorded by confocal microscopy. This strain had the disadvantage that 
erm-1(tm677) homozygous or erm-1(tm677) / unc-63(x18) dpy-5(e61) were theoretically 
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undistinguishable in fixed samples, unless the homozygous worms have a striking defect in 
terms of the visualized proteins. Indeed, some animals were found, which expressed LET-23 
around the plasma membrane of intestinal cells (figure 3.16 F). In wild-type animals, LET-23 
is found exclusively localized on the apical compartment of intestinal cells (figure 3.16 E), 
where it performs a yet unknown function. The animals with misexpressed LET-23 in the 
intestinal cells were analyzed for the LET-23 localization in the VPCs. Compared to wild-
type LET-23 localization (figure 3.16 A, D), the receptor was found to be expressed not only 
on the basolateral membrane, but in intracellular punctae and the junctions (n=5, Figure 3.16 
B). To confirm this result, another strain was constructed to facilitate the analysis of LET-23 
localization. The erm-1(tm677) lethality was rescued with a large genomic DNA fragment 
(around 12kb) of the erm-1 locus. This genomic fragment was introduced into the worms by 
microinjection and presence of the genomic DNA was observed by the coinjection marker 
sur-5::gfp, a ubiquitously expressed transgene (Yochem et al. 1998). The sur-5::gfp marker 
indicated the presence of the extrachromosomal array that rescued the lethality of the erm-
1(tm677) deletion. This strain was subjected to immunostaining against LET-23. Worms 
which had no sur-5::gfp expression (and hence lost the genomic erm-1 rescue transgene) were 
then analyzed using epifluorescence microscopy. Approximatively 50% (n=28) of the sur-
5::gfp negative worms showed mislocalized LET-23 to intracellular punctae when compared 
to wild-type animals. Thus, the effects on LET-23 localization were similar in erm-1(tm677) 
compared to what was observed in tag-60(zh93) animals (figure 3.6). Since the human 
orthologues of ERM-1 and TAG-60 were shown to act together to regulate transmembrane 
proteins (Bretscher et al. 2002) and because both mutants showed similar phenotypes with 
regards to the localization of LET-23, it is a possibility that TAG-60 acts together with ERM-
1 in the retention or recycling of LET-23 at the basolateral membrane of the VPCs. 
 
3.3.5 erm-1(tm677) genetically interacts with the LET-23-pathway 
The erm-1(tm677) mutant strain was next used for epistasis analysis with components of the 
LET-23 pathway. For this purpose, the strain erm-1(tm677) / hT2 [gfp]; let-60(n1046) was 
constructed. hT2 is a chromosome translocation marked with pharyngeal myo-2::gfp. Animals 
with GFP positive (GFP+) pharynx were therefore heterozygous for tm677, whereas GFP 
negative (GFP-) animals were homozygous for tm677. The average vulval index was scored in 
both types of worms and was enhanced from 3.8 (n=39) in GFP+ animals to 5.1 (n=26) in 
GFP- animals (P<0.001) (Table 3.4, rows 4, 5). Since the tm677 allele is considered to be a 
“null” allele (Göbel et al. 2004), these results strongly suggested that ERM-1 represents a 
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novel negative regulator of the inductive pathway. While the scoring of the vulval index in 
erm-1(tm677) is not precise due to severe vulval morphology defects, the enhanced number of 
invaginations of ectopic inductions was nonetheless striking. Interestingly, the combination of 
erm-1(tm677) with gap-1(ga133) did not result in a synthetic vulval phenotype despite both 
genes being negative regulators of the inductive pathway (table 3.4). 
Loss-of-functions mutants of lin-2, lin-7 and lin-10 were next analyzed in combination with 
erm-1(tm677). Due to the previously mentioned difficulties experienced while scoring the 
induction of erm-1(tm677); let-60(n1046) animals, worms were grouped into three distinct 
classes: Completely Vul (induction index I=0), partially induced (0<I<3) and wild-type (I=3). 
Approximatively 80% of both lin-2(n397) and lin-7(e1413) and 65% of lin-10(e1439) animals 
heterozygous for erm-1(tm677) were completely Vul, while in a homozygous erm-1(tm677) 
background the proportion of completely Vul animals was reduced to 11% (lin-2, lin-7) and 
5% (lin-10), respectively (figure 3.17). 
Further genetic experiments were performed by D. Kradolfer, who found that erm-1(tm677) 
was able to suppress the let-23(sy1) but not the lin-3(e1417) or lin-45(sy96) Vulvaless 
phenotypes (unpublished results). Interestingly, the regulation of the LET-23 pathway by 
ERM-1 seems to be independent on the C-terminal PDZ binding motif of LET-23, which is 
missing in the LET-23 variant encoded by the sy1 allele. The results with lin-3(e1417) might 
indicate that the inhibitory role of ERM-1 is dependent on the activation of LET-23. Since the 
lin-45(sy96) allele does not represent a “null” allele, erm-1 does not necessarily act 
genetically upstream of lin-45 raf. The finding that erm-1(tm677) does not alter the average 
number of induced VPCs of lin-45(sy96) could mean that the negative regulation of the LET-
23 pathway by ERM-1 is dependent on LIN-45 Raf activity. Altogether, these results support 
the notion of ERM-1 being a negative regulator of the LET-23 pathway. 
However, erm-1(tm677) suppressed the Vulvaless phenotype of lin-7(e1413), lin-10(e1439) 
and let-23(sy1), whereas tag-60(zh93) did not. In the last paragraph, a model of TAG-60 and 
ERM-1 as a functional unit in the regulation of LET-23 (localization) was proposed, which 
was challenged by the genetic data collected with tag-60(zh93) and erm-1(tm677). The 
genetic data indicates that the two factors regulate the LET-23 pathway in a more complex 
manner. 
 
3.3.6 ERM-1::CFP is localized to the basolateral membrane of the VPCs (D. Kradolfer) 
Work by David Kradolfer from our lab suggests that ERM-1 is not exclusively localized to 
the apical compartment of all tubular epithelia, as stated by Göbel et al. (2004). The 
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translational reporter of erm-1 included the endogenous promoter and the erm-1a cDNA. 
Transgenic worms harbouring this reporter have been shown to rescue the lethality associated 
with erm-1(tm677) mutants. These rescued lines were nevertheless very sick, indicating that 
either the C-terminal CFP interferes with ERM-1 function, or that overexpression of ERM-1 
gives similar phenotypes as reducing its activity. The subcellular localization of the fusion 
protein was similar as reported by Göbel et al. with one important exception: a closer look at 
the developing vulva revealed that in several lines, ERM-1::CFP was specifically localized to 
the basolateral compartment of the primary and secondary vulval cells (Figure 3.18, arrows). 
Some fraction of the fusion protein might also be localized at the apical junctions (Figure 
3.18, arrowheads). These preliminary results extend the data gained by Göbel et al. (2004), 
where they reported exclusive apical localization of ERM-1::CFP in the late L4 stage of 
vulval development. 
 
3.3.7 ERM-1::CFP associates with LET-23 (D. Kradolfer, E. Fröhli) 
The striking subcellular localization of ERM-1::CFP in the VPCs lead to the hypothesis that 
ERM-1 could be an inhibitor of the inductive pathway associated with LET-23. To test this 
possibility, D. Kradolfer and E. Fröhli performed biochemical experiments, where LET-23 
was immunoprecipitated from mixed staged worm lysate of erm-1(tm677); zhEx[erm-1::cfp] 
animals, and probed with GFP on Western Blot. Interestingly, a band around 100kDa was 
observed which accounts for the ERM-1 (~66kDa) fused to CFP (~30kDa). These results 
indicated that ERM-1::CFP is part of a complex with LET-23. 
Moreover, immunoprecipitation of TAG-60 lead to the coprecipitation of ERM-1::CFP, 
supporting the idea of TAG-60 and ERM-1 forming a complex. Further biochemical 
experiments performed by D. Kradolfer and E. Fröhli showed that TAG-60 did not 
coimmunoprecipitate with LET-23, indicating that TAG-60 is not associated with LET-23, 
but rather forms a distinct complex with ERM-1 of unknown function. Since the TAG-60-1 
antibody might not recognize TAG-60c and TAG-60d, it is not clear if these isoforms would 
associate with LET-23 or not. 
Part I: A reverse genetics approach to identify regulators of LET-23 localization 
 48 
3.4 Discussion 
 
C. elegans vulval development is an established system to study LET-23/EGFR signalling 
and its role in cell fate determination and organogenesis (Sternberg 2005). One of the areas of 
interest of our lab is the trafficking of the EGF-receptor and its impact on cell fate 
specification. This study deals with the attempt to characterize putative regulators of LET-
23/EGFR localization. 
PDZ domain containing proteins are known to be conserved scaffolds that organize signalling 
complexes, cell junctions and specialized plasma membrane domains (Fanning and Anderson 
1999). In particular, the PDZ proteins LIN-7, LIN-2 and LIN-10 in C. elegans are thought to 
form a tripartite complex that bind to the C-terminal tail of LET-23 via the PDZ domain of 
LIN-7 and hence target it to the basolateral membrane of the VPCs (Simske et al. 1996, 
Kaech et al. 1998, Whitfield et al. 1999). 
Most of the 4.1 band protein family share an N-terminally located FERM domain (Bretscher 
et al. 2002). It is a protein interaction module shown to bind transmembrane proteins or PDZ-
domain containing scaffolds (Bretscher et al. 2002). Some FERM-domain proteins, such as 
the ERMs, contain a C-terminal F-actin binding site (Bretscher et al. 2002). As reported for 
the cystic fibrosis transmembrane conductance regulator (CFTR) and the 2 adrenergic 
receptor, the ERMs  act as a bridge to the cortical cytoskeleton via the PDZ protein EBP-50 
(Bretscher 1999). 
A previous RNAi screen performed by A. Stetak targeted all uncharacterized genes that 
encode PDZ-domains and FERM-domains in C. elegans. In order to assess whether 
downregulation of these genes would have an impact on the LET-23 pathway, the let-
60(n1046gf) allele was used as a sensitised background. Two genes, frm-8 and tag-60 were 
found as candidate suppressors of the let-60(n1046gf) Muv phenotype. Furthermore, RNAi of 
both frm-8 and tag-60 in the RNAi hypersensitive background rrf-3(pk1426) appeared to 
affect the loclization of the LET-23 receptor to intracellular punctae and the apical junctions 
of the VPCs (A. Stetak, personal communication). We hypothesized that the low penetrant 
defect was possibly due to inefficient downregulation by RNAi. In order to study the function 
of frm-8 and tag-60, we generated deletion mutants by screening 6 deletion libraries in total. 
The isolated deletion mutants frm-8(zh67) and tag-60(zh93) were superficially wild-type. 
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3.4.1 frm-8 is unlikely a regulator of the LET-23 pathway 
The frm-8(zh67) allele was isolated to further characterize the funciton of this gene product. 
The zh67 deletion removes 1’677bp containing the 4th, the 5th and parts of the 6th exon of 
the a-isoform. The zh67 deletion covers part of the PDZ and the FERM domain, which is 
likely to reduce FRM-8 function regarding the PDZ and FERM activity. To date, it is not 
known if the zh67 allele results in a truncated protein or not. However, the putative translated 
FRM-8 proteins would lack most of the FERM domain and the whole uncharacterized C-
terminus, as zh67 results in a frame-shift leading to a premature STOP codon. Although the 
nature of the zh67 has not been studied extensively, it is very likely to strongly reduce FRM-8 
activity. The generation of other alleles of frm-8 would be necessary to deduce the effect of 
the zh67 on the frm-8 gene activity. This option was not feasible because of time restrictions. 
Interestingly, frm-8(zh67) seemed to have an impact on LET-23 localization as depicted in 
figure 3.2 D. 30-40% of the frm-8(zh67) animals showed LET-23 at intracellular punctae and 
the basolateral membrane facing the both primary sister cells in the 2-cell stage. Also in the 4-
cell stage it was possible to observe aberrant LET-23 localization, as in 5% of the animals 
only 3 out of 4 cells showed expression of LET-23. 
Despite its effect on LET-23 localization, the frm-8(zh67) allele did not show significant 
genetical interaction with let-60(n1046gf), and only weakly suppressed the lin-2(n105) 
Vulvaless phenotype. Also, the expression level of the early 1° cell fate marker egl-17::cfp in 
zh67 did not show significant changes in expression. Taken together, these results suggest no 
major role of FRM-8 in the inductive pathway. Since the nature of the frm-8(zh67) allele has 
yet to be determined, it is possible that zh67 represents a weak hypomorphic allele and may 
thus be redundant with other regulators of vulval development. However, this is unlikely 
since no synthetic phenotype on the level of vulval development and LET-23 localization 
were found by downregulation of all available FERM-encoding genes by RNAi in a frm-
8(zh67) background. Similar experiments were performed previously by others, where 
combinatorial RNAi by injection was performed using a mixture of ten different dsRNAs of 
FERM-genes (frm-(1-6), frm-8, frm-10, ptp-1 and nfm-1) but failed to show any obvious 
phenotypes (van Fürden et al. 2004). Further genetic epistasis using mutants of all FERM-
genes might uncover more cryptic functions of this gene family. 
The finding that transcriptional GFP reporters showed expression in the pharynx, the 
intestine, excretory system, ventral nerve cord, some unidentified cells but not in the vulval 
cells, implied that a putative role of FRM-8 as a regulator of the LET-23 pathway would be 
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cell-nonautonomous. This would rule out a model where FRM-8 bridges LET-23 to the 
cortical cytoskeleton of the VPCs. 
In consideration of the facts presented in this study, the gene frm-8 might not directly regulate 
the LET-23 pathway during vulval development and hence the investigation of frm-8 was not 
continued. 
 
3.4.2 TAG-60 may be the C. elegans orthologue of EBP-50 and NHE-RF2 
EBP-50 and NHE-RF2 are closely related proteins harbouring each two PDZ domains and a 
less characterized C-terminus. It has been shown in various reports that these proteins serve as 
scaffolds of signal transduction complexes at the plasma membrane (Bretscher et al. 2000, 
Weinman et al. 2006). In particular, the PDZ domains have been demonstrated to bind to 
transmembrane proteins and their regulators or effectors (Bretscher et al. 2000, Weinman et 
al. 2006). The very C-terminus was shown to harbour an interaction interface for FERM-
domains (Finnerty et al. 2004). TAG-60, although only showing 28% sequence similarity to 
EBP-50 at the sequence level, harbours the same domain architecture as EBP-50/NHERF1 
and NHERF2/E3KARP. The tag-60 locus encodes five different isoforms, from which three 
have two PDZ domains and two isoforms only show one PDZ domain. All isoforms share 
almost the same C-terminus and all isoforms have been confirmed by cDNAs. As no 
paralogue of TAG-60 has been found and predicted so far, it is possible that TAG-60 may be 
the sole C. elegans homologue of the EBP-50 family of proteins. 
 
3.4.3 TAG-60 might be involved in LET-23 retention at the basolateral membrane of  
the VPCs 
This study proposes TAG-60 as a regulator of vulval development. In the preceding RNAi 
screen, downregulation of tag-60 suppressed the Muv phenotype of let-60(n1046gf) and 
mislocalized LET-23 in the primary cells to intracellular punctae and the apical junctions (A. 
Stetak, personal communication). Deletion libraries were set up and screened for deletions in 
the tag-60 locus. The zh93 deletion was isolated after screening 6 deletion libraries and covers 
parts of the 5th exon, the whole exons 6 and 7 and parts of the 8th exon of tag-60a. The zh93 
deletion spans 1’564bp and is an “in-frame” deletion, which means that a truncated protein is 
likely to be expressed. Unfortunately, the deletion does not cover any predicted protein 
domains. Hence, no good prediction of how the deletion affects the protein function can be 
deduced. However, tag-60(zh93) animals are superficially wild-type and undergo normal 
vulval development. 
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The tag-60(zh93) mutants displayed intracellular accumulation of LET-23 in the VPCs in 
40% of the cases, in contrast to wild-type animals, which show predominant basolateral 
localization of LET-23 (Figure 3.6). This result indicates that TAG-60 might be involved in 
the regulation of LET-23 localization at the basolateral membrane. Interestingly, Lazar et al. 
(2004) found a similar effect of EBP-50 on human EGFR trafficking. They could demonstrate 
that the first PDZ domain of EBP-50 directly binds to a DSFL sequence in the C-terminus of 
EGFR. Moreover they found that this interaction is needed for the inhibition of the ligand 
induced endocytosis of EGFR at the plasma membrane. In this event, they showed that the 
interaction between EGFR and EBP-50 occurs at the plasma membrane and that EBP-50 is 
not cointernalized with EGFR upon activation with EGF, indicating that EBP-50 is involved 
in the retention of EGFR at the plasma membrane of COS-7 cells. Unfortunately, Lazar et al. 
(2004) did not investigate the role of the ERM-binding C-terminus of EBP-50 in this process. 
In contrast to these results, Cao et al. (1999) found that EBP-50 interacts with the 2-
adrenergic receptor in HEK293 cells and that it is not involved in retention but rather in the 
recycling of the receptor back to the plasma membrane. 
Given these findings, I propose that TAG-60 is involved in a retention or recycling 
mechanism (or both) of LET-23 at the basolateral membrane of the VPCs. 
 
3.4.4 The tag-60(zh93) allele interacts genetically with the LET-23 pathway 
The tag-60 gene was identified by RNAi as a suppressor of the let-60(n1046gf) Muv 
phenotype (A. Stetak, personal communication). Unfortunately, the tag-60 locus (Chr. IV: 
4.05cM) is too close to the let-60 locus (Chr. IV: 5.21cM) to build a double mutant with a 
reasonable effort. As a substitute experiment to confirm the findings by RNAi, the gaIs36 
integrated transgene was used. gaIs36 contains heat-shock inducible mpk-1 and mek-2, which 
is reported to show a strong Muv phenotype after heat-shock (Lackner et al. 1994). Although 
the Muv phenotype was not as strong as reported by Lackner et al. (1994), no significant 
change in average induced VPCs was observed in a tag-60(zh93) background. Nonetheless, 
the data from the pilot RNAi screen suggested that downregulation of tag-60 results in 
reduced overall LET-23 signalling. Therefore the weak lin-2(n105) mutant was tested in 
combination with tag-60(zh93) for an enhancement of its Vulvaless phenotype, but 
surprisingly tag-60(zh93) was found to have a suppressive effect on lin-2(n105). Consistently, 
also the strong Vulvaless phenotype of lin-2(n397) was suppressed by zh93, but not the 
Vulvaless alleles lin-7(e1413) and lin-10(e1439). These results indicate that tag-60 acts 
genetically upstream of lin-7 and lin-10 and in parallel to or downstream of lin-2. 
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Additionally, it was found that tag-60(zh93) suppressed the Vulvaless phenotypes of sem-
5(n2019), let-23(sy10) but not let-23(sy1). Since the sem-5(n2019) allele does not completely 
abolish sem-5 function, it is not possible to place tag-60 genetically with sem-5. However, the 
genetic interaction between the sy10 and sy1 alleles of let-23 is of very high interest. sy1 is a 
C to T alteration resulting in a LET-23 variant lacking the distal six C-terminal amino acids 
(Aroian et al 1994). As previously mentioned, the very C-terminus of LET-23 is crucial for 
the interaction with LIN-7 and hence, animals homozygous for let-23(sy1) show an apically 
mislocalized receptor. The sy10 allele is a point mutation in the extracellular first cystein rich 
domain of LET-23 which renders it to a receptor with strongly reduced activity (Aroian et al. 
1994). Conclusively, the regulation of the LET-23 pathway by TAG-60 seems to be 
dependent on the C-terminus of LET-23. 
Many mutants of negative regulators of the LET-23 pathway show wild-type vulval 
development, but result in a Muv phenotype when combined with a mutant of another 
attenuator (Yoo et al. 2004). In contrast to this assumption, the combination of tag-60(zh93) 
with previously characterized mutants of negative regulators such as gap-1(ga133), sli-
1(sy143), unc-101(sy108), dpy-23(e840), dep-1(zh34) did not show a Muv or other synthetic 
phenotype whatsoever (figure 3.7). An explanation for this finding could be that the different 
negative regulators do not functionally overlap with TAG-60 and hence, no synthetic effect 
can be generated by removing both genes. 
Interestingly, the expression levels of the early primary cell fate marker egl-17::cfp was found 
to be reduced in tag-60(zh93) animals. This result indicates that the LET-23 pathway is 
attenuated in the primary cells of tag-60(zh93) animals, which appears to be in conflict with 
the suppression of the lin-2(lf) Vulvaless phenotypes. However, it is still possible that there is 
more LET-23 signalling activity in the secondary cells of tag-60(zh93) animals. So far, there 
is no data supporting this notion. Alternatively, enhanced LIN-12 Notch signalling in the 
secondary cell lineage might be the cause for the suppression of the lin-2(lf) Vulvaless 
phenotypes by promoting the secondary fate in P5.p and P7.p. In wild-type animals at the 
time of induction, the LIN-12 protein is expressed in all VPCs but is downregulated in the 
primary lineage following induction (Shaye and Greenwald, 2005). Therefore, it is possible 
that LIN-12 persists in the primary cells of tag-60(zh93) animals, which would account for 
the reduction of the 1° cell fate marker egl-17::cfp expression in the primary cells themselves. 
Preliminary data supports this model, as the lip-1::gfp secondary cell fate marker was found 
to be mis-expressed in the primary vulval lineage until the L4 stage of vulval development 
(data not shown). Since lip-1 is a direct transcriptional target of LIN-12, examination of the 
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LIN-12::GFP translational reporter can be used to assess whether indeed LIN-12 has delayed 
degradation in the 1° cell lineage of tag-60(zh93) animals. Accordingly, the same effect in the 
secondary vulval lineages could account for the suppression of Vulvaless mutants by tag-
60(zh93) as discussed above. Enhanced activity of the LIN-12 Notch pathway (e.g. by 
interfering with LIN-12 degradation) could lead to increased secondary cell fate specification 
of P5.p and P7.p. 
Involvement of TAG-60 in the LIN-12 Notch pathway can be additionally tested by 
combination of tag-60 alleles with mutants of LIN-12. According to the hypothesis 
formulated above, it would be possible that LIN-12 activity is enhanced in tag-60(zh93) 
animals. Therefore it would be interesting to test, whether tag-60(zh93) is able to enhance the 
defects associated with partial gain-of-function alleles of lin-12. 
 
3.4.5 zh93 is a dominant allele of tag-60 
In order to identify the molecular nature of the zh93 allele, genetic experiments were 
performed in the lin-2(n397) sensitized background. This study has shown that animals 
heterozygous for tag-60(zh93) suppress the number of average induced VPCs in a lin-2(n397) 
background, meaning that tag-60(zh93) represents a dominant allele of tag-60.  
In order to determine whether zh93 is a gain-of-function or a reduction-of-function mutation, 
downregulation of tag-60 by RNAi was our first approach of choice. If RNAi against tag-60 
in a lin-2(lf) background suppressed the Vulvaless phenotype, this would indicate a reduction-
of-function nature of the zh93 allele. In contrast, if RNAi of tag-60 in a tag-60(zh93); lin-
2(n397) background would bring the induction index back to lin-2(n397) single mutants level, 
this would speak for a gain-of-function nature of zh93. Unfortunately, RNAi of tag-60 in 
neither the lin-2(n397) nor the tag-60(zh93); lin-2(n397) background showed any significant 
change. However, tag-60 RNAi in tag-60(zh93); lin-2(n397) animals resulted in a weak 
suppression of the induction index with a not significant P-value of 0.057 (Table 3.2, row 6). 
Since this experiment was only peformed once and because the suppression of the vulval 
index was at the border of significance, it is advisable to repeat the RNAi experiments and 
score a larger number of animals. 
More genetic experiments need to be performed to assess whether zh93 represents a reduction 
or a gain-of-function allele. Therefore, all available tag-60 alleles can be tested in a lin-2(lf) 
background to assess whether they suppress the Vulvaless phenotype and if so, to which 
extent. Additional testing of trans-heterozygotes of the different tag-60 alleles with a 
deficiency covering the tag-60 locus will provide more information about the nature of the 
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tag-60 alleles. The proposed genetic experiments and the comparison of all available tag-60 
alleles are crucial to correctly interpret the epistatic analysis and to draw a model of TAG-60 
function during vulval development. 
 
3.4.6 A cell non-autonomous role of TAG-60 during vulval development? 
The expression patterns of various transcriptional GFP reporters for the different tag-60 
isoforms were analyzed by C. Gurnot. A reporter construct containing 6 kb of upstream 
sequence of the ATG of the a isoform drove GFP expression in the pharynx, the intestine and 
some unidentified cells in the head and tail. A very similar GFP expression pattern was found 
by analyzing a reporter with 3kb upstream sequence of the tag-60e isoform. In contrast, no 
GFP expression was found in reporters harbouring 2 kb upstream sequence of the tag-60b 
isoform. These results indicate that the e isoform might use an alternative promoter for its 
expression, lying upstream of its ATG, within the large intron of all the other isoforms. 
Moreover it is possible that the immediate upstream sequence of the tag-60b isoform might 
not contain promoter elements, but rather uses the promoter elements of the tag-60a, c and d 
isoforms for its transcription. No expression of GFP was observed in the vulval cells in all 
transgenic lines analyzed, indicating that either tag-60 is acting from another tissue distant 
from the vulva, or that the GFP reporters did not contain all the necessary regulatory elements 
to represent the endogenous expression pattern.  
Rabbit antibody sera against two distinct peptides were generated. The epitope for TAG-60-
1 is located within the zh93 deletion and possibly recognizes isoforms TAG-60a, b and e. 
Only half of this peptide is present in isoform TAG-60d and only one third in isoform TAG-
60c (figure 3.9 A). Thus, it is not clear if the antibody recognizes the TAG-60c and TAG-60d 
isoforms. However, immunostaining experiments with TAG-60-1 show expression of the 
epitope in the intestinal cells and the pharynx throughout development. The expression in the 
pharynx persisted when staining tag-60(zh93) animals while intestinal staining was lost, 
indicating that the expression in the intestine is indeed specific for TAG-60. The pharynx 
expression in tag-60(zh93) is different from the one recorded in wild-type worms, indicating 
that another epitope is recognized in addition to TAG-60 in the pharynx. No expression was 
observed in the vulval cells in the early developmental stages. However, in the early L4 stage 
when the vulval cells start to invaginate, TAG-60-1 seems to recognize TAG-60 in the 
developing uterine tissue and in all vulval cells. The signal from the uterus is more 
pronounced compared to the vulval cells, where the expression is very low in most analyzed 
animals. The subcellular localization of TAG-60 in the vulval cells was observed in 
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unidentified intracellular compartments. It is possible, that TAG-60 is expressed in the early 
stages of vulval development (e.g. at the time of induction), but at a level that makes it 
undetectable by the immunostaining approach. Another issue is that the antibody TAG-60-1 
might not recognize all TAG-60 isoforms and therefore it remains inconclusive whether the 
recorded expression pattern is representing the endogenous expression. 
The epitope of the second antibody TAG-60-2 is located at the very N-terminus of the TAG-
60e isoform, and is present in all predicted isoforms. Immunostaining experiments using 
TAG-60-2 showed an expression pattern similar to that of the glutamate receptor glr-1 
(Maricq et al. 1995), as it showed signals in the nerve ring and in dotted structures along the 
ventral nerve cord. However, these signals were not sensitive to the zh93 deletion, as 
immunostaining of tag-60(zh93) showed a superficially similar expression and localization of 
TAG-60 compared to wild-type animals. Analyzing TAG-60-2 in the recently received tag-
60 mutants tm3501 and ok2292 could tell if this expression pattern is true and complements 
the TAG-60 expression pattern observed with TAG-60-1. Interestingly, The PDZ protein 
LIN-10 has been reported to be involved in the localization of GLR-1::GFP to postsynaptic 
structures of interneurons (Rongo et al. 1998). Both, mutants in glr-1 and lin-10 have been 
demonstrated to be defective in the nose-touch response (Rongo et al. 1998). Assuming that 
the neuronal TAG-60 expression pattern recorded with aTAG-60-2 is true, it might be 
interesting to test whether TAG-60 is involved in localizing transmembrane proteins in the 
interneurons. However, it is still unknown if tag-60 mutants display a nose-touch response or 
other neurological defects. 
EBP-50 has been shown to inhibit ligand induced endocytosis of EGFR by a direct interaction 
of PDZ domain 1 with the C-terminus of EGFR (Lazar et al. 2004). Furthermore, EBP-50 has 
been shown to regulate retention or recycling of different kinds of transmembrane proteins by 
direct interaction (reviewed in Bretscher et al. 2000, Weinman et al. 2006). Since we observed 
mislocalized LET-23 in the primary vulval cells in tag-60(zh93) animals our working model 
was that TAG-60 functions cell-autonomously in the VPCs to regulate vulval development. 
Both, transcriptional GFP reporter analysis and immunostaining experiments do not provide 
any indications of TAG-60 expression in the VPCs at the time of induction and hence we 
cannot exclude a cell-nonautonomous function of TAG-60. Vulval development has been 
repeatedly shown to be influenced by other tissues as the hypodermal syncitium hyp7 (Cui et 
al. 2006) and neurons (Battu et al. 2003). Battu et al. (2003) showed that the G-protein 
coupled receptor (GPCR) SRA-13 is expressed in chemosensory neurons and that it 
negatively regulates vulval induction. The expression pattern of SRA-13 indicated a cell-
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nonautonomous role in vulval development. Since human EBP-50 has been shown do bind 
and regulate the localization of GPCRs (Weinman et al. 2006), it is possible that TAG-60 
functions in the neurons to regulate vulval development by interacting with GPCRs and hence 
regulating their localization. 
 
3.4.7 TAG-60a::YFP fusion proteins localize to plasma membrane compartments 
To address the cell autonomy of TAG-60 during vulval development, minigenes under the 
control of different tissue specific promoters were generated and introduced into tag-
60(zh93); lin-2(n397) animals. The minigenes consisted of the tag-60a cDNA and the yfp 
sequence. The opt-2 promotor was used to express the minigene construct specifically in the 
intestine and showed exclusive apical localization of the fusion protein, similar to what was 
found in the TAG-60 immunostaining experiments. This result indicated that the YFP did not 
interfere with TAG-60a localization in the intestinal cells. Minigene expression in all 
epithelial cells was driven by the vab-9 promotor and showed predominant apical localization 
of TAG-60a::YFP, but also basolateral localization in some animals. The localization of 
TAG-60a::YFP in this construct could not be assessed in the early stages of vulval 
development, as the simultaneous expression in the uterine tissue was much stronger and 
hence masked the signals originating from the VPCs. The minigene reporter construct under 
the vulval specific element of the lin-31 promotor showed very weak expression of TAG-
60a::YFP on the whole plasma membrane and the junctions of the VPCs. Alltogether, it was 
found that TAG-60a::YFP is preferentially associated with plasma membrane compartments 
in a cell-type specific manner. 
The TAG-60a::YFP fusion proteins were tested for their ability to alter the average number of 
induced VPCs of tag-60(zh93); lin-2(n397) double mutants. None of the established 
transgenic lines significantly affected the vulval induction of tag-60(zh93); lin-2(n397). 
Several explanations could account for this observation. First, the constructs harboured a C-
terminally fused YFP, which theoretically could interfere with TAG-60 function. Second, 
only the tag-60a isoform was used in these experiments. It is possible that another or several 
tag-60 isoforms act in concert to regulate vulval development. Third, the transgenic lines 
constitute of an extrachromosomal array, which is mosaic in its expression and might account 
for the lack of rescue. 
In order to address these issues, a 17kb PCR fragment of the genomic tag-60 locus was 
generated and introduced into tag-60(zh93); lin-2(n397) animals. One transgenic line showed 
a significant enhancement of the vulval induction of tag-60(zh93); lin-2(n397). The remaining 
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four analyzed lines did not alter the vulval induction. This result is to be interpreted very 
carefully, as normally at least three independent transgenic lines should show the same effect 
to substantiate the result. Since only one transgenic line showed an enhancement in vulval 
induction, the indications for tag-60(zh93) representing a gain-of-function allele are weak. 
Similar experiments with different genomic clones have to be performed in the future to 
reproduce these findings. 
The experiments presented in this paragraph were performed before tag-60(zh93) was 
determined to be a dominant allele. In retrospective, providing additional tag-60 copies to the 
putative gain-of-function allele zh93 would in theory enhance the suppressive effect on the 
lin-2(n397) Vulvaless phenotype. However, zh93 could also represent other types of dominant 
variants, such as a neomorphic allele, which has not been ruled out so far. As mentioned 
above, comparison of all available tag-60 alleles in trans to a deficiency is indispensable for 
the future in this project. Once a reduction-of-function allele of tag-60 is confirmed and its 
defects determined, I suggest to systematically analyze all isoforms for their ability to rescue 
these defects. Ubiquitous expression of the tag-60 isoforms with a heat-shock promoter would 
be used in a first step. If one construct results in a rescue, tissue specific expression of the 
corresponding tag-60 isoform needs to be performed to assess the cell autonomy. Considering 
the neuronal expression pattern reported with TAG-60-2, it would be interesting to 
additionally test a neuron-specific promoter in the rescue constructs. 
If however, several TAG-60 isoforms are needed in concert to fulfil TAG-60 function, 
combinations of the heat-shock constructs have to be tested for rescue activity. 
 
3.4.8 The tag-60 locus encodes more than 5 different isoforms 
The antibody TAG-60-1, which recognizes an epitope encoded within the zh93 deletion, 
was tested in Western Blot experiments. It was found that in mixed stages of wild-type 
animals a band of around 80kDa is recognized by this antibody, which is missing in tag-
60(zh93) samples. None of the annotated TAG-60 proteins have a size of 80kDa. Hence, this 
result indicates that either the TAG-60 proteins are being post-translationally modified or that 
other not annotated isoforms of TAG-60 exist. There are additional indications that the latter 
possibility might be true. The assumption was that the first three exons of the tag-60a isoform 
would be spliced together with tag-60b, which would account for the 80kDa protein found in 
the Western Blot experiment. Therefore, a forward primer within the first exon of tag-60a and 
a reverse primer within the first exon of tag-60b were tested together in a PCR reaction on 
whole worm cDNA templates. Indeed, the two primers amplified the expected sequence, 
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which indicates the existence of an additional isoform encoded within the tag-60 locus. So far 
the attempt to clone the whole cDNA of the putative novel isoform failed. 
It is not clear why the Western Blot experiments only showed one specific band for TAG-60. 
The worm lysates used in this experiment originated from mixed staged worm cultures and 
therefore it might be advisable to synchronize the worm cultures and analyze the lysates in a 
time course experiment. It is possible that some TAG-60 isoforms are only expressed in 
specific stages of C. elegans development and maybe are expressed at a low level. Since 
vulval induction and patterning is initiated at the late L2 stage, the time-course experiment 
might tell which isoforms are expressed at this time-point and which might be involved in the 
regulation of vulval development. 
 
3.4.9 ERM-1 and TAG-60 might form a complex 
Since the putative human homologue of TAG-60 has been demonstrated to bind to ERM-like 
proteins (Finnerty et al. 2004), we analyzed the mutant allele erm-1(tm677) in respect to its 
function during vulval development and LET-23 localization. Indications for a TAG-
60/ERM-1 complex in C. elegans were collected in this study and by others: First, ERM-1 
and TAG-60 physically interacted in yeast-2-hybrid experiments (Li et al. 2004). Second, 
apical TAG-60 localization in intestinal cells was abrogated in erm-1 RNAi (Vidal RNAi 
clone) animals (figure 3.14 B, C). Lastly, D. Kradolfer and E. Fröhli demonstrated that ERM-
1::CFP is coimmunoprecipitated with TAG-60 (unpublished results). 
 
3.4.10 ERM-1 is a putative regulator of LET-23 retention or recycling at the basolateral 
membrane of the VPCs 
The erm-1 gene was a candidate in the preceding targeted RNAi screen (using the Ahringer 
library RNAi clones), but did not show any defects compared to the erm-1(tm677) allele (A. 
Stetak, personal communication). erm-1 is an essential gene and is needed for morphogenesis 
of tubular epithelia (Göbel et al. 2004). It was shown that the erm-1(tm677) allele represents a 
“null” mutant, as placing tm677 in trans to a deficiency did not increase the severity of the 
defects observed in tm677 homozygous animals (Göbel et al. 2004). 
LET-23 seemed to be mislocalized to intracellular punctae in erm-1(tm677) animals, similarly 
to the defects observed in tag-60(zh93) animals. In both cases, the identity of the intracellular 
compartments, which are positive for LET-23, are unknown. 
EBP-50 and ERM proteins have been repeatedly demonstrated to form a link between the 
peripherical actin cytoskeletion and plasma membrane proteins, and in this way regulate their 
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localization and activity (Bretscher et al. 2002). Taken together, the indications of a C. 
elegans TAG-60/ERM-1 complex and the effect of tag-60(zh93) and erm-1(tm677) on LET-
23 localization led to the working model, where TAG-60 and ERM-1 act together to regulate 
LET-23 localization in the VPCs. Since both single mutants tag-60(zh93) and erm-1(tm677) 
display wild-type induction, it is likely that LET-23 is normally targeted to the basolateral 
membrane, but is not efficiently retained or recycled in these animals. 
 
3.4.11 ERM-1 is a novel negative regulator of vulval development 
Epistasis experiments were performed to study the genetic interactions of erm-1(tm677) with 
mutants of components of the inductive pathway. Interestingly, erm-1(tm677) significantly 
enhanced the Multivulva phenotype of let-60(n1046gf) animals. As mentioned above, tm677 
was determined to be a “null” mutation (Göbel et al. 2004). Therefore, the enhancement of the 
let-60(n1046gf) Muv phenotype indicated that erm-1 encodes a negative regulator of vulval 
development. Consistently, erm-1(tm677) was able to suppress the Vulvaless phenotypes of 
lin-2(n397), lin-7(e1413) and lin-10(e1439). 
Additional genetic experiments performed by D. Kradolfer, showed that erm-1(tm677) could 
suppress the Vulvaless phenotype of let-23(sy1), encoding the LET-23 variant lacking the six 
C-terminal amino acids (Aroian et al. 1994). This result demonstrated that the regulation of 
vulval development by ERM-1 is independent of the distal C-terminus of LET-23. D. 
Kradolfer also found that regulation of vulval development by ERM-1 seems to be dependent 
on LIN-3 EGF and LIN-45 Raf, since erm-1(tm677) did not alter the vulvaless phenotypes of 
lin-3(e1417) and lin-45(sy96) mutants. So far, no “null” mutant of the core LET-23 pathway 
was tested, which would genetically place erm-1 in the inductive pathway. mpk-1(0) alleles 
are the only mutants of the core inductive pathway that do not result in lethality (Lackner and 
Kim 1998). The combination erm-1(tm677); mpk-1(0) would help to place erm-1 either up- or 
downstream of mpk-1. 
Comparison of the genetic data collected with the tag-60(zh93) and the erm-1(tm677) mutants 
is difficult because of the unknown molecular nature of the tag-60(zh93) allele. Assuming that 
zh93 encodes a dominant-negative form of TAG-60, it is possible that TAG-60 acts as an 
attenuator of vulval development. However, the model of the TAG-60/ERM-1 complex 
negatively regulating vulval development would then be challenged. tag-60(zh93) suppressed 
the lin-2(n397), but not the lin-7(e1413) and lin-10(e1439) Vulvaless phenotypes, suggesting 
that TAG-60 and ERM-1 do not regulate vulval development as one sole functional unit, but 
as part of differently composed protein complexes. As mentioned before, different tag-60 
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alleles have to be tested in genetic experiments to characterize TAG-60 and its general role in 
vulval development. 
However, biochemical experiments performed by D. Kradolfer and E. Fröhli demonstrated 
that ERM-1::CFP but not TAG-60 is coimmunoprecipitated with LET-23. Therefore, ERM-1 
might be associated with LET-23 and inhibit the inductive pathway in a TAG-60 independent 
mechanism. ERM-1 is the sole orthologue of Ezrin, Radixin and Moesin in C. elegans (Göbel 
et al. 2004). However, the nfm-1 gene product is the putative C. elegans orthologue of the 
human ERM-like protein Merlin/Nf2 (Göbel et al. 2004). Merlin, together with EBP-50, was 
reported to be involved in contact dependent inhibition of EGFR (Curto et al. 2007, Cole et al. 
2008). EGFR bound to EBP-50 and Merlin is thought to be localized to specialized 
microdomains, which inhibit receptor activation and internalization (Curto et al. 2007, Cole et 
al. 2008). Similarly, it is possible that in C. elegans TAG-60 inhibits LET-23 in a Merlin 
dependent mechanism. However, the fact that TAG-60 is not coimmunoprecipitated with 
LET-23 speaks against this theory. In addition, NFM-1 function during vulval development 
cannot be investigated, as the mutants die as L1 larvae and alternative nfm-1 RNAi (Ahringer 
clone) seems to be not effective. 
 
3.4.12 ERM-1::CFP is localized to the basolateral membrane of the VPCs (D. Kradolfer) 
To study the subcellular localization of ERM-1 a translational ERM-1::CFP fusion protein 
was constructed under the control of its endogenous promoter (D. Kradolfer, unpublished 
results), as reported by Göbel et al. (2004). erm-1(tm677) harbouring the ERM-1::CFP 
encoding transgene were viable, indicating that the ERM-1::CFP fusion protein was 
functional. In contrast to the findings of Göbel et al. (2004), ERM-1::CFP localized to the 
apical compartment of all tubular epithelia with one exception. ERM-1::CFP appeared to be 
localized exclusively at the basolateral membrane of the P5.p, P6.p and P7.p lineages during 
early vulval development. This result is consistent with the defects in LET-23 localization 
found in erm-1(tm677) animals and with the biochemical experiments, which indicate that 
ERM-1 is associated with LET-23. So far it was not tested if ERM-1::CFP fusion protein is 
able to revert the effects of erm-1(tm677) on the Vulvaless phenotypes of loss-of-function 
alleles of lin-2, lin-7 or lin-10. 
 
3.4.13 Putative mechanisms for ERM-1 function during vulval development 
Genetic experiments clearly indicate that ERM-1 is a novel attenuator of vulval development. 
Further epistatic experiments have to be performed to genetically place erm-1 in the inductive 
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pathway. However as stated above, ERM-1 might associate with LET-23 and thus regulate 
LET-23 localization. At the moment we cannot exclude the possibility of ERM-1 regulating 
the inductive pathways by other mechanisms. Additionally, the cell-autonomy of ERM-1 was 
not per se investigated. Vulva-specific expression of ERM-1::CFP in erm-1(tm677); lin-
2(n397) has to be performed to assess this question. 
 
3.4.13.1 Models for C. elegans ERM-1 activation 
Krieg and Hunter (1992) found Ezrin as a putative phosphorylation target of human EGFR. 
Following stimulation of A431 cells by EGF, Ezrin was predominantly phosphorylated at 
residues Tyr145 and Tyr353. Subsequent in vitro kinase assays demonstrated that EGFR 
directly phosphorylates Ezrin at the mentioned residues (Krieg and Hunter 1992). As shown 
in figure 3.12 (blue dots), the residues Tyr145 and Tyr353 are not conserved in C. elegans 
ERM-1. Nevertheless, it is possible that ERM-1 is a phosphorylation target of LET-23 and 
that these putative phophorylation events could acivate ERM-1 or modulate its activity (figure 
3.19). ERM proteins have been demonstrated to switch from the globular inactive state to the 
extended active state by phosphorylation of a conserved threonine in the C-terminus 
(Bretscher et al. 2002, figure 3.12 red dot). Because of the high sequence conservation 
between C. elegans ERM-1 and human Ezrin and Moesin (figure 3.12), it is likely that the 
activation mechanism is conserved as well (figure 3.19). Therefore, LET-23 might only 
modulate ERM-1 activity. ERM-1 variants, with mutated candidate phosphorylation sites 
could be introduced into C. elegans, followed by the investigation of their effects on vulval 
induction. For example, substitution of threonins (or serines, tyrosines) by alanine (or 
phenylalanine) would abolish phosphorylation. On the other hand, substitution with 
phosphomimicking amino acids could also serve to dissect the mechanism of ERM-1 function 
during vulval development. Additionally, expression of epitope tagged dominant negative 
ERM-1 constructs in loss-of-function mutants of lin-2, lin-7 or lin-10 could uncover the 
mechanism of ERM-1 function. 
 
3.4.13.2 Putative ERM-1 effectors 
ERM-1 could act as a direct inhibitor of LET-23 (figure 3.19) by linking the receptor to the 
peripherical cytoskeleton, as was proposed for human EGFR and Merlin/Nf2 (Curto et al. 
2007, Cole et al. 2008). erm-1(tm677) suppressed the let-23(sy1) Vulvaless phenotype, 
indicating that the ihibition of vulval development by ERM-1 is independent of the distal C-
terminus of LET-23. It is possible that ERM-1 directly interacts with LET-23 or via an 
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unknown factor. Interaction studies by yeast-2-hybrid or in vitro binding assays have to be 
performed to assess these questions. It would be furthermore interesting to test, whether the 
localization of ERM-1::CFP is sensitive to the let-23(sy1) or lin-2(n397) background, where 
LET-23 is displayed on the apical surface of the VPCs. It is possible that in these Vulvaless 
mutants ERM-1::CFP shows similar mislocalization compared to LET-23. 
Other hypothetical effectors of C. elegans ERM-1 could be components of the RHO-1 
pathway (figure 3.19). The RhoGEF (Guanine nucleotide exchange factor) ECT-2 was found 
to positively regulate vulval induction via RHO-1 (Canevascini et al. 2005). Although not 
providing a mechanism, Speck et al. (2003) demonstrated that D. melanogaster Moesin acts 
antagonistically to the Rho pathway in vivo. Therefore, a possible model constitutes of ERM-
1 as a negative regulator of the RHO-1 signalling pathway (figure 3.19), and thus indirectly 
attenuates the inductive pathway. Ubiquitous expression of a dominant negative variant of 
RHO-1 (Canevascini et al. 2005) in erm-1(tm677); lin-2(n397) animals would test this 
possibility. 
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3.5 Methods 
 
3.5.1 General methods and alleles 
Standard methods were used to maintain and manipulate C. elegans (Brenner 1994). The C. 
elegans Bristol srain (N2) was used as the wild-type reference strain. The mutations used in 
this study are listed below by their linkage group. 
 
LGI: lin-10(e1439) (Whitfield et al. 1999), erm-1(tm677) (Göbel et al. 2004), unc-101(sy108) 
(Lee et al. 1994). 
LGII: let-23(sy1) (Aroian et al. 1994, Hajnal et al. 1997), let-23(sy10) (Aroian et al. 1994), 
lin-7(e1413) (Simske et al. 1996); dep-1(zh34) (Berset et al. 2005). 
LGIII: frm-8(zh67) (this study) 
LGIV: tag-60(zh93) (this study), tag-60(ok297), let-60(n1046gf) 
LGX: lin-2(n105) (Hoskins et al. 1996), lin-2(n397) (Hoskins et al. 1996); sem-5(n2019) 
(Clark et al. 1992), sli-1(sy143) (Jongeward et al. 1994), gap-1(ga133) (Hajnal et al. 1997), 
dpy-23(e840) (Pan et al. 2007). 
Integrated transgenic arrays: arIs92[egl-17::cfp; tax-3::gfp] (Yoo et al. 2004), gaIs36[hs-
mpk-1(+); EF1alpha-D-mek(gf); unc-30(+)] (Lackner and Kim, 1998). 
Extrachromosomal transgenic arrays: zhEx308.1[Plin-31::tag-60a::yfp, lin-48::gfp] through 
zhEx308.3, zhEx309.1[Pvab-9::tag-60a::yfp, lin-48::gfp] through zhEx309.3, 
zhEx310.1[Popt-2::tag-60a::yfp lin-48::gfp] through zhEx310.2, zhEx312.1[tag-60 genomic 
fragment, sur-5::dsRed] 
Rearrangements: hT2[bli-4(e937) let-?(q782) qIs48] (I;III) 
 
 
3.5.2 Buffers 
 
Worm lysis buffer (WLB) 
50mM KCl 
10mM Tris pH8.2 
2.5mM MgCl2 
0.45% NP-40 
45% Tween-200 
0.01% Gelatine 
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20mg/ml Proteinase K 
 
1xPBS 
Instamed 9.55g/l PBS Dulbecco w/o Ca2+, Mg2+ (Biochrom AG) 
 
Paraformaldehyde 
100mg Paraformaldehyde 
+ 450μl H2O 
+ 0.5μl 12M NaOH 
vortex 
incubate at 60°C for about 10min (vortex after every 2min) 
+ 5μl 1M HCl 
+ 50μl 10xPBS 
 
2xRFB (always keep at -20°C) 
160mM KCl 
40mM NaCl 
20mM Na2EGTA 
10mM Spermidine HCl 
30mM Na PIPES pH7.4 
50% Methanol 
 
1xTTB 
100mM Tris HCl, pH7.4 
1mM EDTA 
0.1% Triton X-100 
 
100x BO3 buffer 
5M H3BO3 
2.5M NaOH 
(pH should not be lower than 9.5) 
 
4xBO3 buffer 
Dilute 100x BO3 buffer 1:25 
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0.01% Triton X-100 
 
ABA buffer 
2% bovine serum albumin (BSA) in 1x PBS-T 
 
Mowiol 
Mowiol 4-88  2.4g 
Glycerol  6g 
H2O   6μl 
0.2M Tris pH8.5 12μl 
DABCO  2.5% (w/v) 
 
 
3.5.3 RNA-interference 
The Ahringer RNAi library is based on bacterial E.coli strains HT115(DE3), that produce 
dsRNA against specific C. elegans genes (Kamath et al. 2003; Kamath and Ahringer, 2003). 
The gene specific sequence within the plasmid L4440 is flanked by T7 promoters. Production 
of dsRNA by the bacteria is hence inducible by IPTG (Isopropyl -D-1-
thiogalacotpyranoside). An alternative high-throughput RNAi rescource was generated by the 
Vidal laboratory (Rual et al. 2004). 
RNAi clones were grown for 5 hours in 2xTY at 37°C and subsequently seeded on NGM 
plates (3g/l NaCl, 2.5g/l tryptone, 17g/l agar, 5μg/ml cholesterol, 1mM MgSO4, 1mM CaCl2, 
1mM KPO4) containing 1mM IPTG and 50 μg/ml ampicillin. Seeded RNAi plates were 
incubated at room temperature for 24 hours. L4 larvae were aliquoted onto the RNAi plates 
and allowed to grow at 20°C. The next generation was analyzed at the indicated stages. 
 
 
3.5.4 Purification of polyclonal TAG-60 antibodies 
To characterize TAG-60 expression, we assigned “Zymed laboratories” (now part of 
Invitrogen Inc.), with the production of rabbit polyclonal anitsera against TAG-60 peptides. 
“Peptide 1” (NSAYQYKESSTAYD) was used for the purification of TAG-60-1 and 
“peptide 2” (LPRLAELNKGTPD) was used for the purification of TAG-60-2. 
Peptides (2mg) were coupled to NHS(N-hydroxysuccinimide)-activated sepharose columns 
(HiTrap, GE Healthcare) as described by the manufacturer. 1ml of antiserum was diluted 1:10 
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in 10mM Tris-HCl (pH 7.5). Remaining cellular debris was removed by centrifugation. 
Antisera were passed three times through the column. Washing buffer (10mM Tris / 500mM 
NaCl / pH7.5) was used to remove unspecific bound molecules. Elution of antibodies was 
performed using 100mM Glycine (pH2.5) and pH was neutralized using 1M Tris (pH 8.0). 
Handling and storage of the column was performed as described by the manufacturer (GE 
Healthcare). 
 
 
3.5.5 Whole-mount immunostaining 
Immunostaining was used to visualize expression and localization of LET-23 and TAG-60. 
Monoclonal and polyclonal antibodies recognizing LET-23 have been generated and used by 
our laboratory before this study (Stetak et al. 2006). The immunostaining method used in this 
study is based on the protocol established by Finney and Ruvkun (1990).  
One 6cm dish full of mixed staged worms was washed with 1xPBS and transferred into an 
eppendorf tube. The worm suspension was washed with 1xPBS until the remaining bacteria 
was removed and the supernatant was clear. The spinning steps in this protocol are henceforth 
performed at 2’000rpm for 1min. The volume was adjusted to 450μl. If the worms were being 
processed on another day, 500μl of 2xRFB buffer (-20°C) was added. The tubes were then 
inverted several times and subsequently frozen in liquid nitrogen. Further storage of the tubes 
was done at -70°C. The samples have been reported to be stable for months. 
 
Fixation 
After adding the 2xRFB-buffer, 50μl of the fixating agent paraformaldehyde (1% end 
concentration) was added. Afterwards the tubes were subjected to 3 rounds of freeze-thaw 
cracking in liquid nitrogen to allow the paraformaldehyde to penetrate the cuticle of the 
worms. Thawing was done with handwarm tapwater. Fixation was done by incubating the 
tubes for 30min at 4°C on a rocker. The fixation reaction was stopped by washing the worms 
3 times with 1xTTB. 
 
Permeabilization 
During the permeabilization reactions, the cuticle of the worms is processed to allow the 
antibodies to penetrate. Therefore the disulfide bonds of the cuticle collagen were reduced by 
rocking the tubes with 1ml 1xTTB, 40μl Triton X-100 (10%) and 10μl -Merkaptoethanol for 
6h at 37°C. In order to finish the reaction, the worms were washed 2 times with 4xBO3 buffer. 
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The following two reactions were performed to modify and seal the reduced disulfide bonds. 
First, the worms were treated with a solution consisting of 990μl of 4xBO3 buffer and 10μl of 
DTT (1M) for 15min rocking at RT. The reaction was stopped by 2 washes with 4xBO3 
buffer. Afterwards, the worms were incubated in 990μl 4xBO3 buffer with 10μl H2O2 for 
15min. This oxidation step was stopped by 2 washes with 4xBO3. 
The permeabilized worms were treated with 1ml of the blocking ABA-buffer for 15min 
rocking at RT, in order to minimize unspecific binding of the antibodies. Primary antibodies 
were diluted in 200μl ABA-buffer and then added to the worms. Incubation was done rocking 
overnight at 4°C. On the next day, the solution with the primary antibody was removed with 
one quick and 3 washes (15min rocking at RT) of PBS-T. The secondary antibodies were 
diluted 1:100 in 200μl of ABA-buffer. Worms were incubated with secondary antibodies for 
2h rocking at RT. As the fluorophores coupled to the antibodies are light-sensitive, this step 
had to be performed in the dark. For this purpose, the tubes were wrapped in aluminium foil. 
Henceforth, all steps were carried out in the dark. 
 
Staining of DNA 
In some cases it was of interest to visualize the nuclei. This was done by staining the DNA 
with the Hoechst (Sigma) dye. Worms were incubated with 1ml PBS-T plus 1μl of Hoechst 
dye (10mg/ml) for 5min rocking at RT. Two subsequent washes with PBS-T of 5min at RT 
were concluding the staining protocol. 
 
Mounting 
After the last washing step, the supernatant was removed as much as possible, which 
corresponded to an approximate final end volume of 20μl. This worm suspension was mixed 
with 20μl of Mowiol and then immediately distributed on 2 drops on one slide. The drops 
were covered carfully with a coverslip using forceps. The mounted samples were dried 
overnight at RT in the dark. Long term storage was done at 4°C. 
 
 
3.5.6 Scoring the VPC induction index 
Worms were analyzed at the L4 stage. The induction index I is the average number of induced 
VPCs (P3.p-P8.p) of a certain worm strain. In the wild-type reference strain N2, only P5.p, 
P6.p and P7.p are induced which accounts for an induction index of 3. A worm population 
that shows an induction index of 0  I < 3 is underinduced and is therefore called “Vul” 
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(Vulvaless). Overinduced animals have an induction index of 3 < I  6 and are termed “Muv” 
(Multivulva). 
 
 
3.5.7 Generation of C. elegans gene knockout libraries 
Synchronisation and mutagenesis of worms 
In order to create and isolate deletion mutants of frm-8 and tag-60, we constructed six 
knockout libraries. Large numbers of N2 worms were grown on OP50 and gravid adults were 
collected with sterile M9 buffer. Remaining bacteria was washed off with sterile M9-buffer. 
The worms were subsequently bleached and transferred onto empty NGM-plates. Surviving 
eggs hatched overnight at 20°C and stopped development because of lack of food. On the 
next day the synchronized L1 worms were transferred onto NGM-plates containing OP50. 
After two days at 20°C the synchronized animals reached L4 stage and hence were collected 
with sterile M9 buffer. Remaining bacteria was washed away with M9-buffer. The final 
volume of worm suspension was 2ml. We used the mutagen EMS (ethyl methane sulfonate) 
to generate small DNA lesions. 30μl of EMS was diluted in 2ml of sterile M9 by inverting the 
tube several times. The diluted EMS was then transferred into the tube with the worm 
suspension. The total volume of the new worm suspension was 4ml and the end EMS 
concentration was 75mM. The mutagenesis was performed during 4h at RT by rocking the 
tube. Afterwards, the EMS was eliminated with 3 washes of M9 buffer. The volume of the 
worm suspension was adjusted to approximatively 0.5ml and the worms were subsequently 
transferred onto NGM-plates with OP50. The worms were kept at 20°C overnight and then 
distributed by 5 worms per plate. In total we constructed six different libraries of different 
proportions. Our smallest library contained 5x5x96 and our largest 3x20x96 (3 worms per 
plate instead of 5) mutagenized worms, respectively. 
 
Collection of samples from the worm populations 
The worms were allowed to produce progeny for the next 7 days at 20°C. The different plates 
represent different complex populations of mutagenized worms. In order to screen these 
populations a sample was taken by applying 1ml of Q-H2O onto the plate and transferring 
200μl of worm suspension into 96 well plates. The 96 well plates were spun for 1min at 
2000rpm and 150μl of supernatant was removed from each well. 50μl of 2x WLB and 1μl 
Proteinase K (60μg/μl) were added to the remaining 50μl of worm suspension. Worms were 
lysed at 60°C for 3h. Subsequent inactivation of Proteinase K was performed at 95°C for 
Part I: A reverse genetics approach to identify regulators of LET-23 localization 
 
 69 
10min. For the first screening round, we generated pools of the bulk lysates. Of every 96well 
plate, each row was pooled separately by mixing 20μl of each sample into a new well. These 
pools were then transferred into eppendorf tubes for Phenol/Chloroform-purification. 
 
Purification of genomic DNA derived from worm pools 
Each pool had a volume of 12x20μl=240μl. 260μl of TE-buffer was added to a final volume 
of 500μl for better handling. The first purification step was done by adding 500μl PCI 
(Phenol/Chloroform/Isoamylalcohol) solution. After a thorough vortex step, the eppendorf 
tubes were spun for 2min at maximum speed. The upper (aqueous) phase was transferred to a 
new eppendorf tube and the step with the PCI solution was repeated. In the next step, the 
isolated aqueous phase was mixed with 500μl of CI (Chloroform/Isoamylalcohol) solution, 
thoroughly vortexed and again spun for 2min at maximum speed. The upper phase was again 
isolated and after all these purification steps, the starting volume of 500μl was reduced to an 
approximate volume of 400μl. The reason for this reduction lies in the interphase. Between 
the lower (organic solution) phase and the upper (aqueous) phase cellular debris accumulated. 
It was of particular importance to not transfer this debris to the successive purification step, 
meaning that it was only possible to recover approximatively 95% of the aqueous phase in 
each step. 
A further purification step was done by ethanol precipitation as follows: We added 1/10 Vol. 
of 3M Sodiumacetate (pH5.2) and 2 Vol. of  EtOH (100%) to the 400μl of DNA solution, 
inverted the tubes several times and incubated them at -70°C for 2h. The precipitated DNA 
was spun at 4°C for 10min and the resulting supernatant was removed by carefully inverting 
the tubes. The eppendorf tubes were carefully tipped on a towel to remove remaining ethanol. 
Afterwards, another ethanol precipitation step was performed with 2 Vol. of EtOH (70%). 
The tubes were inverted several times and spun at 4°C for 10min. The supernatant and 
remaining ethanol was removed as described above. Additionally we tried to remove 
persisting ethanol around the DNA pellet with the P200 pipette. The pellets were 
subsequently dried on air for 20min. To dissolve the DNA pellets, 40μl of TE-buffer were 
added and incubated at 40°C for 30min on a shaker. Another way to dissolve the DNA was to 
incubate the tubes overnight at 4°C. In some cases it was not possible to dissolve the DNA 
completely. Our optimization experiments showed that the DNA was too concentrated for the 
PCR screening. The DNA samples were therefore diluted 1:20 by transferring 10μl of each 
eppendorf tube to a 96 well plate and adding 190μl of TE-buffer. 
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3.5.8 Screening the C.elegans gene knockout-libraries 
A nested PCR based assay to screen for small deletions 
Before generating the knockout-library, we optimized a nested PCR assay, which covered 
approximatively 3kb of our genes of interest. As we were performing large scale PCR assays 
on a complex mix of genomic DNA as template, we chose nested PCR because of its 
increased sensitivity and specificity. The PCR screening was therefore done in two parts: the 
first PCR was performed with the two outer primers (henceforth called “outer reaction”) and 
the purified DNA-pool-samples as templates. The second PCR was done with the two inner 
primers (henceforth called “inner reaction”) and 0.1μl of the first PCR as a template. All 
PCRs were done in duplicates to show reproducibility of any band. As the WT band size was 
around 3kb, any smaller band would indicate a deletion in this region. The primers used to 
screen for the frm-8 and the tag-60 deletions are shown in following table. 
 
Gene Primer Description 
frm-8 OPG13 
TTTGAAAATTGATATCTCGCTC 
forward primer 
outer reaction 
frm-8 OPG14 
AATTGTTCAGCTATCTAACAAG 
forward primer 
inner reaction 
frm-8 OPG15 
AAATGATCGAAACCTAGTCATG 
reverse primer 
outer reaction 
frm-8 OPG16 
TTAAATTGAAGCTGACAACGAG 
reverse primer 
inner reaction 
tag-60 OPG5 
CTTGCAAGGTAGGTGCAGATAATG 
forward primer 
outer reaction 
tag-60 OPG6 
GCATAGATAAGTAATCGGAGTATC 
forward primer 
inner reaction 
tag-60 OPG7 
CACTAGTCGAGCTTGCTGCATATC 
reverse primer 
outer reaction 
tag-60 OPG8 
CCATTGCTCAATGGAGATGGTTG 
reverse primer 
inner reaction 
 
Isolation of deletion mutants 
Once a reproducible band shorter than 3kb was found by screening the DNA pools, we had to 
identify the original worm plate that might harbour the deletion mutant. Every DNA pool 
represented the DNA lysates of one complete row of a 96 well plate (12 samples per row). We 
therefore performed the nested PCR as described above. The only difference was that these 
lysates were not Phenol/Chloroform purified. Once one well gave the same PCR band as from  
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the pool, we identified the worm plate. The worms on this plate were already starved at this 
time-point. The positive plate was chunked onto six new NGM-plates with OP50 and 
incubated at 20°C overnight. The worms were redistributed on fresh NGM-plates with food. 
This sib selection was done, by putting 20 worms on each plate. We used always at least 200 
plates at this step. If the impression was that there are still a lot of worms on the chunked 
plates, we optionally used up to 300 plates. The following steps were done as described for 
the construction of the library. The worms were allowed to grow at 20°C until they were 
starved (5-7 days), followed by taking a sample as described above. The differences are, that 
during the sib selection steps we never pooled nor purified the bulk lysates. The nested PCR 
assay was done as described before. Once a positive plate was found again, the plate was 
chunked and a new sib selection round started. For every round we decreased the complexity 
of the worm populations, meaning that we put always less worms on the plates. Following 
numbers of worms were used in the different subsequent sib selection rounds: 10, 5, 2 and 1. 
To genotype the isolated deletions, novel PCR assays were designed and optimized, which 
were easier and faster to handle than the nested PCR from the screen. We designed PCR 
assays with 3 primers, from which one was a “poison” primer located within the deletion. 
These assays are described in the next paragraph. 
 
 
3.5.9 Genotyping PCR assays 
Genotyping was performed in most cases by 2 primers flanking the correspondent deletion 
and one primer lying within the deletion. All genotyping PCR reactions were done with the 
Invitrogen Taq Polymerase in 25 μl reactions. The composition of the reaciton mix is shown 
in following table.  
 
Ingredient Volume 
Invitrogen reaction buffer (10x) 2.5μl 
dNTP mix (2mM of each nucleotide) 3.0μl 
Primer 1 (2uM) 2.5μl 
Primer 2 (2uM) 2.5μl 
Primer 3 (2uM) 2.5μl 
MgCl2 (50mM) 1.0μl 
Invitrogen Taq Polymerase 0.1μl 
Q-H2O 10.0μl 
Template 1.0μl 
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In the cases where only two flanking primers were used, the volume of the third primer was 
compensated with Q-H2O. Single worm lysates (SWLs) were used as a template for 
genotyping PCRs. One SWL was produced by lysing 1 worm in 10μl of WLB. The following 
tables show the PCR-programs and primers used to genotype different deletion alleles. The 
shaded fields indicate the cycling of the correspondent PCR program. 
 
tag-60(zh93) (deletion) 
  
Time Temp. [°C] 
2min 95 
30sec 95 
30sec 58 
2min 72 
5min 72 
forever 12 
  
cycling: 30x 
 
Primers Sequence 
OPG98 TGGAGTTGCATATGCATCGTATGC 
OPG102 ACAGAGAATTGTTGGAGTAAATGG 
OPG104 GATGATGAGTTTGAGAGTGTTGC 
  
  
WT bands Deletion band 
1046bp 312bp 
1877bp  
 
 
frm-8(zh67) (deletion) 
  
Time Temp. [°C] 
2min 95 
30sec 95 
30sec 60 
1min 72 
5min 72 
forever 12 
  
cycling: 30x 
 
Primers Sequence 
OPG58 ATATTGCAGTCGTAGGCGACCTGTTGGAC 
OPG59 GACGAGTAGGATAAGCCTGCTGAGGC 
OPG60 ACCATGGGCGTCATGGAGATGTCG 
  
  
WT bands Deletion band 
1088bp 765bp 
2642bp  
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erm-1(tm677) (deletion) 
  
Time Temp. [°C] 
2min 95 
30sec 95 
30sec 58 
1.5min 72 
3min 72 
forever 12 
  
cycling: 30x 
 
Primers Sequence 
OPG135 TGATCTCTATCTTGGTGTCGATGC 
OPG136 AACACATTACTCGATATCGAGGCG 
OPG137 CAATTGCAATTGCTTGAGTTGAGC 
  
  
WT bands Deletion band 
698bp 339bp 
1310bp  
 
 
gap-1(ga133) (deletion) 
  
Time Temp. [°C] 
2min 95 
40sec 95 
40sec 55 
1min 72 
5min 72 
forever 12 
  
cycling: 30x 
 
Primers Sequence 
OPG182 (S1C) CTGTTATCCCCTATTTTAGTGG 
OPG183 (S1D) CTCTTGCTGGATCCACTTCAC 
  
  
  
WT band Deletion band 
500bp 190bp 
 
 
rrf-3(pk1426) (deletion) 
  
Time Temp. [°C] 
2min 95 
40sec 95 
40sec 58 
40sec 72 
3min 72 
forever 12 
  
cycling: 30x 
 
Primers Sequence 
rrf3 del up1  
rrf3 del up2  
rrf3 del dn  
  
  
WT band Deletion band 
320bp 500bp 
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gaIs36 (integrated transgene) 
  
Time Temp. [°C] 
2min 95 
30sec 95 
30sec 58 
1min 72 
5min 72 
forever 12 
  
cycling: 35x 
 
Primers Sequence 
OAH159 GCAAAAGGAGGGCGACTCAC 
OAH160 TTTCCCGAAGTGTCCGTTGAC 
  
  
  
WT band Deletion band 
- Between 500bp and 650bp 
 
 
let-60(n1046gf) (point mutation / use OAS604 for sequencing) 
  
Time Temp. [°C] 
2min 95 
30sec 95 
30sec 58 
30sec 72 
2min 72 
forever 12 
  
cycling: 30x 
 
Primers Sequence 
OAS596 GGTAATGACGGAGTACAAGCTTG 
OAS604 GTTTCAATTTGCTCCCACCACATG 
  
  
  
WT band  
appr. 400bp  
  
 
 
lin-2(n397) (deletion) 
  
Time Temp. [°C] 
2min 95 
30sec 95 
30sec 58 
2min 72 
5min 72 
forever 12 
  
cycling: 35x 
 
Primers Sequence 
L5.1 CGCCTATGAAATCTCAGTTT 
L12.2 CGCGCATTTTCATAATTGCG 
  
  
  
WT band Deletion band 
9’373bp appr. 2’000bp 
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lin-2(n105) (point mutation) 
  
Time Temp. [°C] 
2min 95 
30sec 95 
30sec 58 
30sec 72 
1min 72 
forever 12 
  
cycling: 30x 
 
Primers Sequence 
L1.1 CCTACGCTCGAGAACAAATA 
L1.2 GTGGAAAAACCCCAGGTTTT 
  
  
  
WT band Deletion band 
600bp  
  
 
 
 
3.5.10 DNA constructs 
Transgenes were produced using the PCR fusion technique (Hobert 2002). Following primers 
were used for the DNA constructs encoding the TAG-60a::YFP translational fusion proteins: 
Primer Description 
OPG299 
ATGGTGCACATTCCGAGCGACGTG 
tag-60a cDNA forward 
OPG303 
TTACATGTTGCTGACCAATTGATAC 
tag-60a cDNA reverse 
OPG307 
CGAGAAGTATCAATTGGTCAGCAACAT 
GATGAGTAAAGGAGAAGAACTTTTCACTGG 
yfp::unc-54(3’UTR) forward 
FireVector D 
AAGGGCCCGTACGGCCGACTAGTAGG 
yfp::unc-54(3’UTR) reverse 
FireVector D* 
GGAAACAGTTATGTTTGGTATATTGGG 
yfp::unc-54(3’UTR) reverse nested 
OAS522 
CAATCAAGAATAGAACTAACCTCTC 
vab-9 promoter forward 
OAS523 
CAAAGACAGCCTGTCTTTCTCAG 
vab-9 promoter forward nested 
OPG306 
CACGTCGCTCGGAATGTGCACCAT 
TTTGTCCCTTGAAGAGGATCTCTCG 
vab-9 promoter reverse 
OIR150 
CTATGCCATGGAGGTCTTCG 
opt-2 promoter forward 
OIR151 
CGAATGGCGGAGGACCTCG 
opt-2 promoter forward nested 
OPG308 
CACGTCGCTCGGAATGTGCACCATA 
GTGGCGATACTGACGAGGAATGAGC 
opt-2 promoter reverse 
OPG309 
ACGAGGAGCGGTGGTGTGGCCAGC 
lin-31 promoter forward 
OPG310 
TCAACCGTGCGATCGAGCGGCACC 
lin-31 promoter forward nested 
OPG311 
CACGTCGCTCGGAATGTGCACCAT 
ACACACGTAAAACGTGATACTTCG 
lin-31 promoter reverse 
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The DNA constructs (end concentration estimated to 10 ng/μl) were injected into gonads of 
tag-60(zh93); lin-2(n397) animals together with carrier DNA (pBS-KS-, 100 ng/μl) and a 
coinjection marker (lin-48::gfp, 30 ng/μl). 
Following primers have been used to amplify 3 overlapping fragments of the tag-60 locus, 
which were stiched together using the PCR fusion technique (Hobert, 2002). 
 
Primer Description 
OPG107 
TGTCTACAAATGTACATAACGGCG 
Reaction 1 forward 
OPG317 
AGTTTTAATCAGATTTCAATCGCC 
Reaction 1 reverse 
OPG111 
GCTTGTGATCTCTGAAGAAGGAGC 
Reaction 2 forward 
OPG322 
ATCAGTCTTCTGTGCTCAATGAGC 
Reaction 2 reverse 
OPG114 
CATTGAAACGCATCTTGTAATCCG 
Reaction 3 forward 
OPG320 
TATCACGAACAACTTCTAGGAGCC 
Reaction 3 reverse 
OPG108 
GTGCTTGTTTTGGCGTGTCAGCCG 
Fusion reaction forward 
OPG319 
ATCGTTTGTACTCTGTTTACTGGC 
Fusion reaction reverse 
 
The genomic tag-60 fragment was injected into gonads of tag-60(zh93); lin-2(n397) animals 
together with carrier DNA (pBS-KS-, 100 ng/μl) and a coinjection marker (sur-5::dsRed, 25 
ng/μl). 
 
 
3.5.11 Quantification of egl-17::cfp expression 
Large amounts of gravid adult worms containing the arIs92 transgene (Yoo et al. 2004) were 
bleached on NGM plates without food. The survived eggs hatched overnight at 20°C. The 
synchronized population of L1 larvae were tranferred on plates with food and allowed to grow 
at 20°C until the 1-cell stage (28h), the 2-cell stage (32h) and the 4-cell stage (36h) 
respectively. The worms were mounted on a slide with an agarose pad (4% in Q-H20) and 
immobilized with Azide-solution (25mM). The focal plane was adjusted to the center of the 
nuclei of the primary VPCs in the DIC channel and a picture was taken. Then the microscope 
settings were changed to detect CFP and a picture was taken. In order to quantify the 
expression levels of the egl-17 reporter, the blue nuclear signal was selected using the magic 
wand tool and the mean fluorescence intensity was measured for each picture. For the 2- and 
4-cell stage, the mean intensity of all nuclei together was measured. Aquirement of the DIC 
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and fluorescence pictures was done with the Openlab software (Improvision Inc.). 
Quantification of fluorescence intensity was done with the Volocity software (Improvision 
Inc.).  
 
 
3.5.12 Lifespan assay 
A total amount of 100 L4 larvae was distributed on 10 NGM plates. Every second day the 
worms from one plate were transferred onto a fresh plate. The reason for this transfer was 
first, to avoid any confusions with the F1 generation and second, to avoid any fungal 
contaminations which might have appeared after several days of incubation at 20°C. During 
the transfer steps, the state of the worms was scored. The worms were either stated as “alive”, 
“dead”, “bursted”, “bag” or “censored”. A worm was censored, if it was not found anymore 
(e.g. it escaped from the plate). The censored worms were later not accounted into the 
statistical analysis (Kaplan-Meier). 
 
 
3.5.13 Protein alignments 
Protein sequence alignments were performed with the ClustalX 2.0.9 software. The layout of 
the alignment was optimized with the BioEdit software (Ibis Biosciences). 
 
 
3.5.14 Western Blot 
One 6cm NGM plate full of mixed stage worms was washed with Q-H2O and the worms 
transferred into an eppendorf tube. Remaining bacteria was removed by additional washes 
with Q-H2O. The supernatant was removed and the remaining worm pellet was resuspended 
in 200ul of 2xSDS loading buffer and subsequently boiled at 95°C for 5min. Total protein 
concentration was measured using the Weizmann-Schaffner test. Between 10 and 20ug of 
total protein were separated on a SDS-PAGE and afterwards blotted onto a PVDF membrane. 
To avoid unspecific binding of the antibodies, the membrane was blocked with 5% milk in 
TBS-T. Afterwards, the primary antibody was diluted in the blocking solution and applied 
onto the membrane overnight at 4°C. Excess antibody was removed by six washes of 10min 
with TBS-T rocking at RT. Secondary antibodies conjugated with horse radish peroxidase 
were diluted 1:10’000 in 5%milk in TBS-T and applied onto the membrane for 1h at RT. The 
same washing conditions were used as to remove the excess primary antibodies at this step. 
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Activation of the horse radish peroxidase was done by applying the ECL (GE Healthcare) 
onto the membrane for 4min.  
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Row Genotype n VPC index P 
1 WT many 3.0  
2 frm-8(zh67) many 3.0  
3 let-60(n1046gf) 46 3.5  
4 let-60(n1046gf); frm-8(zh67) 41 3.4 >=0.05† 
5 lin-2(n105) 25 0.9  
6 lin-2(n105); frm-8(zh67) 27 1.1 <0.05@ 
 
Table 3.1: Epistasis experiments with frm-8(zh67). 
The frm-8(zh67) allele does not genetically interact with let-60(n1046gf), but suppresses very weakly the lin-
2(n105) Vulvaless phenotype. All strains containing the temperature sensitive lin-2(n105) allele were grown at 
25°C. All the other strains were grown at 20°C. Statistical significance was determined with the Mann-Whitney 
U test. †compared to row 3. @compared to row 5. 
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Fig. 3.4: Protein alignment of EBP-50, NHE-RF-2 and TAG-60a. 
ClustalX software was used to perform a multiple alignment of TAG-60a and its putative human orthologues. 
Regions of high identity/similarity are found in the first PDZ domain (red line) and the second PDZ domain (red 
dashed line). Similarities are also found at the carboxy-terminus, the ERM-binding domain (EBD) of EBP-50 
and NHE-RF-2 (red dotted line). Black boxes symbolize identical and grey boxes similar amino acids 
respectively. 
PDZ 1 
PDZ 2 
EBD 
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Row Genotype RNAi clone n VPC index P 
1 lin-2(n397) vector 33 0.14  
2 lin-2(n397) tag-60 #1 29 0.17 0.44 (1) 
3 lin-2(n397) tag-60 #2 24 0.15 0.38 (1) 
4 tag-60(zh93); lin-2(n397) vector 28 1.55 <0.001(1) 
5 tag-60(zh93); lin-2(n397) tag-60 #1 27 1.15 0.096 (4) 
6 tag-60(zh93); lin-2(n397) tag-60 #2 26 1.06 0.057 (4) 
 
Table 3.2: Determination of the molecular nature of the tag-60(zh93) allele by RNAi. 
tag-60 RNAi by feeding was performed in either lin-2(n397) or tag-60(zh93); lin-2(n397) animals. Both tag-60 
RNAi clones #1 and #2 harbour the tag-60a cDNA and originate from the Vidal RNAi library. None of the 
RNAi experiments could significantly alter the average number of induced VPCs compared to the vector control 
experiments. Only the two vector controls are highly significantly different as expected. Statistical significance 
was determined using the Mann-Whitney U test. Numbers in brackets indicate, to which row the VPC index was 
compared to for statistical analysis. 
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Row Ex. Array Type n VPC index P 
1 - - 32 1.77  
2 zhEx309.1 Pvab-9::tag-60a::YFP 44 1.60  
3 zhEx309.2 Pvab-9::tag-60a::YFP 39 2.10  
4 zhEx309.3 Pvab-9::tag-60a::YFP 48 1.83  
5 zhEx310.1 Popt-2::tag-60a::YFP 42 1.52  
6 zhEx310.2 Popt-2::tag-60a::YFP 36 2.17  
7 zhEx308.1 Plin-31::tag-60a::YFP 31 1.76  
8 zhEx308.2 Plin-31::tag-60a::YFP 49 1.73  
9 zhEx308.3 Plin-31::tag-60a::YFP 40 2.10  
10 zhEx312.1 tag-60 genomic 35 2.60 <0.01† 
11 zhEx312.2 tag-60 genomic 20 1.98  
12 zhEx312.3 tag-60 genomic 52 1.83  
13 zhEx312.4 tag-60 genomic 35 1.97  
14 zhEx312.5 tag-60 genomic 24 1.60  
 
 
Table 3.3: The effects of tag-60 transgenes on the vulval induction of tag-60(zh93); lin-2(n397). 
tag-60 minigenes consisting of either the vab-9 (epithelial tissue, rows 2, 3, 4), opt-2 (intestine, rows 5, 6) and 
lin-31 (VPCs) promotors combined with the tag-60a cDNA and c-terminal encoded YFP were introduced into 
tag-60(zh93); lin-2(n397) animals. All the minigenes variants harboured the standardized unc-54 3’UTR. No 
significant change of VPC induction was observed (rows 2-9) compared to animals without transgene (row 1). 
Additionally, a 17kb PCR fragment containing the genomic tag-60 locus, covering 5.8kb upstream of the ATG 
of the a isform and 1kb of 3’UTR region, was introduced into tag-60(zh93); lin-2(n397) animals. One 
established line showed a significant increase of vulval induction to 2.6 (row 10) compared to the control 
animals (row 1). Four addtional lines did not show a significant change in vulval induction (rows 11-14). 
Statistical significance was assessed with the Mann-Whitney U test. 
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Fig. 3.12: ERM-1 is the C. elegans orthologue of human Ezrin, Radixin and Moesin. 
ClustalX protein alignment of Ezrin, Moesin and ERM-1 shows high levels of conservation in the N-terminal 
FERM-domain (N-ERMAD, N-terminal ERM association domain, red line) and lower levels of conservation in 
the C-ERMAD (C-terminal ERM association domain). Radixin is a protein highly similar to Ezrin and Moesin 
and is not shown in this alignment. Blue dots indicate tyrosine residues of Ezrin that have been shown to be 
phosphorylated by EGFR (Krieg and Hunter 1992). Red dot indicates threonine residue of Ezrin and Moesin that 
has been shown to activate ERM proteins when phosphorylated (reviewed in Bretscher et al. 2002). Black boxes 
indicate identical amino acids and grey boxes indicate similar amino acids. 
•
•
•
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Row Genotype n VPC index P 
1 WT many 3.0  
2 erm-1(tm677) many 3.0  
3 let-60(n1046gf) 23 3.4  
4 erm-1(tm677)/+; let-60(n1046gf) 29 3.5 <0.05† 
5 erm-1(tm677); let-60(n1046gf) 26 5.1 <0.001@ 
6 gap-1(ga133) many 3.0  
7 erm-1(tm677); gap-1(ga133) 24 3.0  
 
Table 3.4: Preliminary epistasis experiments with erm-1(tm677). 
erm-1(tm677) animals show a wild-type vulval induction (row 2). However, the erm-1(tm677) allele 
significantly enhances the Multivulva  phenotype of let-60(n1046gf) animals (rows 3, 4, 5). In contrast, erm-
1(tm677) does not result in overinduction when combined with gap-1(ga133) (rows 6, 7). Statistical significance 
was determined using the Mann-Whitney U test. †compared to row 3. @compared to row 4. 
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4. Part II: A forward genetic screen for gap-1(lf) interactors 
 
4.1 Introduction 
 
4.1.1 GAP-1 is a negative regulator of the EGFR/Ras/MAPK pathway 
The evolutionary conserved EGFR/Ras/MAPK pathway has been implicated in processes 
such as cell differentiation and proliferation (Yarden and Sliwkowski, 2001). Intensity and 
timing of the signal is tightly regulated on many levels of the signalling cascade. The Ras 
proto-oncogene is the founding member of the Ras superfamily of small GTPases, which have 
been proven to act as central switches in various signalling pathways (Bollag and 
McCormick, 1991). The analogy of a “switch” arose from the fact that GTPases exist in both 
active (GTP bound) or inactive (GDP bound) states. Ras harbours a low intrinsic GTPase 
activity, which allows it to hydrolyse the bound GTP molecule and therefore to inactivate 
itself. GTPase activating proteins (GAPs) do not possess any enzymatic activity themselves 
but rather increase the intrinsic GTPase activity of their target GTPases (Bollag and 
McCormick, 1991). Hence, GAPs are negative regulators of Ras signalling, since the 
enhanced turnover of GTP to GDP results in the inactivation of Ras. 
So far, four sub-families of RasGAP proteins have been found in humans: the Gap1 (gap-1 in 
C. elegans), synGAP (gap-2), p120 RasGAP (gap-3) and the Neurofibromin 1 (no orthologue 
predicted in C. elegans) family. All are inhibitors of Ras, but differ in their tissue specificity 
(Stetak et al. 2008). 
gap-1, in addition to gap-3,  is the major negative regulator of let-60/ras during vulval 
development (Stetak et al. 2008). gap-1 loss-of-function animals show elevated levels of 
inductive signal in the VPCs but undergo normal vulval development (Hajnal et al. 1997, Yoo 
et al. 2004). Removal of additional negative regulators of the EGFR/Ras/MAPK pathway in 
gap-1(lf) animals may result in ectopic induction and hence in a Muv phenotype. This 
observation is in accordance with the general belief that the inductive signal has to pass a 
certain threshold to result in a cell fate transformation of the 3° VPCs. Many other mutants of 
negative regulators of the EGFR/Ras/MAPK pathway with similar properties like gap-1(lf) 
alleles have been identified in C. elegans: single mutants of dep-1 or lip-1 result in elevated 
levels of inductive signalling, but undergo wild-type vulval development (Berset et al. 2005, 
Berset et al. 2001). 
 
 
Part II: A forward genetic screen for gap-1(lf) interactors 
 
 103 
4.1.2 Rationale of the forward genetic screen 
The property of gap-1 and lip-1 loss-of-function alleles to render VPCs susceptible to 
abnormal development have been exploited in forward genetic screens in the past. Those 
alleles served as sensitized backgrounds in order to identify additional regulators of the 
EGFR/Ras/MAPK pathway by means of a visible Muv phenotype (Canevascini et al. 2005, 
Walser et al. 2006, Berset et al. 2005). Two types of genes are expected to be isolated in such 
a screen: genes encoding negative regulators of the EGFR/Ras/MAPK pathway that act 
redundantly with gap-1 (Figure 4.1 A), and – although for less obvious reasons - genes which 
are involved in the regulation of basolateral localization of LET-23. Why mutations in the 
latter genes cause a Muv phenotype when combined with a gap-1 (lf) allele can be explained 
on the basis of the gradient distribution of secreted LIN-3/EGF ligand: In the wild-type 
situation LET-23 of P6.p sequesters most of the AC-derived LIN-3 ligand, whereas the 
flanking VPCs receive lower LIN-3 levels. In mutants where the majority of LET-23 is 
mislocalized to the apical compartment of the VPCs, the same amount of LIN-3 is still 
produced, but it is no longer predominantly sequestered by P6.p. Consequently, more LIN-
3/EGF is able to reach the distal VPCs and LET-23 activation on these cells is increased. In a 
gap-1(lf) background, the threshold for the inductive signal to induce a cell fate 
transformation of the 3° cells is thus passed (Figure 4.1 B). Proof of principle for this model 
comes from the finding that the Vul phenotype of loss-of-function alleles of lin-7, lin-2 and 
lin-10, in which LET-23 is mislocalized to the apical compartment of the VPCs (Kaech et al. 
1998, Whitfield et al. 1999), is not only rescued but overinduced in combination with a gap-
1(lf) allele (Hajnal et al. 1997).   
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4.2 Results 
 
4.2.1 Isolation of six mutant alleles 
To perform the described screen, gap-1(ga133) worms were synchronized and then 
mutagenized at the L4 stage, after which these animals were allowed to lay eggs. The F1 
generation was heterozygous for any mutation and hence did not show a phenotype (assuming 
a recessive mutation). These F1 animals were singled out and allowed to lay eggs. As shown 
in figure 4.2, the F2 generation was screened for the Muv phenotype, which is expected to 
appear in approximatively 25% of the progeny of a single F1 animal. As the same screen 
settings were previously applied (Canevascini et al. 2005, Walser et al. 2006, Stetak et al. 
2008), we seeked to isolate mutations that might give rise to sterility or a late lethal phenotype 
in addition to the Muv phenotype. By screening for those more complex phenotypes, 
previously uncharacterized genes might be identified. Once a plate with Muvs was found, 
unhealthy mutants were maintained by picking worms with wild-type appearance that 
segregated mutant worms. In this study, 1400 F1 plates were screened for Muv animals. Out 
of 15 strains displaying a Muv phenotype, only six were considered for further analysis, as the 
remaining strains had a highly variable or very low penetrant phenotype. The mutants zh78, 
zh94, zh95, zh96, zh98 and zh99 were chosen for characterization and mapping. 
Preliminary characterization of the isolated mutants was performed by two means: First, 
visualization of LET-23 using whole mount immunostaining to determine if LET-23 
localization was affected, and second, the assessment of whether the Muv phenotype is due to 
a synthetic interaction between gap-1(ga133) and the zh alleles. The mutants were grouped 
according to their effect on LET-23 localization. Group I consists of the alleles zh96 and zh98 
and represent mutants that display mislocalized LET-23. Group II contains the alleles zh94, 
zh95, zh99 and zh78, which show normal localization of LET-23 in the VPCs. 
Mapping was performed in most cases by automated FLP (Fragment Length Polymorphism, 
(Zipperlen et al. 2005, figure 4.13 A) and SNP (Single Nucleotide Polymorphism) assays. 
Additionally, deficiency mapping and classical three-factor crosses were used to confirm the 
FLP and SNP-mapping results. Once the region of the mutation was confined to a few 100 
genes, candidates were determined by consulting the “Manchester RNAi dataset” (see chapter 
5) or by literature search. The “Manchester RNAi dataset” consists of a list of candidate genes 
that were obtained in a preliminary genome-wide RNAi screen for Muv animals in a rrf-
3(pk1426); gap-1(ga133) background. It was assumed that downregulation of the candidates 
in the sensitized background phenocopied the mutants found in the forward genetic screen 
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presented in this section. The last step in the mapping process was to confirm a candidate 
gene by either a complementation assay or by sequencing the coding regions of the candidate. 
 
4.2.2 zh96 is a novel allele of lin-2 
The allele zh96 was found to cause a highly penetrant synthetic Muv phenotype (Fig. 4.3 A) 
with gap-1(ga133). Besides the ectopic induction of VPCs, no other obvious defects were 
detected. The strain was first maintained heterozygous for zh96 because homozygous animals 
were sick and had reduced fertility. Therefore the strain was outcrossed 4 times, which 
resulted in normal fertility.  
Interestingly, whole-mount staining of mixed stages of zh96; gap-1(ga133) animals 
uncovered apically mislocalized LET-23 in the VPCs of all animals (Fig. 4.3 B, arrowheads). 
This strongly resembles the phenotypes of loss-of-function alleles of lin-7, lin-2 or lin-10. As 
shown in figure 4.3 C, Tier1 FLP-mapping results show a clear linkage of zh96 to the X 
chromosome. Two FLP-assays, namely ZHX-11 and ZHX-13, show that of 16 different 
recombinants more than 80% had Bristol DNA. These results exclude lin-7 (LG II) and lin-10 
(LG I) as candidates. Detailed FLP-mapping on chromosome X placed zh96 on the right arm 
of chromosome X between the assays ZHX-12 (11’464’550bp / 3.85cM) and ZHX-05 
(13’288’921bp / 11.98cM), restricting zh96 to 360 predicted candidate genes (figure 4.3 D). 
One of these genes encodes the previously characterized membrane associated guanylate 
kinase (MAGUK) LIN-2 (Hoskins et al. 1996, Kaech et al. 1998). Therefore, the coding 
regions of the lin-2 gene were sequenced in zh96, and a C to T transition was found in exon 
19 of lin-2a. This resulted in a Q700STOP nonsense mutation that is located to the C-
terminally encoded GUK domain. The kinase activity of this domain has previously been 
shown not to be involved in LET-23 localization (Hoskins et al. 1996). Nevertheless, C-
terminally located premature STOP codons in lin-2 mutants can interfere with LIN-2 function 
towards LET-23 localization, as has been shown for the lin-2(n105) allele (A. Stetak, personal 
communication). Indeed, zh96 failed to complement the lin-2(n105) allele, as the trans-
heterozygous animals were egg-laying defective and forming bags of worms. zh96 thus 
represents an allele of lin-2 and hence validates the rationale of the gap-1(lf) screen. 
 
4.2.3 zh98 is a novel allele of lin-7 
The zh98; gap-1(ga133) animals displayed a strong gap-1(ga133)-dependent Muv phenotype 
(data not shown). The fertility of these animals was normal and therefore this mutant was not 
backcrossed at first. zh98; gap-1(ga133) completely mislocalized LET-23 to the apical 
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compartments of the VPCs similar to lin-2(zh96) and the previously described lin-2(lf), lin-
7(lf) and lin-10(lf) alleles (Figure 4.4 A, Simske et al. 1996, Kaech et al. 1998, Whitfield et al. 
1999). As shown in figure 4.4 B, the Tier1 FLP-mapping results show a clear linkage to 
chromosome II, since over 80% of 16 recombinant lysates had Bristol DNA at the assay ZH2-
01. In the Tier2 mapping experiments 4 assays distributed along the whole chromosome II 
were chosen and run on 48 different recombinant lysates. As shown in figure 4.4 C, 11 
recombinants showed Hawaii DNA from the left side until ZH2-27 (10’527’682bp / 3.06cM) 
and 1 recombinant until ZH2-12 (14’045’121bp / 22.35cM). These results strongly indicated 
that zh98 was located on the right arm of chromosome II. It was further possible, that zh98 
was very close to the assay ZH2-12, as we obtained only one Hawaii recombinant at this 
position. Indeed, lin-7 is located very close to this FLP-assay (14’349’309bp / 22.9cM) and 
hence was the best candidate in this region. Confirming this hypothesis, the transheterozygote 
with the lin-7(e1413) allele failed to complement zh98. By sequencing the coding regions of 
lin-7, a C to T transition in exon 4 was found which results in a premature STOP codon. The 
Q208STOP transition is located just before the PDZ domain, which is responsible for the 
interaction with, and correct basolateral localization of, LET-23. Thus, zh98 represents an 
allele of lin-7 and is together with lin-2(zh96) emphasizing the correct rationale of the screen 
as positive controls.  
 
4.2.4 zh94 is a novel allele of the Ras inhibitor gap-3 
The double mutant zh94; gap-1(ga133) showed a strong Muv phenotype (figure 4.5 A, Stetak 
et al. 2008), which was fully dependent on gap-1(ga133). The isolated mutant after 
mutagenesis was very sick and showed reduced fertility, even following four rounds of 
backcrosses. zh94; gap-1(ga133) showed predominant basolateral expression of LET-23 in 
the VPCs (figure 4.5 B), hence zh94 likely encodes a negative regulator of the inductive 
signalling pathway. 
The Tier1 FLP-mapping results were at first not conclusive, as many of the assays showed 
Bristol DNA between 50-70% and only ZH1-03 (4’557’221bp / -0.98cM) over 70% of 16 
recombinant lysates (figure 4.5 C). To confirm this linkage to chromosome I, two different 
FLP-assays on the distal ends of the chromosome were probed with the same 16 recombinant 
lysates: As shown in figure 4.5 D, ZH1-16 (470’031bp / -19.02cM) showed Bristol DNA in 
over 80% of the cases, in contrast to ZH1-24 (13903448bp / 22.19cM), which showed Bristol 
DNA in slightly more than 50% of the cases. These results strongly indicated that zh94 was 
located on the distal left arm of chromosome I. 
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The Tier2 mapping results were at first also not conclusive: after analyzing 144 recombinant 
lysates (accounts for 1.5 96well plates), the region of zh94 was bordered by the FLP-assays 
ZH1-16 (470’031bp / -19.02cM) and ZH1-10a (1’724’899bp / -13.32cM). The assay in 
between, ZH1-17 (1’038’236bp / -17.34cM), showed Bristol DNA in all recombinant lysates 
probed (figure 4.6 A). This finding could be due to two reasons: either zh94 was located very 
close to ZH1-17, so that the recombination event between the two loci would be very 
unlikely, or the mapping strain Hawaii; gap-1(ga133) was not suitable for mapping in this 
particular region. To test the second theory, the mapping strain Hawaii; gap-1(ga133) was 
analyzed with the same FLP-assays shown in figures 4.6 A and 4.6 B, which are distributed 
along the whole first left third of chromosome I. Interestingly, the mapping strain showed 
Hawaii DNA in all FLP assays but ZH1-17 (data not shown). This error most likely was 
caused during the generation of this mapping strain, where the gap-1(ga133) allele was 
crossed six times into Hawaii background. Further investigation of this phenomena showed 
that other research groups also experienced challenges mapping mutations in this part of the 
C. elegans genome (Stephan Gysi, personal communication). In order to bypass the 
incomplete Hawaii background of our generated mapping strain, the mapping crosses were 
then repeated with pure Hawaii worms. Tier2 FLP-mapping was performed with the same 
assays as in figure 4.6 A, this time using the new recombinant lysates (figure 4.6 B). The 
results of this experiment confirmed the finding that the mapping strain was corrupt and that 
recombination can happen on the location of ZH1-17, indicating that zh94 was bordered either 
between the FLP-assays ZH1-17 and ZH1-10a or between ZH1-10a and ZH1-25 (figure 4.6 
B). The first region consists of 80 predicted genes, from which smo-1 has been shown to 
exhibit a Muv phenotype with gap-1(lf) (G. Poulin, personal communication). Additionally, 
the genes gsa-1, dapk-1 and Y92H12BR.8 were found to be positives in the Manchester 
RNAi dataset. Sequencing of the coding regions of gsa-1 did not show any aberrations. The 
second possible region, between ZH1-10a and ZH1-25, encodes 71 predicted genes from 
which gap-3 was a candidate gene studied at that time in our lab. Transheterozygous 
zh94/gap-3(ga139) ; gap-1(ga133) animals showed that gap-3(ga139) failed to complement 
zh94, and subsequent sequencing of the gap-3 cDNA of zh94; gap-1(ga133) animals 
uncovered a point mutation at the beginning of the last exon (figure 4.7 A). zh94 results in a Q 
to STOP exchange at position 872 within the predicted RasGAP domain (figure 4.7 B). The 
gap-3(ga139) allele is the same type of point mutation as in zh94 but is located further N-
terminally within the RasGAP-domain. The fact that both ga139 and zh94 perturb the 
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inhibitory domain of the GAP-3 protein and both alleles are synthetic Muv with gap-1(ga133) 
strongly indicates that zh94 represents a novel allele of gap-3. 
gap-3 encodes the only predicted p120 Ras GAP family member in C. elegans. The gap-
3(ga139) allele was found in an independent forward genetic screen with a gap-1(ga133) 
sensitized background. This allele was mapped and characterized by A. Stetak in our lab. It 
was shown that gap-3 encodes a negative regulator of the EGFR/Ras/MAPK signalling 
pathway, acting redundantly with gap-1 and gap-2. These 3 RasGAPs were tested for their 
tissue specificity by analyzing the correspondent mutants and their effect on Ras-mediated 
processes during C. elegans development and behaviour (Stetak et al. 2008). Reduction-of-
function alleles of let-60/ras have defects in excretory duct cell specification, sex myoblast 
migration, specification of the P12 cell fate, pachytene exit during miosis in the germline, 
vulval development and chemotaxis (Sundaram 2006). Mutants of gap-1, gap-2 and gap-3 
were tested for their ability to suppress the defects provoked by let-60(rf). All three GAPs 
seem to have redundant functions during sex myoblast migration and chemotaxis (Stetak et al. 
2008, figure 4.7 C). 
The gap-3(zh94) allele from this study was additional proof that a mutation in the RasGAP 
domain of GAP-3 interferes with the inhibitory function towards LET-60, since rescue 
experiments of the gap-3(ga139); gap-1(ga133) with a minigene of gap-3 did not succeed (A. 
Stetak, personal communication). Altogether, both alleles ga139 and zh94,  as well as gap-3 
RNAi, in a gap-1(ga133) background resulted in a Muv phenotype and hence established 
GAP-3 as a negative regulator of LET-60 mediated processes. 
 
4.2.5 zh95 is a putative allele of lin-13 
The double mutant zh95; gap-1(ga133) was maintained heterozygous for zh95 since the 
homozygous double mutant showed a maternally rescued fertility but the F2 animals were 
100% sterile. The Muv phenotype was only partially dependent on gap-1(ga133) since gap-
1(ga133) heterozygousity was enough to result in ectopic inductions at 20°C. Not only the 
sick phenotype but also the level of ectopic induction seemed to be less in the F1 (I = 3.58 / 
53% Muv) than in the F2 generation (I = 5.5 / 100% Muv) (figure 4.8 A). Additionally, zh95; 
gap-1(ga133) worms showed a dramatic decrease of intestinal cell size, aberrant DTC 
migration and gonad morphology defects. All the described defects persisted after 
backcrossing the strain 4 times. 
In whole mount immunostaining of zh95; gap-1(ga133) mixed stage animals, LET-23 was 
found to be predominantly expressed at the basolateral compartment of the VPCs (figure 4.8 
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B). This indicates that zh95 rather represents a gene that encodes a negative regulator of the 
inductive pathway. 
Tier1 FLP-mapping results positioned zh95 to chromosome III, since the two FLP-assays 
ZH3-07 (2’328’170bp / -14.68cM) and ZH3-11 (11’399’237bp / 9.26cM) detected more than 
80% and 90% of Bristol DNA from 16 independent recombinant lysates respectively (figure 
4.8 C). 
Further mapping using the Tier2 FLP-assays determined the region for zh95 between the 
assays ZH3-05a (7’772’487bp/-0.59cM) and ZH3-32 (8’691’426bp/-0.20cM), which 
harboured 241 predicted genes. This result had to be interpreted with care because out of 256 
analyzed samples only one recombinant from the left and three recombinants from the right 
side are defining this region. For some unknown reason the mapping crosses with Hawaii did 
not result in many recombinants in that particular region. Out of the 241 predicted genes, four 
were found in the Manchester RNAi dataset and were tested as candidates for zh95 by 
different approaches: rfp-1 by complementation analysis, and apc-2, gsto-1 and ZK652.6 by 
sequencing the coding regions. However, all tests turned out to be negative and hence render 
these genes unlikely candidates for zh95. 
The lysates of the four informative recombinants were further analyzed by fine-mapping. 
Eight different SNPs distributed along the considered area further restricted the mapping 
region. Shown in figure 4.8 D are the results of the fine-mapping with the SNPs: only the 
lysate of recombinant #247 showed Hawaii DNA as far as the SNP (uCE3-1047) at position 
7’938’720bp / -0.48cM. Between this SNP and the FLP assay ZH3-05a 37 genes are located.  
Considering the low number of informative recombinants though, final proof for the accuracy 
of the resulting region was still missing.  
In order to confirm the region of zh95 found by FLP and SNP mapping, we used 3 different 
overlapping deficiencies, which in total span the region from ZH3-05a (-0.59cM) to ZH3-32 
(-0.20cM). Mapping with deficiencies can be an easy and fast way to determine the region of 
a certain mutation, but it has to be borne in mind that the breakpoints of the deficiencies are 
often unknown or roughly estimated. The ends of the deficiencies used in this study were 
assumed to be correct as annotated on www.wormbase.org (figure 4.9 A): sDf128 (from -
0.61cM to -0.56cM), nDf20 (from -0.57cM to -0.13cM) and nDf22 (from -0.28cM to -
0.13cM). The different deficiencies were put in trans to zh95 in a gap-1(ga133) background. 
Unfortunately, all three deficiencies complemented zh95, indicating that the zh95 mutation 
lies outside the region covered with the deficiencies. 
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Since the FLP- and deficiency mapping results were contradictory, a classical mapping 
strategy was applied. Three-factor mapping was chosen as an alternative approach, where two 
flanking mutations with visible phenotypes are used. Since the location of zh95 was only 
estimated by FLP-mapping (around -0.50cM), the choice of these markers had to be 
optimized first. On the left side, dpy-17(e164) was chosen, which is located at -2.15cM. unc-
69(e587) at the position 2.31cM was chosen for the right side. The two markers were put 
trans to zh95 in a gap-1(ga133) background and the next generation was screened for Unc-
nonDpy (Figure 4.9 B). These recombinants were singled out and their phenotypic 
segregation pattern was scored. The presence of Unc-nonDpys indicates that the 
recombination event occurred between the dpy and the unc mutation. If the recombination 
were between the dpy marker and zh95, one would expect Unc-nonDpys and Dpy-Uncs in the 
progeny, whereas if the recombination were between zh95 and the unc marker, Unc-nonDpys, 
Dpy-Uncs and Unc-Muvs would be expected. With this method, one can estimate the genetic 
location of zh95 by calculating the ratio of the two segregation groups. In this study only the 
Unc-nonDpy recombinants were considered, because some of the Dpy-nonUnc recombinants 
were sterile, which might be due to an unknown genetic interaction. As shown in figure 4.9 B, 
16 Unc-nonDpy recombinants were found to segregate Unc-nonDpys, Dpy-Uncs and Unc-
Muvs and only 8 segregated Unc-nonDpys and Dpy-Uncs. The ratio between the segregation 
groups located zh95 closer to dpy-17 than to unc-69, namely to an estimated genetic location 
of -0.66cM. This genetic position was outside the region determined by FLP-mapping, to the 
left of the assay ZH3-05a (-0.59cM).  
Close to this position, two previously characterized negative regulators of the inductive 
pathway can be found: the synMuv genes lin-13 (-0.63cM) and lin-37 (-0.8cM) (Fay and 
Yochem, 2007). lin-13 encodes a protein of 2248 amino acids containing multiple zinc fingers 
of the C2H2 type and a LXCXE retinoblastoma binding motif (Meléndez and Greenwald, 
2000). With respect to vulval development, LIN-13 was found to be a synMuv B protein 
acting together with LIN-35/Rb to inhibit the inductive pathway. Interestingly, Meléndez and 
Greenwald (2000) furthermore showed that the null phenotype of lin-13 is temperature 
sensitive, meaning that single mutants show a Muv phenotype at 25°C, but at lower 
temperatures only in combination with a mutation in another negative regulator of the 
inductive pathway (e.g. a synMuv A). Meléndez and Greenwald hypothesize that the process 
in which lin-13 is functioning is temperature sensitive, rather than the mutant gene product. 
To test whether zh95 might be an allele of lin-13, the dependency of gap-1(ga133) for the 
Muv phenotype was assessed at 25°C. Similar to the results obtained by Meléndez and 
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Greenwald, zh95 seemed to exhibit a Muv phenotype independently of gap-1(ga133) at 25°C. 
This result suggests that zh95 is an allele of lin-13, as such temperature sensitive synthetic 
phenotypes are considered to be very rare. Sequencing or complementation assays were not 
performed due to time restrictions.  
Mutations in lin-37 are not likely to result in a synthetic Muv phenotype together with gap-
1(lf), since lin-37 is part of the synMuv B class of genes, whose mutants generally do not 
genetically interact with gap-1(lf) (Fay and Yochem, 2007). However, further 
complementation experiments need to be performed to rule out lin-37 or other candidates 
being affected by zh95. 
 
4.2.6 zh99 affects the gene encoding LET-19, a mediator subunit 
The double mutant zh99; gap-1(ga133) was found to be 64% Muv (figure 4.10 A) and 100% 
sterile. However, the Muv phenotype was determined to be independent of gap-1(ga133), 
rendering this mutant to a lower priority in this study. Moreover, zh99 showed a protruding 
vulva phenotype (Pvl) in 100% of the cases, which was also independent of gap-1(ga133). 
Interestingly, 16% of the overinduced animals showed a rather rare phenotype, as the 
posterior Pn.p cells (P9.p, P10.p, P11.p) seemed to have divided one round before fusing with 
hyp7. In one case, even P9.p was induced and formed an invagination. In wild-type animals it 
is known that expression of the Hox-factor LIN-39 protects the VPCs from fusion to hyp7. It 
is assumed that in the Pn.p cells, which fuse to hyp7, the expression of lin-39 is repressed by 
the canonical wnt-signalling pathway (Yoda et al. 2005). Additionally, the immunostaining of 
LET-23 showed basolateral localization (figure 4.10 B, arrowheads), suggesting that zh99 
likely encodes a negative regulator of the inductive pathway. Considering these findings, zh99 
encodes a gene involved in the process of cell fusion and hence negatively regulates vulval 
fates. 
By coincidence, it was also found that zh99; gap-1(ga133) males exhibit male tail 
development defects. As shown in figure 4.10 C-F, zh99; gap-1(ga133) animals have 
degenerated rays and spicules. These kinds of defects are also found in mutants that 
misexpress other hox factors, such as MAB-5 in specific cells of the male tail (Yoda et al. 
2005). 
FLP-mapping showed a clear linkage of zh99 to chromosome II with a slight bias to the right 
arm, as in Tier1 the assay ZH2-05 showed Bristol DNA in over 90% and the assay ZH2-09 in 
100% of 16 analyzed recombinant lysates (figure 4.11 A). Further FLP-mapping on 
chromosome II confined zh99 to a region bordered by the FLP-assays ZH2-20 
Part II: A forward genetic screen for gap-1(lf) interactors 
 
 112 
(8’612’029bp/0.83cM/ 1 recombinant) and ZH2-09 (11’359’409bp/3.44cM/ 2 recombinants). 
As only 3 informative recombinants have been found by analyzing a total of 192 recombinant 
lysates (accounts for 2x96well plates) the determined region might not be accurate.  
In order to confirm the FLP-mapping results, deficiencies were used to narrow down the 
region of zh99. Fortunately, Sigurdson et al. (1984) characterized a plethora of different 
deficiencies on chromosome II. Putting the deficiencies in trans to zh99 showed that mnDf89, 
mnDf16, mnDf29 and mnDf83 complemented the zh99 defects. In contrast mnDf66, mnDf85 
and mnDf80 failed to complement zh99 and resulted in sterile animals with Pvl phenotype 
(figure 4.11 B). The smallest positive deficiency used was mnDf80, which covers 
chromosome II from 0.86cM to 0.91cM, harbouring 59 genes. One of these genes was let-19 
(also known as mdt-13), which was determined to be a good candidate after literature review. 
The let-19(os33) mutant has been shown to result in a Muv phenotype and sterility, and os33 
failed to complement zh99. 
Moreover, the let-19(hd135) allele was shown to have on average 2.30.9 extra VPC 
divisions per animal (Clayton et al. 2008). Clayton et al. furthermore found that let-19 was 
involved in VPC quiescence. Earlier studies by Yoda et al. (2005) demonstrated that let-19 
encodes the orthologue of the human MED13/TRAP240 protein. This protein is a component 
of the Mediator complex, a multicomponent complex that can regulate transcription in a 
positive or negative manner, depending on the cellular context (Kornberg 2005). 
 
4.2.7 zh78 is a putative allele of lin-1 
The double mutant zh78; gap-1(ga133) was strongly Muv (figure 4.12 A) and very sick even 
after four rounds of backcrossing in the gap-1(ga133) background. Nevertheless it was 
possible to maintain the strain homozygous for zh78. The strong Muv phenotype was 
determined to be not dependent on the gap-1(ga133) allele. Hence, zh78 was a mutant with 
lower priority during this study. 
Visualizing LET-23 by immunostaining showed that the receptor is predominantly expressed 
on the basolateral plasma membrane of the vulval cells. Additionally LET-23 was expressed 
in unidentified vulval cells besides P6.p descendants (figure 4.12 B). Hence, zh78 most likely 
abrogates the function of a negative regulator of the inductive pathway. 
FLP-mapping of zh78 showed a clear linkage to chromosome IV with a slight bias to the left 
arm, as 100% of 16 recombinant lysates showed Bristol DNA in the assay ZH4-05 and around 
95% of the lysates in the assay ZH4-10a (figure 4.12 C). Tier2 FLP-mapping on the left arm 
of chromosome IV confined the region for zh78 between the assays ZH4-05 (1’740’251bp/-
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15cM) and ZH4-16 (4’581’704bp/0.48cM) (figure 4.12 D). This region contains 517 
predicted genes. Since in this particular experiment the resolution of the automated FLP-
mapping approach was not exploited, the analyzed samples should be assessed with FLP 
assays within the region between ZH4-05 and ZH4-16. Most likely more recombinant lysates 
would have to be analyzed in order to determine a reliable region. 
Among the genes from the determined region, we suspect lin-1 being a very good candidate 
for zh78, as it is a well-characterized negative regulator of vulval fates. LIN-1 is a nuclear 
protein and target of MPK-1 in the VPCs. Before induction, LIN-1 represses vulval fates 
together with LIN-31. Once MPK-1 phosphorylates this complex, LIN-1 and LIN-31 
dissociate from each other and their repressing function is abolished (Tan et al. 1998). 
Mutants of lin-1 exhibit a very strong Muv phenotype which is independent of gap-1(lf). 
Considering the high phenotypic similarity of lin-1 alleles with zh78, we wished to perform a 
complementation assay with the previously characterized allele lin-1(n304) (Beitel et al. 
1995). Unfortunately the crosses were unsuccessful, most probably because both lin-1(lf) and 
zh78 animals are very sick. Therefore, the coding regions of lin-1 were sequenced (except 
exon 5, where sequencing failed for unknown reasons) but no mutation was found. Hence, it 
is not clear, which gene is affected by zh78. Further mapping experiments need to be 
performed to reduce the putative region determined by FLP-mapping and to propose and test 
further candidate genes. 
 
4.2.8 Summary 
In this study, six mutant strains exhibiting a Muv phenotype were isolated from a forward 
genetic screen in the gap-1(ga133) background. The characterization and mapping of these 
mutants are summarized in Table 4.1. 
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4.3 Discussion 
The second approach to find regulators of LET-23 during vulval development was based on 
forward genetics. An EMS mutagenesis screen was performed in a gap-1 loss-of-function 
background and strains with a Multivulva phenotype were isolated. The same setting was 
already used to exclusively find mutants that are homozygous fertile (Canevascini et al. 2005, 
Walser et al. 2006, Stetak et al. 2008, personal communication A. Hajnal). In order to find 
uncharacterized components of vulval development, this study’s goal was to additionally 
screen for mutants that are homozygous sick or sterile. In total, 15 mutant lines were isolated 
and six (zh78, zh94, zh95, zh96, zh98 and zh99) were chosen for further characterization, as 
the other lines showed either a very variable or a very low penetrant phenotype. 
 
4.3.1 A gap-1(lf) enhancer screen can reveal factors involved in LET-23 localization 
Two mutants zh96 and zh98 seemed to affect genes involved in the localization of LET-23, as 
immunostaining of the receptor in the respective gap-1(lf) double mutant showed 
predominant apical expression of LET-23. Interestingly, zh98 was homozygous fertile when 
isolated after mutagenesis. In contrast, zh96 was homozygous sterile when isolated, but turned 
out to be fertile after 4 rounds of outcrossing with gap-1(ga133) animals. This finding 
suggested that during mutagenesis other mutations besides zh96 were generated, which 
affected the animal’s fitness. These other mutations were “eliminated” by the outcrossing 
procedure. FLP-mapping soon showed that zh96 is located in the same region as lin-2 on the 
X chromosome. Sequencing the exons of the lin-2 gene in zh96 animals revealed a C to T 
transition, which exchanges Q700 with a premature STOP. Similarly, zh98 turned out to be an 
allele of lin-7. These results emphasize the rationale of the screen and serve as positive 
controls. Unfortunately, the remaining 4 mutant lines did not show mislocalized LET-23, but 
rather ectopic basolateral expression in the VPCs. The ectopic expression of LET-23 indicates 
a cell fate transformation from tertiary/secondary to primary vulval fate. Altogether, these 
findings show that zh78, zh94, zh95 and zh99 might encode negative regulators of the LET-23 
pathway. During the first steps of characterization it was found that the Muv phenotype in 
zh94 and zh95, but not in zh78 and zh99 was dependent on gap-1(ga133). Nevertheless, the 
characterization and mapping of these mutants was continued, as identifying novel negative 
regulators of the inductive pathway would be of high interest. 
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4.3.2 zh94 is a mutant allele of the conserved RasGAP gene gap-3 
The double mutant zh94; gap-1(ga133) showed a Muv phentoype, which was completely 
dependent on gap-1(ga133). These animals also had reduced fertility and none of the 
observed phenotypes changed after outcrossing the mutant in gap-1(ga133) animals. LET-23 
localization in these animals seemed to be predominantly on the basolateral compartment, 
indicating that zh94 abrogates the function of a negative regulator of the inductive pathway.  
The FLP-mapping of zh94 was at first misleading, as the mapping strain Hawaii; gap-
1(ga133) was not suitable to map mutations on the left arm of chromosome I. We analyzed 
the DNA composition of the Hawaii; gap-1(ga133) strain on the left arm of chromosome I 
and found Bristol DNA at the position of ZH1-17. It is not exactly known, why this specific 
part of the genome was not exchanged by Hawaii DNA. This selection event might indicate 
that worms harbouring Bristol DNA around the loci of ZH1-17 are fitter than those with 
Hawaii DNA. Similarly, Seidel et al. (2008) found a genetic incompatibility locus between 
Bristol and Hawaii, also located on the left arm of chromosome I, but this does not cover the 
region of the FLP assay ZH1-17. These findings indicate that there might be several such 
incompatibility loci between Bristol and Hawaii. Thus, the generation of mapping strains 
constituting Hawaii DNA in a sensitized background generated in a Bristol background can 
lead to misinterpretations during the mapping procedure. Therefore, in order to map zh94, 
pure Hawaii animals were used in the crossing scheme as shown in figure 4.13 B. 
One of the candidates in this region was the gene gap-3, previously described by our group 
(Stetak et al. 2008). Indeed, complementation analysis showed that gap-3(ga139) failed to 
complement zh94 in a gap-1(ga133) background. Furthermore, it was found that the gap-3 
cDNA of zh94 animals harboured a point mutation at the beginning of the last exon, resulting 
in a premature STOP codon within the RasGAP domain of GAP-3 (Q872STOP, figure 4.7 A 
and B). The gap-3(ga139) allele encodes a similar point mutation within the RasGAP domain 
(Q844STOP, figure 4.7 B). Both, gap-3(ga139) and zh94 showed a similar effect when 
combined with gap-1(ga133) as shown by Stetak et al. (2008): in gap-3(ga139); gap-
1(ga133) double mutants, the VPC induction index was determined to be 4.03 (n=35), 
compared to zh94; gap-1(ga133) animals with an average indcution of 3.79 (n=31). These 
results strongly indicated that zh94 is a loss-of-function allele of the RasGAP activity of 
GAP-3. 
GAP-3 is the C. elegans orthologue of the human p120-type RasGAP, an inhibitor of LET-60 
RAS redundant to two other RasGAPs, gap-1 and gap-2. The three RasGAPs have different 
tissue specificities, assessed by the potential of the gap-mutants to suppress phenotypes 
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caused by let-60(rf) alleles. In this way it was determined that GAP-3 is the main inhibitor of 
LET-60 during germ cell development, where it regulates the exit of the germ nuclei from the 
pachytene stage. Furthermore, it was shown that gap-3 plays a minor role in other processes 
such as vulval development, sex myoblast positioning, P12.p specification and excretory duct 
cell specification. LET-60 RAS is also involved in behavioural processes such as 
chemosensation, in which all three gap genes seem to contribute equally in the inhibition of 
LET-60 (Stetak et al. 2008). The main gap-3 allele used by Stetak et al. (2008) is ga139. zh94 
was used to support the finding that the gap-3 gene encodes a negative regulator of LET-60, 
as rescue experiments with a gap-3 minigene introduced into gap-3(ga139); gap-1(ga133) 
animals did not show any effect (A. Stetak, personal communication). 
 
4.3.3 zh95 is a putative allele of lin-13 
As shown in figure 4.8, zh95; gap-1(ga133) animals showed a highly penetrant Muv 
phenotype at 20°C. LET-23 localization in these double mutants was predominantly 
basolateral in the VPCs. Therefore zh95 was classified as a putative negative regulator of the 
EGFR/Ras/MAPK pathway.  
The mapping of zh95 turned out to be accompanied by contradicting results, as the FLP 
approach determined a region on chromosome III between the FLP assays ZH3-05a and ZH3-
32 (figure 4.8 D). In contrast, 3 different overlapping deficiencies spanning this region 
complemented the zh95; gap-1(ga133) Muv phenotype (figure 4.9 A), indicating that zh95 
lies outside this region. The region assessed by the FLP-approach was based on only three 
informative recombinants, which renders this region to a rather poor reliability. For an 
unknown reason, only few Hawaii recombinants were obtained in this region of chromosome 
III. Therefore, another mapping approach was used. Classical three-factor mapping placed 
zh95 at the genetic position of -0.66cM. This position lies outside of the region determined by 
FLP-mapping, left from ZH3-05a (-0.59cM). Three-factor mapping was thus consistent with 
the findings by the deficiency mapping and showed that the results obtained by FLP-mapping 
are not reliable, most likely because of the lack of a higher number of informative 
recombinants. 
Around the genetic position -0.66cM, two candidates were found by literature search: lin-37 
and lin-13 (Fay and Yochem, 2007). Both candidates are previously characterized synMuv 
genes found to negatively regulate the LET-23 pathway. Interestingly, Meléndez and 
Greenwald (2000) found that loss-of-function alleles of lin-13 exhibited a peculiar 
temperature sensitivity, as lin-13(lf) animals exhibit a wild-type phenotype at 15°C, but 
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develop a Muv phenotype at 25°C. Considering these findings, zh95 was assessed for this 
temperature sensitive phenomenon. Indeed, zh95 seemed to exhibit a Muv phenotype 
independent of gap-1(ga133) at 25°, in contrast to 20°C, where the Muv phenotype was 
dependent on gap-1(ga133). To our knowledge, this kind of temperature sensitivity is a rather 
seldom phenomenon, which was not studied further. However, this phenotypic resemblance 
between zh95 and lin-13 alleles makes lin-13 a very likely candidate for the zh95 allele. So far 
no further experiments were performed to show that this is really the case. Complementation 
analysis with previously characterized alleles of lin-13 would be the approach of choice, as 
sequencing the cDNA of lin-13 (6’747bp) would be costly and very time consuming. 
lin-13 encodes a protein with various zinc-fingers of the C2H2 type. Meléndez and 
Greenwald (2000) show that LIN-13 harbours a LIN-35/Rb binding motif, and they 
hypothesize that this complex is part of the synMuv B branch, which antagonizes the 
inductive pathway. Interestingly, as the loss-of-function mutations are concerned, Meléndez 
and Greenwald hypothesize that not these mutations themselves, but rather the process in 
which LIN-13 is involved seems to be temperature sensitive.  
 
4.3.4 zh99 is most likely an allele of let-19/mdt-13 
zh99; gap-1(ga133) animals exhibited a 100% penetrant Pvl, a 64% penetrant Muv (figure 
4.10 A) and a 100% penetrant sterility phenotype. It was found that the vulval phenotypes 
were independent of gap-1(ga133), which rendered this mutant to a lower priority of 
characterization and mapping within this study. LET-23 localization appeared to be 
predominantly on the basolateral plasma membrane compartment of the VPCs, indicating that 
zh99 affects a negative regulator of the LET-23 pathway (figure 4.10 B). By coincidence it 
was found that zh99; gap-1(ga133) exhibited male tail developmental defects, as the rays 
were degenerated or missing (figure 4.10 D) and the spicules were missformed (figure 4.10 F) 
compared to the control animals (figure 4.10 C and E respectively). 
FLP-mapping showed a clear linkage to chromosome II (figure 4.11 A) but did not reveal 
enough information to determine a subchromosomal region of good confidence. Therefore, 
deficiencies were used to confirm this region and to increase the resolution of mapping. 
Sigurdson et al. (1984) established and characterized a plethora of deficiencies on 
chromosome II. The smallest deficiency used (mnDf80) harbours 59 genes from which let-19 
was found as a candidate by literature search. let-19 encodes a subunit of the Mediator 
complex, which is known to regulate transcription of target genes by influencing the activity 
of the RNA polymerase (Kornberg 2005). Clayton et al. (2008) showed that LET-19 is 
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important for cell-cycle arrest of the VPCs prior to induction. Removing let-19 activity 
resulted in 2.3±0.9 extra VPC divisions per animal on average. Furthermore, Yoda et al. 
(2005) found that the let-19(mn19) allele showed fusion defects of Pn.p cells, that usually fuse 
to the hypodermal syncitium hyp7. As indicated in chapter 4.2.6, zh99 worms showed an 
increased number of posterior Pn.p cells. In one animal even P9.p was induced, leading to the 
conclusion that the fusion of the posterior Pn.p cells was disturbed. Considering the similarity 
of the defects described for let-19 alleles and zh99, a complementation assay was performed, 
which showed that zh99 most likely represents an allele of let-19. Since zh99 was not a 
mutant of high priority, the time consuming and costly sequencing of the let-19 cDNA 
(8’589bp) was not considered. 
Given the facts collected by Yoda et al. (2005) and Clayton et al. (2008), LET-19 controls the 
cell-cycle arrest of the VPCs and the fusion of all Pn.p cells to hyp7, rather than inhibiting the 
LET-23 pathway directly. The model is that unfused Pn.p cells stay competent to receive and 
process the inductive signal originating from the AC. gap-1(lf) thus renders unfused VPCs 
sensitive to be induced by the AC. 
 
4.3.5 zh78 might be an allele of lin-1 
zh78 was found to exhibit a strong Muv phenotype, which was independent of gap-1(ga133) 
(figure 4.12 A). Therefore, zh78 was a mutation with a relatively low priority for 
characterization and mapping. LET-23 localization was assessed by immunostaining and 
found to be predominantly basolateral in the VPCs, indicating that the affected gene might 
encode a negative regulator of the LET-23 pathway.  
FLP-mapping placed zh78 on the left arm of chromosome IV to a region harbouring 517 
predicted genes (figure 4.12 A and B). No further mapping experiments were performed 
because of the low priority of zh78 and time restrictions. However, the previously 
characterized negative regulator of vulval induction lin-1 was found in the interval mentioned 
above. Since lin-1 loss-of-function alleles show a very strong Muv phenotype independently 
of gap-1(lf) it is possible that zh78 represents an allele of lin-1. Complementation crosses with 
the lin-1(n304) allele failed most probably because the animals were very sick. Sequencing 
the coding regions of lin-1 (except exon 5) in zh78 animals did not reveal any mutations. In 
order to map zh78, it might be useful to repeat the complementation analysis with lin-1(n304), 
since among the 517 genes no other obvious candidate genes are found. Assuming that zh78 is 
not an allele of lin-1, it would be worth to continue the mapping of this mutant, as it seems to 
be an important negative regulator of vulval development. 
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However, it is very unlikely that zh78 defines an uncharacterized inhibitory gene, as most 
negative regulators exhibiting a phenotype as single mutants have probably already been 
found. We assume that new regulators of vulva development might only be found by 
screening in sensitized backgrounds for a synthetic phenotype. 
 
4.3.6 Concluding remarks 
In this chapter, a forward genetic screen for synthetic Multivulva animals in a gap-1(ga133) 
background was presented. Six mutant strains were isolated, characterized and mapped. The 
novel alleles lin-2(zh96) and lin-7(zh98) showed apically mislocalized LET-23 in the VPCs 
and validated the concept of the forward genetic screen in a gap-1(lf) background. 
Additionally, the novel allele gap-3(zh94) was isolated, which supported the previous 
findings of A. Stetak with the gap-3(ga139) allele. GAP-3 was found to be a negative 
regulator of LET-60 mediated processes, redundantly with GAP-1 and GAP-2 (Stetak et al., 
2008). 
The mutant zh95 exhibited a temperature sensitive synthetic Muv phenotype with gap-
1(ga133). Similar findings by Meléndez and Greenwald (2000) highly suggest lin-13 as a 
candidate for zh95. Complementation analysis has to be performed to confirm this notion. 
zh99 was found to exhibit a Muv phenotype independently of gap-1(ga133). Hence, the 
characterization of this mutant had a lower priority within this study. let-19 is a very likely 
candidate for the zh99 mutation, as let-19(os33) failed to complement zh99. However, the 
sequencing of the let-19 locus was not performed, mainly because of time restrictions. 
Another mutant, which showed a Muv phenotype independent of gap-1(ga133), was zh78. 
The FLP-mapping approach was not exploited to full extend. However, the mapping 
experiments position zh78 on the left arm of chromosome IV. A prominent negative regulator 
in this region is lin-1. Unfortunately, the complementation crosses failed and have to be 
repeated. 
In total, progeny of 1400 F1 animals (figure 4.2) were screened for a Muv phenotype. All 
mutants mapped represent previously characterized regulators of the inductive pathway (zh96, 
zh98 and zh94) or genes involved in the regulation of the Pn.p cell fusion to hyp7 (zh99). It is 
clear that this screen was not saturated for various reasons: first, other known genetic 
interactors of gap-1 such as lin-10 (Hajnal et al. 1997) and puf-8 (Walser et al. 2006), were 
not picked up in this screen. Second, the novel mutants of lin-2, lin-7 and gap-3 discovered in 
this screen were only single hits. Third, a preliminary genome-wide RNAi screen in a gap-
1(ga133) background indicated the existence of many more genetic interactors of gap-1 (See 
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chapter 5). Therefore, it is very likely that gap-1(lf) as a sensitized background in genetic 
screens has not been exploited to full extent yet. 
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4.4 Methods 
 
4.4.1 Mutagenesis procedure for the forward genetic screen 
EMS (ethyl methane sulfonate) is an alkylating agent, which can induce point mutations or 
small deletions in DNA molecules. gap-1(ga133) worms were grown on ten 6cm petri dishes 
and bleached as soon as many adults were gravid. Synchronized eggs were transferred on 
NGM plates without food and let hatch o/n at 20°C. On the next day, the L1 larvae were 
transferred to NGM plates with OP50 bacteria and incubated for 2 days at 20°C. Animals 
were collected at the L4 stage with sterile M9 (figure 4.2, P0 generation). Worms were 
washed three times using sterile M9 and the final volume of the suspension was set to 2ml. 
Spinning steps were always performed at 1’000rpm for 2 minutes. In parallel, a 100mM EMS 
solution in 2ml sterile M9 was generated. After dissolving the viscous EMS in the M9 buffer, 
the solution was transferred to the worm suspension. Worms in EMS solution were incubated 
for 4 hours at room temperature while rocking. After mutagenesis, the worms were washed at 
least 3 times with sterile M9 to remove remaining EMS. The final volume was set to 1ml and 
the worm suspension was distributed on 10 NGM plates with OP50 and kept overnight (at 
least 12 hours) at 20°C. 
 
4.4.2 Organization of mutagenized worms and screening 
100 mutagenized P0 animals were distributed on 10 NGM plates with OP50 (10 worms per 
plate) and kept for 3 days at 20°C until the F1 progeny reached the L4 stage (figure 4.2, F1 
generation). In each mutagenesis round, 200-500 F1 animals were singled out on NGM plates 
with OP50 and subsequently incubated for 5 to 7 days at 20°C. The F2 generation (figure 4.2) 
was screened for animals with a Muv phenotype. Once a positive plate was determined, the 
strain was maintained by picking 12 wild-type looking worms, which were either +/+ or 
mutant/+. Muv animals that were fertile were maintained homozygous and sick animals were 
maintained heterozygous. In total, the progeny of 1400 F1 plates were analyzed.  
 
4.4.3 Automated FLP mapping 
An automated high-throughput mapping method based on fragment length polymorphisms 
(FLPs) was established at the University of Zurich (Zipperlen et al. 2005). This approach uses 
sequence polymorphisms called InDels (small insertions or deletions), which appear to be 
unique for certain wild-type isolates of C. elegans. The laboratory wild-type background 
originates from a Bristol isolate (N2). For this mapping approach we use additionally the 
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Hawaii isolate (CB4856). Zipperlen et al. (2005) established PCR assays, which can 
differentiate between Bristol and Hawaii DNA at specific loci along all the 6 chromosomes of 
C. elegans (figure 4.13 A). Physical and genetic positions of the FLP-assays can be found in 
Zipperlen et al. (2005).  
Mutant hermaphrodites, generated in a Bristol background, were crossed with Hawaii males, 
and wild-type F1 cross-progeny were isolated. Self-progeny exhibiting the mutant phenotype 
were lysed for genotyping. Different classes of recombinants can be recovered from these 
crosses as indicated in figure 4.13 B. The loci that were positive for Hawaii DNA are 
therefore excluded as a putative region for the corresponding mutation. Tier1 experiments 
determine the chromosomal linkage by analyzing 16 recombinant lysates with 2 FLP-assays 
per chromosome. The assay with the highest percentage of Bristol DNA would therefore 
indicate the chromosome on which the mutation was generated. Tier2 experiments determine 
the sub-chromosomal region by analyzing at least 48 recombinant lysates with 8 FLP-assays 
of choice. Depending on the mutant that was being mapped, variable amounts of 
recombinants were generated and analyzed. 
This study deals with Muv phenotypes that are synthetically generated when combined with 
the gap-1(ga133) mutation. In order to increase the frequency of recombinants exhibiting a 
Muv phenotype, a modified mapping strain was used by crossing gap-1(ga133) into the 
Hawaii strain in 6 subsequent rounds. This Hawaii; gap-1(ga133) strain was found to work 
for the mapping of zh78, zh96 and zh98, but could not be used for the left arm of chromosome 
I due to residual Bristol DNA in this region. 
 
4.4.4 Manual SNP-mapping 
Single nucleotide polymorphisms were used during the mapping process of zh95. The SNPs 
were chosen from www.wormbase.org and correspondent PCR assays were established to 
amplify and sequence the loci. The SNPs used to map zh95 on chromosome III and the 
corresponding primers are listed below. 
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SNP Genetic position Primers 
pkP3048 -0.58 cM OPG273 
TCTTACAAAGCTAACGTGTAACGC 
OPG274 
GATATAGGAACGTGGAAACTTACG 
CE3-166 -0.57 cM OPG271 
CGGTTCCGAATTTCAATTGGATCG 
OPG272 
AGTAAGAGGAGTCACCATCAATCG 
uCE3-1047 -0.48 cM OPG269 
TTCGCTAAATCCTACGGGGCACCG 
OPG270 
TCCATTCGAAATCCTTCACCAGCC 
snp_C14B9 -0.38 cM OPG267 
GTTAGTATGCTGACCACCACTACG 
OPG268 
TGACAGATGAAACGTTGCATATGC 
snp_C50C3 -0.37 cM OPG265 
ATCGACAACATCAGAATGGCTTCG 
OPG266 
ACATCAAGCATACCGAATGCGTCG 
snp_F09G8 -0.35 cM OPG263 
TCTTGCTTCATTACCAGGATCAGC 
OPG264 
AGACTGACTGACAATCATTGGTGC 
CE3-171 -0.27 cM OPG261 
GTAAGCTTCAAGCATTCCAGCGGC 
OPG262 
TTTGCAGCTCACCAACGAGGATGC 
oxP1 -0.26 cM OPG259 
ACCTTTTGGAACTTCAATCCGACG 
OPG260 
TTGTGCTGTAGAAGTCGTTGGTCG 
 
4.4.5 Alleles 
LGI: gap-3(ga139) 
LGII: let-19(os33), lin-7(e1413) 
LGIII: dpy-17(e164), unc-69(e587), rfp-1(ok572) 
LGIV: lin-1(n304) 
LGX: gap-1(ga133), lin-2(n105) 
Rearrangements:  hT2[bli-4(e937) let-?(q782) qIs48] (I;III) 
   mIn1[mIs14 dpy-10(e128)] (II) 
 
4.4.6 Whole-mount immunostaining 
See chapter 3.5.5 
 
Part II: A forward genetic screen for gap-1(lf) interactors 
 
 124 
 
Part II: A forward genetic screen for gap-1(lf) interactors 
 
 125 
 
Part II: A forward genetic screen for gap-1(lf) interactors 
 
 126 
 
Part II: A forward genetic screen for gap-1(lf) interactors 
 
 127 
 
Part II: A forward genetic screen for gap-1(lf) interactors 
 
 128 
 
Part II: A forward genetic screen for gap-1(lf) interactors 
 
 129 
 
Part II: A forward genetic screen for gap-1(lf) interactors 
 
 130 
 
Part II: A forward genetic screen for gap-1(lf) interactors 
 
 131 
 
Part II: A forward genetic screen for gap-1(lf) interactors 
 
 132 
 
Part II: A forward genetic screen for gap-1(lf) interactors 
 
 133 
 
Part II: A forward genetic screen for gap-1(lf) interactors 
 
 134 
 
Part II: A forward genetic screen for gap-1(lf) interactors 
 
 135 
 
Part II: A forward genetic screen for gap-1(lf) interactors 
 
 136 
 
Mutant Muv dep. on 
gap-1(lf) 
Mislocalized 
LET-23 
Fertility Back -
crossed 
LG Candidates Fails to 
complement 
PM 
zh96 yes yes fertile 4x X lin-2* lin-2(n105) yes 
zh98 yes yes fertile 0x II lin-7* lin-7(e1413) yes 
zh94 yes no partial 
fertile 
4x I smo-1* 
gsa-1* 
dapk-1 
Y92H12BR.8 
gap-3* 
gap-3(ga139) yes 
zh95 yes (20°C) 
no (25°C) 
no sterile 4x III apc-2* 
gsto-1* 
ZK652.6* 
lin-37 
lin-13 
- - 
zh99 no no sterile 0x II let-19 let-19(os33) - 
zh78 no no partial 
fertile 
4x IV lin-1† - - 
 
Table 4.1: Summary of the phenotypic characterization and mapping of the six isolated mutants. 
Characterization of the mutants zh96, zh98, zh94, zh95, zh99 and zh78 involved assessing the Multivulva 
phenotyp and its dependence on the gap-1(ga133) background, immunostaining of LET-23 and the fertility. The 
corresponding linkage groups (LG), as well as some of the candidates deduced by either RNAi or literature 
search are listed. Candidates, whose coding regions have been sequenced are indicated with an asterisk. †lin-1 
coding regions sequenced except exon 5. The alleles used for the complementation crosses are indicated. PM 
indicates whether a point mutation was found in the coding regions of the correspondent candidate. 
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5. Part III: A preliminary genome-wide RNAi screen in a gap-1(lf) 
background 
 
5.1 Introduction 
 
5.1.1 RNAi is a powerful reverse genetics tool 
Craig Mello and Andrew Fire discovered RNA interference (RNAi) and established it as a 
genetic tool in C. elegans for in vivo gene silencing (Fire et al. 1998). Providing cells with 
dsRNA of a certain targeted gene initiates its degradation (Fire et al. 1998). They were 
rewarded with the Nobel Prize in Physiology or Medicine in the year 2006.  
The Ahringer laboratory was interested in using RNAi for high-throughput screening and 
established a large library of 16’757 bacterial clones, each of which possessed a plasmid with 
a unique sequence targeting in total approximatively 86% of the predicted genes in C. elegans 
(Kamath et al. 2003). This sequence was flanked by the T7 promotor and hence the 
production of dsRNA of the corresponding sequence was inducible by IPTG. By feeding C. 
elegans with the dsRNA-producing bacteria, the downregulation of the targeted gene can be 
accomplished (Kamath and Ahringer 2003). The RNAi library made it possible to 
systematically analyze the function of genes on a genomic level (Kamath et al. 2003). Since 
then, many different laboratories have been successfully using the Ahringer RNAi library in 
genome-wide screens (Kamath et al. 2003, Simmer et al. 2003, Poulin et al. 2005, Hamilton et 
al. 2005). However, RNAi seems not to be completely effective, as some RNAi clones did not 
show any effect compared to the corresponding mutant phenotypes (Kamath et al. 2003). 
Sijen et al. (2001) and Simmer et al. (2003) reported that mutations in the gene rrf-3 render 
the animals hypersensitive for RNAi, thereby increasing the potential of the technique to 
analyze gene function. 
 
5.1.2 Rationale of the preliminary genome-wide RNAi screen presented in this study 
The RNAi screen presented in this section underlies the same rationale as described in chapter 
4.1. The allele gap-1(ga133) was used as a sensitized background to screen for Multivulva 
animals. Downregulation of other attenuators of the EGFR/Ras/MAPK pathway or regulators 
of LET-23 localization in gap-1(ga133) animals can result in the synthetic Muv phenotype 
(see figure 4.1). 
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Two lines of interest were followed during this project: first, the RNAi experiments that result 
in a Muv phenotype would constitute a list of candidate genes, which would aid the mapping 
process of the mutants isolated in the forward genetic screen presented in chapter 4 of this 
study. Second, to our knowledge nobody ever performed an RNAi screen on a genome-wide 
level in a gap-1(lf) background. It was therefore of great interest to determine if the forward 
genetic screens in a gap-1(lf) background were saturated or not and to exploit and compare 
the two different genetic approaches. On the other hand, it is clear that mutagenesis screens 
can lead to very specific alleles of genes, which might render them constitutivly active or just 
inactivate a certain domain of a gene product. These kinds of genetic interactions would not 
be found in an RNAi screen, as the downregulation of the target gene affects the total gene 
activity. Nevertheless, mutations which totally inactivate a certain essential gene activity 
cannot be maintained, but might be uncovered in an RNAi approach, where downregulation 
of some genes might not be fully efficient. 
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5.2 Results 
 
The RNAi screen presented in this section was performed in collaboration with the Poulin 
laboratory in Manchester. The resulting candidate lists are called the “Manchester Dataset” 
henceforth. The Ahringer library clones of chromosomes I, II and III were fed to rrf-
3(pk1426); gap-1(ga133) animals at the L4 stage and the progeny was screened for a 
Multivulva phenotype under the dissecting microscope. In total, 8’718 RNAi experiments 
were performed and screened and the positive experiments were grouped into three classes. 
“Muv>4” constitutes the high confidence class, as more than four Multivulva (Muv) animals 
were scored. “Muv2-4” were determined to be the class of middle confidence, as only two to 
four Muvs were scored per plate. The third class was called “Muv1”, which constituted all 
clones, where only one Muv animal was observed and hence represented the low confidence 
class. 
 
5.2.1 Thirty-six candidates constitute the high confidence class 
From the 8’718 RNAi experiments, thirty-six were part of the “Muv>4” class, which are 
listed in Table 5.1. This class of positives was of high confidence for various reasons: first, 
the penetrance of the Muv phenotype was often in a striking range (20% or higher, data not 
shown). Second, within this list previously characterized genetic interactors of gap-1 were 
found. For example, the puf-8 (Table 5.1, row 22) gene product was shown to regulate the 
temporal competence of the VPCs (3° cell fusion to hyp7 delayed) and consequently puf-
8(zh17); gap-1(ga133) animals exhibited a synthetic Muv phenotype (Walser et al. 2006). 
Downregulation of fbf-1 and fbf-2 (Table 5.1, rows 19, 20) was also found to cause a highly 
penetrant Muv phenotype in a gap-1(ga133) background. In contrast, neither fbf-1(ok91); 
gap-1(ga133) nor fbf-2(q738); gap-1(ga133) were reported to exhibit a Muv phenotype 
(Walser et al. 2006). The explanation for the findings in the RNAi screen is that both fbf-1 
and fbf-2 share over 90% identity on the nucleotide level and RNAi against either gene would 
downregulate both fbf’s. Accordingly, 94% of the fbf-1(ok91) fbf-2(q704); gap-1(ga133) 
triple mutants displayed a Muv phentoype (Walser et al. 2006). The fact that puf-8, fbf-1 and 
fbf-2 were identified in the RNAi screen presented in this study, validates the rationale of the 
screen. 
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5.2.2 The rrf-3(pk1426); gap-1(ga133) background results in many false positives 
209 RNAi experiments showed two to four Muvs, and 916 showed one Muv per plate. These 
findings indicated at first sight that approximatively 10% of the C. elegans genes would 
genetically interact with gap-1. This finding is unlikely to be true and hence control 
experiments were performed. First, 96 RNAi experiments from the screen were repeated 
twice (96well plate #49 of the Ahringer library). Indeed, most of the positives from the 
category “Muv2-4” and “Muv1” were not reproducible. Only the positives from the “Muv>4” 
class were clearly reproducible and hence represent the category of high confidence. It is still 
possible that some of the RNAi experiments from both “Muv2-4” and “Muv1” categories 
represent true positives, but since the penetrance is that low (in average 100 worms per plate), 
repetition experiments would be needed to determine them. Repetition of all positives from 
the categories of low confidence was not feasible due to time restrictions. 
It was hypothesized, that the combination of the rrf-3(pk1426) with the gap-1(ga133) allele 
might be the cause of the high frequency of false positives. In order to test this possibility, the 
double mutant rrf-3(pk1426); gap-1(ga133) was scored for Muvs on NGM-plates with OP50 
(“RNAi off”). Indeed, scoring 8’674 rrf-3(pk1426); gap-1(ga133) animals revealed a very 
low penetrant Muv phenotype. Of the 8’674 scored animals, two were Muv, two Pvl, two 
showed general body morphology defects and nine exhibited the “roller” phenotype. This low 
Muv penetrance might not be a problem if one conducts a few RNAi experiments. However, 
in a large-scale context as this high-throughput RNAi screen, it can generate a high rate of 
false positives. Assuming that in average 100 worms are scored in each RNAi experiment, 
9’600 animals would be present in 96 experiments. Comparing these numbers to the Muv 
penetrance of rrf-3(pk1426); gap-1(ga133) makes it clear that roughly two to three “Muv1” 
observations are possible within 100 RNAi experiments. G. Poulin and K. Fisher performed 
further control experiments, where the rrf-3(pk1426); gap-1(ga133) double mutant was tested 
on either 96 RNAi experiments targeting gfp and 96 RNAi experiments targeting dpy-2 
(“RNAi on”). Consistent with our findings from the main screen, eleven and eight 
experiments were determined to be of the “Muv1” class in the gfp and dpy-2 RNAi 
respectively. One additional experiment targeting dpy-2 was of the “Muv2-4” category. 
Alltogether, these results demonstrate that the rrf-3(pk1426); gap-1(ga133) is the likely cause 
for the high number of false positives in our screen. 
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5.3 Discussion 
 
A preliminary genome-wide RNAi screen for Multivulva animals was performed in the gap-
1(ga133) background. All clones for targets on chromosomes I, II and III of the Ahringer 
RNAi library were screened (Kamath et al. 2003). Of the 8’718 RNAi experiments, Thirty-six 
constitute the high confidence list of positives (Table 5.1). Within these 36 candidates, puf-8, 
fbf-1 and fbf-2 were previously characterized genetic interactors of gap-1 (Walser et al. 2006). 
Most of these 36 candidates did show a Muv phenotype dependent on gap-1(ga133) in 
repetition experiments (G. Poulin, personal communication). Furthermore, some of these 
candidates were downregulated in wild-type animals harbouring the early 1° cell fate marker 
egl-17::cfp (transgene arIs92, Yoo et al. 2004). In wild-type worms egl-17::cfp is only 
expressed in the P6.p lineage during early vulval development. In contrast, downregulation of 
some of the high confidence candidates (Table 5.1) resulted in egl-17::cfp expression in the 
P5.p or P7.p lineages (G. Poulin, personal communication). These findings indicate, that the 
rationale of the genetic screens in a gap-1(lf) background is valid, and that it is possible to 
find new attenuators of the inductive pathway. However, the positive genetic interactions 
found with RNAi should be tested with mutants of the corresponding genes. 
As stated above, one of the reasons this screen was performed was to generate a candidate list 
of genetic interactors of gap-1, which would serve as a mapping aid for the mutants isolated 
in the forward genetics screen (chapter 4). The mutants lin-2(zh96) (LG X) and lin-7(zh98) 
(LG II) were already mapped before the RNAi screen was performed. In retrospective, the 
candidate list obtained by the RNAi screen was not of great help to map the remaining 
mutants, since let-19 RNAi did not show any effects and the RNAi clones for gap-3 (LG I) 
and lin-13 (LG III) were not present in the Ahringer library. The zh78 mutation was placed on 
chromosome IV by FLP-mapping, a chromosome which was not covered in this RNAi screen. 
So far, it is not clear if some of the 36 candidates encode proteins that are involved in LET-23 
localization. Repetitions of these RNAi experiments with subsequent immunostaining of 
LET-23 or using a LET-23::GFP reporter might answer this question. However, since both 
RNAi and immunostaining of LET-23 are techniques with variable effectiveness, it is 
important to construct the corresponding double mutants and analyze those for LET-23 
localization. 
Once the genetic interaction with gap-1(lf) is validated by mutants, one can start to compare 
the forward (chapter 4) and reverse genetic approach (chapter 5) and test, whether they are 
biased or not. Confirming some of the positive candidates found by RNAi would indicate that 
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the forward genetic screens in gap-(lf) sensitized backgrounds are not saturated yet, since to 
our knowledge only puf-8 of the thirty-six candidates was found in a mutagenesis screen 
(Walser et al. 2006). From these thirty-six candidates, two are discussed below in more detail. 
 
5.3.1 The candidate gene cdc-37 
The gene cdc-37 was among the thirty-six high confidence positives from the RNAi screen 
(Table 5.1). CDC-37 is the C. elegans orthologue of the human co-chaperone of Hsp90. Beers 
and Kemphues (2006) reported that RNAi of cdc-37 causes polarity defects in the early 
embryo, most likely because it affects the localization of the PAR-proteins. The proteins 
PAR-1 and PAR-2 localize to the posterior cortex of the one-cell embryo and the PAR-
3/PAR-6/PKC-3 complex localizes to the anterior cortex (Goldstein and Macara, 2007). 
These PAR-proteins are involved in the establishment and maintenance of polarity in many 
different cell types (Goldstein and Macara, 2007). Furthermore, Xu et al. (2001) showed that 
human ErbB2 associates with Hsp90 and that this interaction is necessary for ErbB2 stability. 
They suggest that Hsp90 is needed for receptor maturation and function. It is therefore 
possible that C. elegans CDC-37, maybe in concert with a heat shock protein, is involved in 
LET-23 maturation and trafficking to the basolateral membrane. Hence, I propose CDC-37 as 
a candidate regulator of LET-23 localization. 
 
5.3.2 The candidate gene F43G9.1 
The gene F43G9.1 encodes the alpha subunit of the isocitrate dehydrogenase (IDH). RNAi 
against F43G9.1 exhibited a reproducible synthetic Multivulva phenotype in a gap-1(ga133) 
background and expression of the 1° cell-fate marker egl-17::cfp in the P5.p and P7.p lineage 
in a wild-type background (G. Poulin, personal communication). These results indicate that 
the alpha subunit of C. elegans IDH represents a novel negative regulator of the inductive 
pathway. Sara Vassalli, a former Ph.D student from our lab, determined that F43G9.1 is 
needed for anchor cell invasion into the vulval tissue at the late L3 stage (S. Vassalli, personal 
communication). This fos-1 mediated migration event initiates the development of the cellular 
structures that connect the adult vulva to the uterus (Sherwood et al. 2005, Rimann and Hajnal 
2007). RNAi against F43G9.1 in animals harbouring the anchor cell marker cdh-3::cfp 
abrogated the anchor cell invasion into the vulval tissue (S. Vassalli, personal 
communication). So far, there is no direct molecular link between the cell-fate specifications 
of the vulval tissue and the AC invasion process. 
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IDH is an enzyme of the citric acid cycle and catalyzes the oxidative carboxylation of 
isocitrate to -ketoglutarate (Parsons et al. 2008). In this reaction, nicotinamide adenine 
dinucleotide phosphate (NADPH) is generated as a byproduct, which is thought to be 
involved in the control of oxidative damage (Lee et al. 2002). Unfortunately, there is no 
mutant available to reproduce the data collected with RNAi. However, it is unclear how a 
metabolic enzyme might be involved both vulval cell fate specification and anchor cell 
migration. It is possible but highly speculative that the gene product of F43G9.1 harbours two 
independent activities, one being the dehydrogenase activity and an additional one with 
unknown function. 
Interestingly, Parsons et al. (2008) reported that the human IDH1 gene was mutated in 12% of 
analyzed glioblastoma multiforme (GBM) samples (n=149). In all cases, the arginine at 
position 132 was mutated, which is localized to the isocitrate binding site (Xu et al. 2004). To 
date it is not clear what consequences result through alterations in the IDH1 gene and the 
associated role in tumour formation or progression. 
 
5.3.3 Screening the remaining three chromosomes IV, V and X 
Because of time restrictions, we screened only the RNAi clones of chromosomes I, II and III 
and found 36 high confidence candidates. Most of these candidates have not been yet 
validated with genetic mutants. Nevertheless, preliminary experiments with the cell fate 
marker egl-17::cfp performed by K.Fisher and G. Poulin (personal communication) highly 
support the rationale of the screen. 
The combination of the rrf-3(pk1426) and gap-1(ga133) was an unfortunate choice, since it is 
very likely the cause of the high frequency of false positives in the RNAi screen. The very 
low penetrant Muv phenotype observed in the double mutant indicate that these two genes 
interact genetically with each other. Therefore, future screens in sensitised backgrounds 
should be performed without rrf-3(pk1426) to avoid the high number of false positives. 
The data collected in the genome-wide RNAi screen performed by Kamath et al. (2003) 
indicated that the different chromosomes harbour unique features. RNAi experiments 
resulting in postembryonic phenotypes were enriched on chromosome II, whereas clones on 
chromosome III resulted in more nonviable phenotypes compared to experiments on other 
chromosomes. Similarly, chromosome V seemed to contain fewer essential genes (Kamath et 
al. 2003). Taking these observations into account, it would make sense to continue the RNAi 
screen in a gap-1(lf) background on chromosomes IV, V and X. In order to reduce the number 
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of false positives, it would be advisable to avoid the RNAi hypersensitive background rrf-
3(pk1426). 
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5.4 Methods 
 
5.4.1 RNAi screen setup 
The experimental procedure was adapted from Kamath and Ahringer (2003). RNAi plates 
consisting of NGM agar including 25 μg/ml carbenicillin and 1mM IPTG were poured and 
dried for 7-10 days at room temperature. RNAi bacterial clones were grown for 6-8 hours at 
37°C in LB-miller medium and subsequently spotted on the RNAi plates. Induction of the 
dsRNA production was performed by incubating the RNAi plates for 24 hours at room 
temperature. rrf-3(pk1426); gap-1(ga133) animals were synchronized with hypochloride 
solution. L1 larvae were allowed to grow on OP50 until the L4 stage at 20°C for 2 days. 
Then, the L4 animals were aliquoted onto the RNAi plates and allowed to grow at 22°C for 4 
days. Every RNAi plate was screened for Multivulva animals on three subsequent days. 
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Row Plate Well Sequence name Public name Function 
1 1 H9 K12C11.4 dapk-1 signalling 
2 3 B5 K03E5.3 cdk-2 cell cycle 
3 4 A10 F55C7.7 unc-73 signalling 
4 4 E12 C43E11.10 cdc-6 DNA replication 
5 5 E4 C10H11.9 let-502 signalling 
6 7 E11 T19B4.6 unc-40 signalling 
7 7 G10 C32F10.5 hmg-3 chromatin 
8 10 D3 C37A2.4 cye-1 cell cycle 
9 10 H1 F15C11.1 sem-4 signalling 
10 11 B1 K10D3.5 (H37N21.1) signalling 
11 14 A7 F43G9.1 - metabolism 
12 15 A9 W06D4.1 hgo-1 metabolism 
13 15 B5 W10D5.3 gei-17 sumo ligase 
14 15 H5 F30A10.10 - ubiquitin processing 
15 25 E4 C37A5.10 - uncharacterized 
16 26 C1 Y54E5A.5 - uncharacterized 
17 32 C6 W08F4.8 cdc-37 chaperone 
18 32 G10 C08G5.6 - uncharacterized 
19 46 C3 H12I13.a fbf-1 translation 
20 46 C12 F21H12.5 fbf-2 translation 
21 47 C7 C56E6.3 - uncharacterized 
22 49 C5 C30G12.7 puf-8 translation 
23 50 B1 B0495.2 - signalling 
24 50 D4 T05A6.1 cki-1 cell cycle 
25 52 E4 T01B7.6 - uncharacterized 
26 58 G4 F07A11.6 din-1 RNA binding 
27 69 F8 R13G10.1 dpy-27 chromatin 
28 70 B2 E03A3.4 his-70 chromatin 
29 72 G11 T10F2.3 ulp-1 ubiquitin protease 
30 74 A2 F54E7.4 par-3 signalling 
31 75 H4 T26A5.7 set-1 chromatin 
32 76 D2 K07E12.1 dig-1 extra cell matrix 
33 81 B4 ZK637.7 lin-9 chromatin 
34 81 F1 F02A9.6 glp-1 signalling 
35 86 E1 C18D11.4 rsp-8 splicing 
36 87 B10 Y49E10.6 his-72 chromatin 
 
Table 5.1: List of genes within the „Muv>4“ high confidence category. 
In the RNAi screen with the Ahringer clones from chromosome I, II and III, 36 experiments showed more than 4 
Muvs per plate. Plate and Well indicate the position of the RNAi clone within the library. 
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6. General discussion 
 
The aim of this study was to isolate and characterize novel proteins involved in C. elegans 
LET-23 EGFR localization. The predominantly basolateral localization of LET-23 in the 
VPCs is crucial for correct induction of vulval development (Kaech et al. 1998). In particular, 
each of the three PDZ proteins LIN-7, LIN-2 and LIN-10 were found to be essential for this 
process. Loss-of-function mutants of lin-7, lin-2 and lin-10 show apically mistargeted LET-23 
in the VPCs and hence result in a highly penetrant Vulvaless phenotype (Kaech et al. 1998, 
Withfield et al. 1999). Similar phenotypes were reported for the let-23(sy1) mutant, which 
encodes a LET-23 variant lacking the distal C-terminus (Aroian et al. 1994, Kaech et al. 
1998). LIN-7, LIN-2 and LIN-10 interact with each other in vitro and the PDZ domain of 
LIN-7 binds the distal C-terminus of LET-23 (Kaech et al. 1998). These findings lead to the 
current model of basolateral LET-23 localization in the VPCs, where the tripartite complex 
consisting of LIN-7, LIN-2 and LIN-10 bind to LET-23 and ensure its correct targeting 
(Kaech et al. 1998). Despite the fact that LIN-7, LIN-2 and LIN-10 bind each other 
simultaneously in vitro (Kaech et al. 1998), each of these proteins display distinct subcellular 
localizations within the VPCs. LIN-7::GFP was found to be associated with the apical 
junctions (Simske et al. 1996). Immunostaing of overexpressed LIN-2 showed basolateral 
localization (A. Hajnal, personal communication). LIN-10 localized to perinuclear structures 
in immunostaining experiments (Withfield et al. 1999). These findings raise new questions 
about the mechanism of LET-23 targeting. So far, no other components were found to be 
involved in the LET-23 targeting mechanism and it is not clear how proper localization is 
achieved. 
Regulatory processes after LET-23 targeting to the basolateral membrane involve the protein 
EPS-8, a positive regulator of vulval induction. Stetak et al. (2006) showed that EPS-8 can 
bind directly to LIN-2. However, eps-8(lf) animals display LET-23 accumulated in 
intracellular punctae and wild-type vulval induction. These findings indicate that LET-23 is 
correctly targeted to the basolateral membrane in eps-8(lf) animals and that EPS-8 is involved 
in retention or recycling mechanisms of LET-23. However, the molecular mechanism of EPS-
8 function is not clear yet. 
In order to investigate LET-23 localization and the underlying molecular mechanisms, we 
sought for novel components using different genetic approaches. 
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6.1 The candidate based approach to find regulators of LET-23 localization 
 
A preceding candidate RNAi screen targeting genes endocing PDZ- or FERM-domains  
performed by A. Stetak in our laboratory identified frm-8 and tag-60 as putative regulators of 
LET-23 localization. In order to substantiate the results obtained by RNAi, deletion mutants 
were generated and stained for LET-23. It has to be noted that immunostaining of LET-23 
resulted in highly variable expression compared with other antibodies used in this study 
(AJM-1 and TAG-60-1). It is likely that the epitope of the LET-23 antibody becomes 
instable after fixation and permeabilization treatments. It was observed that identical worm 
samples were immunostained for LET-23 at the same day but resulted in high quality 
differences. Therefore, immunostaining of LET-23 was not the only criteria to decide whether 
or not to follow a candidate gene. Genetic interaction with the inductive pathway was used to 
test a role in vulval development. 
 
frm-8(zh67) animals showed intracellular accumulation of LET-23 but only weak genetic 
interaction with lin-2(n105). However, egl-17::cfp expression in the 1° cells of frm-8(zh67) 
animals was not significantly different compared to wild-type animals and downregulation of 
other FERM-domain encoding genes in a frm-8(zh67) background did not result in a synthetic 
phenotype. Considering these findings, the project was not continued. It is possible that frm-8 
plays a minor role in vulval development, which might be only visible in combination with 
more complex sensitized backgrounds (e.g. more than two mutations). It is also possible that 
FRM-8 acts redundantly with other proteins that do not harbour a FERM-domain or that 
RNAi of other FERM domain genes was not effective. 
 
The tag-60(zh93) deletion mutant was isolated after screening six different deletion libraries, 
which were performed in a time-frame of about one year. It is unclear why no positive 
deletion mutants were found in earlier screens. Colleagues that screened the same libraries did 
not find their target gene deletions. Therefore, it is possible that the mutagenesis was not 
performed properly. However, the subsequent performed forward genetic screen, which 
involved a similar mutagenesis step (50mM instead of 75mM EMS), produced many different 
mutant strains. A possible explanation why no tag-60 allele was found earlier is that the null 
mutants of tag-60 might be inviable. Genetic experiments involving other tag-60 alleles and a 
deficiency covering the tag-60 locus are underway to assess this possibility. 
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Most of the experiments in this study were performed with the tag-60(zh93) allele. zh93 is an 
in-frame deletion, which does not remove any sequences encoding known domains. It was 
found that in tag-60(zh93) animals mRNAs of the tag-60 locus are produced and that these 
mRNAs were shorter than in wild-type animals, corresponding to the size of the zh93 
deletion. Hence, it is likely that in tag-60(zh93) animals truncated proteins are being 
produced. We determined that the tag-60(zh93) allele is dominant, but the question whether it 
represents a reduction-of-function or a loss-of-function allele remains open. Therefore, it is 
difficult to interprete the results obtained with the tag-60(zh93) allele and to draw a model at 
this time, but the analysis of the recently obtained alleles tag-60(tm3501) and tag-60(ok2292) 
should answer this question. 
In immunostaining experiments of tag-60(zh93) mutants we found that LET-23 is 
accumulated in intracellular compartments. The genetic interactions of tag-60(zh93) with 
components of the inductive pathway neither supports nor contradicts the finding of LET-23 
mislocalization. The suppression of the lin-2(n397) and also the let-23(sy10) and sem-
5(n2019) Vulvaless phenotypes by tag-60(zh93) demonstrates that tag-60(zh93) animals have 
elevated inductive or lateral signalling. On the other hand, tag-60(zh93) animals show 20-
30% reduced egl-17::cfp expression in the 1° cell lineage, indicating a reduction of LET-23 
signalling activity. It is therefore likely that TAG-60 might also have effects on the 2° cells 
and that TAG-60 might be involved in multiple signalling pathways. 
Since we only analyzed the tag-60(zh93) allele, it is possible that all the observed effects are 
allele-specific and might not represent general tag-60 features. It is also possible that a closely 
cis-linked mutation is responsible for the observations presented in this study. As already 
mentioned before, it is indispensable to analyze and compare all available tag-60 alleles. 
Assuming that the results presented here are specific for tag-60, we can conclude that TAG-
60 is a regulator of vulval development, which is involved in LET-23 localization. 
Expression analysis with TAG-60-1 antibodies in immunostaining experiments showed that 
TAG-60 is expressed in the vulval cells at the L4 stage, when the vulval tissue starts to 
invaginate. At this time point, the vulval induction and patterning events are already 
completed. The genetic data supports the notion of TAG-60 being involved in the induction 
process. However, no TAG-60 expression was observed in the VPCs at the time of induction, 
where TAG-60 was detected mainly in the intestine and the pharynx. The putative human 
homologue of TAG-60, EBP-50, has been shown to directly bind EGFR and inhibit ligand 
induced endocytosis (Lazar et al. 2004). So far, we cannot exclude a cell-nonautonomous 
model, where TAG-60 might regulate vulval development by a distant tissue. However, it is 
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also possible that TAG-60 is expressed at low levels in the VPCs at the time of induction, 
which are not detectable by the TAG-60-1 antibody. Additionally, the TAG-60-1 antibody 
might not recognize all TAG-60 isoforms.  
 
Three possible models for TAG-60 function 
Since the molecular nature of tag-60(zh93) has not been determined so far, the interpretation 
of the results and the resulting model of TAG-60 function is highly speculative. The similarity 
between TAG-60 and the human orthologue EBP-50 suggests a similar function of both 
proteins. EBP-50 was shown to bind directly to EGFR in human tissue culture cells and hence 
controls the localization of EGFR (Lazar et al. 2004). Therefore the model where TAG-60 
acts cell-autonomously in the vulval cells to regulate LET-23 is favourable. Assuming that 
zh93 represents a reduction-of-function allele (e.g. haploinsufficient, dominant negative) the 
genetic data would indicate that TAG-60 is a negative regultor of vulval development (figure 
6.1 A). Mislocalization of LET-23 to intracellular punctae in tag-60(zh93) would indicate that 
TAG-60 is either an inhibitor of LET-23 internalization or promoting LET-23 recycling or 
degradation. Similarly, EBP-50 was found to inhibit ligand-induced endocytosis of EGFR 
(Lazar et al. 2004). The data shown in this study do not support or disprove this model. TAG-
60 was not detected in the VPCs at the time of induction, which could be due to low levels of 
TAG-60 expression within the vulval cells undetectable by immunostainig. If present in the 
VPCs, TAG-60 could bind to ERM-1 and form a molecular linker between LET-23 and the 
cortical cytoskeleton. tag-60(zh93) and erm-1(tm677) animals show similar genetic 
interactions with mutants of the LET-23 pathway, supporting the idea of both proteins being 
involved in the same process (figure 6.1 A). Similarly, human EBP-50 was found to 
physically interact with the ERM-like protein Merlin and to link EGFR to detergent insoluble 
compartments (Curto et al. 2007; Cole et al. 2008). However, erm-1(tm677) suppressed the 
Vulvaless phenotypes of lin-7(e1413) and lin-10(e1439), whereas tag-60(zh93) did not. This 
difference could indicate that TAG-60 function, in contrast to ERM-1, is somehow dependent 
on LIN-7 and LIN-10. A possible interpretation would be that TAG-60 acts redundantly with 
another PDZ-domain protein in ERM-1-mediated LET-23 localization and regulation of 
vulval development (figure 6.1 A). 
Assuming that tag-60(zh93) represents a gain-of-function allele (e.g. constitutive active), this 
would indicate that C. elegans TAG-60 has the opposite function to that described for its 
human orthologue EBP-50. In this case, TAG-60 would promote LET-23 internalization or 
inhibit LET-23 recycling and/or degradation. The genetic data would then indicate that TAG-
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60 is a positive regulator of vulval induction, since tag-60(zh93) was able to suppress 
significantly the lin-2(n397) Vulvaless phenotype. On the other hand, tag-60(zh93) did not 
suppress the Vulvaless phenotypes of either lin-7(e1413) or lin-10(e1439), indicating that 
TAG-60 function is dependent on LIN-7 and LIN-10 but not on LIN-2. The proteins LIN-7, 
LIN-2 and LIN-10 were shown to be necessary for initial basolateral targeting of LET-23 in 
the VPCs (Kaech et al. 1998). It was furthermore shown that LIN-2, together with EPS-8, is 
involved in LET-23 retention at the basolateral membrane (Stetak et al. 2006). It is possible 
that LIN-7, LIN-10 and TAG-60 are involved in LET-23 trafficking after the initial LET-23 
targeting event, similar to what was shown for LIN-2 and EPS-8 (Stetak et al. 2006). If tag-
60(zh93) was indeed a gain-of-function allele, the model of TAG-60 regulating vulval 
development together with ERM-1 would be rejected. erm-1(tm677) is a null allele (Göbel et 
al. 2004) and has similar genetic interactions as tag-60(zh93). Therefore, TAG-60 and ERM-1 
would have opposite regulatory effects on vulval development (figure 6.1 B). In this case, 
ERM-1 might be linked to LET-23 by another PDZ-domain protein or might bind directly to 
LET-23 (figure 6.1 B), as was shown for other transmembrane proteins (Bretscher et al. 
2002). ERM-1 would thus link LET-23 to the cortical cytoskeleton independently of TAG-60 
(figure 6.1 B). 
At the time of vulval induction, TAG-60 was detected in the intestine but not in the vulval 
cells using immunostaining. The similarity between TAG-60 and human EBP-50 speaks for a 
cell-autonomous model. However, it is also possible that TAG-60 functions within the 
intestinal cells to regulate vulval development. To our knowledge, there is no known example, 
where a factor from the intestine influences vulval induction. However, it is known that 
surrounding tissues such as the hypodermis (hyp7) are involved in regulating the development 
of the vulva (Cui et al. 2006). LET-23 is also expressed in intestinal cells and localizes to the 
apical membrane compartment (figure 3.16 E, arrowheads). TAG-60 and ERM-1 share the 
subcellular localization of LET-23 within the intestinal cells (figure 6.2). The function of 
LET-23 and TAG-60 in the intestine is unknown. Our data do not exclude a model where 
intestinal LET-23 together with TAG-60 and ERM-1 regulate vulval development cell non-
autonomously (figure 6.2). In erm-1(tm677) animals, intestinal LET-23 is not localized 
exclusively on the apical side (lumenal side) of the intestinal cells as in wild-type animals 
(figure 3.16 E, arrowheads), but LET-23 is rather distributed on the whole plasma membrane 
(figure 3.16 F, arrows). The anchor cell in the somatic gonad secretes the LIN-3 EGF protein, 
which activates LET-23 in the VPCs (Hill and Sternberg, 1992; Aroian and Sternberg, 1991). 
It is possible that LIN-3 in the extracellular space can diffuse and reach tissues other than the 
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vulva. Therefore, a model is possible where ERM-1, maybe in concert with TAG-60, 
localizes LET-23 to the apical membrane of intestinal cells, rendering it inactive to LIN-3 
produced by the anchor cell on the basolateral side (figure 6.2). By removing ERM-1, LET-23 
might be activated by basolateral LIN-3. In the hypodermis, the synMuv pathways function to 
repress LIN-3 production in a cell-autonomous manner (Cui et al. 2006). By removing certain 
combinations of synMuv factors, the hypodermis produces LIN-3, leading to ectopic vulval 
induction (Cui et al. 2006). It is possible that a similar mechanism takes place in the intestine, 
where active LET-23 might induce the production of LIN-3 or another growth factor (figure 
6.2). Excess LIN-3 in erm-1(tm677) mutants would account for the suppression of the 
Vulvaless phenotype observed in mutants such as lin-2(n397). So far, the localization of LET-
23 in the intestine of tag-60(zh93) animals is unknown and hence it is not clear if TAG-60 
would work in concert with ERM-1 or not. 
 
Investigation of ERM-1 was part of this study because it is a putative binding partner of TAG-
60. The fact that the human homologues directly interact (Finnerty et al. 2004) and that the C. 
elegans proteins bind in yeast-2-hybrid experiments (Li et al. 2004) were the basis for this 
project. In this study, we provide further evidence for the existence of a TAG-60/ERM-1 
complex. First, TAG-60 localization in the intestinal cells is dependent on ERM-1 and 
second, ERM-1::CFP could be coimmunoprecipitated with TAG-60 (D. Kradolfer and E. 
Fröhli, unpublished results). 
Experiments with the erm-1(tm677) allele show similar genetic interactions with the EGFR 
pathway as tag-60(zh93). The tm677 allele represents a null allele of erm-1 (Göbel et al. 
2004), which suppresses the Vulvaless phenotypes of lin-2, lin-7 and lin-10 loss-of-function 
alleles and enhances the let-60(n1046) gain of function Multivulva phenotype. Therefore, 
ERM-1 is a novel negative regulator of vulval development. 
This study presents further results, which indicate that the regulation of vulval development 
by ERM-1 occurs at the level of LET-23. Immunostaining experiments showed that LET-23 
in the VPCs of tm677 animals is mislocalized to intracellular compartments. Consistently, 
ERM-1::CFP is localized to the basolateral membrane compartment of the VPCs and could be 
coimmunoprecipitated with LET-23 (D. Kradolfer and E. Fröhli, unpublished results). 
However, it is not clear if ERM-1 is acting upstream of downstream of LET-23. The human 
homologue of ERM-1, Ezrin, was shown to be activated by threonine phosphorylation in the 
C-terminus (Bretscher et al. 2002). On the other hand, EGFR was found to directly 
phosphorylate Ezrin in vivo and in vitro and therby modulate Ezrin activity (Krieg and 
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Hunter, 1992). The tyrosine residues of Ezrin that were phosphorylated by EGFR are not 
conserved in C. elegans ERM-1, and hence it is not clear whether LET-23 kinase activity is 
necessary for ERM-1 function. 
NFM-1 is the putative C. elegans homologue of Nf2/Merlin, which was shown to be involved 
in contact-dependent inhibition of EGFR in tissue culture cells, by linking the receptor to 
insoluble membrane compartments and hence render it inactive and blocking its 
internalization (Curto et al. 2007, Cole et al. 2008). Since Nf2/Merlin is a protein closely 
related to the ERM family (Bretscher et al. 2002), it is possible that LET-23 is an effector of 
ERM-1 at the plasma membrane and inhibits its activity similarly to what was shown for 
Nf2/Merlin and EGFR. Other possible effectors of ERM-1 are components of the RHO-1 
pathway, which positively regulates the inductive pathway in the VPCs (Canevascini et al. 
2005). Speck et al. (2003) showed that D. melanogaster Moesin antagonizes the Rho pathway 
in vivo. Therefore it is possible that this is also the case for C. elegans ERM-1. Since the 
genetic studies presented here do not include any “null” mutation of a core component of the 
inductive pathway, we cannot place erm-1 genetically in this pathway. Therefore, ERM-1 
could act at any level of the inductive pathway. Further genetic experiments have to be 
performed to pinpoint the level, at which ERM-1 functions during vulval development. 
 
One of the questions that arose during this study is, why genes like tag-60 and erm-1 have not 
been identified before in forward genetic screens for regulators of vulval development. We 
present evidence that TAG-60 and ERM-1 regulate vulval development during the induction 
and patterning processes. erm-1 is an essential gene and mutations affecting its activity have 
dramatic effects on the viability of the animals. Therefore, the probability is low to find erm-1 
mutations in a forward genetic screen. This clearly emphazises the importance of candidate 
based and RNAi approaches. Furthermore, erm-1(tm677) animals show pleiotropic defects, 
which complicate the analysis of this mutant. It is important to note that erm-1(tm677) 
animals display severe morphological defects of all tubular epithelia (Göbel et al. 2004), 
which makes it difficult to properly analyze erm-1 function during vulval induction. The tag-
60(zh93) mutants seem to be undistinguishable from wild-type animals.  
Loss-of-function mutants of lin-2, lin-7 or lin-10 show apically mislocalized LET-23 and 
hence display a high penetrant Vulvaless phenotype (Kaech et al. 1998). However, the 
combination of those mutants with a gap-1(lf) allele results in a Multivulva phenotype (Hajnal 
et al. 1997). This genetic interaction formulated the rationale of the forward genetic screen 
presented in this study. The tag-60 and erm-1 mutants analyzed in this study showed 
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intracellular accumulation of LET-23 in the VPCs. The fact that in these mutants vulval 
induction is executed as in wild-type animals, leads to the conclusion that LET-23 is targeted 
correctly to the basolateral membrane and that both TAG-60 and ERM-1 might be involved in 
the retention or recycling of LET-23. Both tag-60(zh93) and erm-1(tm677) do not show a 
synthetic Muv phenotype when combined with gap-1(lf), indicating that not all mutants that 
mislocalize LET-23, genetically interact with gap-1(lf). Consistently, eps-8 was found in a 
candidate-based approach to be a positive regulator of vulval development (Stetak et al. 
2006). eps-8(lf) animals showed intracellular accumulation of LET-23 in the VPCs but did not 
result in a Muv phenotype in combination with gap-1(lf) (Stetak et al. 2006, A. Stetak 
personal communication). Therefore, from a genetical point of view, it would be impossible 
to find regulators of LET-23 localization such as TAG-60, ERM-1 and EPS-8 in a forward 
genetic screen using gap-1(lf) as a sensitized background. 
 
Immunostaining of LET-23 turned out to have variable efficiencies. In order to substantiate 
the findings presented in this study, we wish to reproduce these results with a LET-23::GFP 
fusion protein. Our laboratory recently succeeded to construct a LET-23::GFP variant, which 
is sensitive to loss-of-function mutations of lin-2, where it was mislocalized to the apical 
plasma membrane compartment (J. Escobar, personal communication). Unfortunately, the 
LET-23::GFP did not rescue the induction defects of let-23(sy1) (J. Escobar, personal 
communication). However, this translational LET-23 reporter might facilitate the study of 
TAG-60 and ERM-1 regarding LET-23 localization. In addition, it would be possible to use 
the LET-23 reporter as a tool in future screens for proteins involved in LET-23 localization (J. 
Escobar, personal communication). 
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6.2 The forward genetic approach to find regulators of LET-23 localization 
 
At the beginning of this study, the generation of deletion mutants for frm-8 and tag-60 was 
very time consuming, as especially for the tag-60 allele no deletion was found at first. Since it 
was unclear whether the deletion screens would be successful, we decided to start a parallel 
backup project. A forward genetic screen for Multivulva animals in a gap-1(ga133) sensitized 
background was started to find regulators of LET-23 localization, such as LIN-2, LIN-7 and 
LIN-10. The same rationale was already used before to screen for fertile mutants (A. Hajnal, 
personal communication). In order to identify novel factors, the screen was performed with a 
focus on mutants with more complex phenotypes such as late lethality and sterility. In 
addition to proteins involved in LET-23 localization, we hoped to find novel attenuators of 
vulval development. Six mutant lines were isolated from 2’800 mutagenized genomes. Two 
of them turned out to apically mislocalize LET-23 and were found to represent novel alleles 
of lin-2 and lin-7. The remaining four mutants showed predominantly basolateral LET-23 
localization and hence represented putative negative regulators of vulval development. zh94 
turned out to be an allele of GAP-3, an inhibitor of LET-60/Ras (Stetak et al.2008). The 
discovery and study of gap-3(zh94) was used to substantiate the previous characterization of 
the gap-3(ga139) allele (Stetak et al. 2008). The three remaining mutants turned out to exhibit 
a Multivulva phenotype, which is independent of the gap-1(lf) allele: zh99 is likely to be an 
allele of let-19, a gene encoding a subunit of the mediator complex (Yoda et al. 2005, Clayton 
et al. 2008), and the location of zh95 (candidate gene lin-13; Melendez and Greenwald, 2000) 
and zh78 was not yet determined. For this backup project, 1400 clones were analyzed and 
only three mutant lines were found to be synthetic Muv with gap-1(lf). The fact that we found 
lin-2 and lin-7 once but not lin-10 makes clear that the screen is not saturated yet.  
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6.3 The large-scale RNAi screen in a gap-1(lf) background 
 
In colaboration with the Poulin laboratory in Manchester, we peformed a large-scale RNAi 
screen of chromosomes I, II and III using the Ahringer RNAi feeding library (Kamath et al. 
2003). The idea was to generate a list of candidate genetic intarctors of gap-1, which would 
facilitate the mapping of the mutants isolated during the forward genetic screen. Thirty-six 
candidate genes showed a high-confidence synthetic Muv phenotype in a gap-1(lf) 
background. Unfortunately, this list of candidates was not useful for the mapping process of 
the mutants. It turned out that the RNAi clones for gap-3 and lin-13 (candidate gene affected 
by zh95) are not present in the Ahringer library. Additionally, RNAi against let-19 did not 
have any defects. 
The previously characterized attenuators of vulval development puf-8, fbf-1 and fbf-2 (Walser 
et al. 2006) were found, which validated the rationale of the screen. Additionally, the thirty-
six candidates might include novel genetic interactors of gap-1, which still have to be 
analyzed in detail. Deletion mutants of the candidates have to be used to substantiate the 
RNAi results and to confirm the genetic interactions. The candidate genes could encode 
regulators of LET-23 localization or attenuators of vulval development. The LET-23::GFP 
reporter (J. Escobar, personal communication) could be used to answer this question. 
Assuming that most of the new candidates are true, it would be interesting to continue this 
project and to screen the remaining chromosomes IV, V and X. It appears that the RNAi 
screen can reveal a different set of genetic gap-1 interactors, compared to previously 
performed forward genetic screens. 
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